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ABSTRACT
The ability to manipulate complex genomes in a precise manner is essential for studying
biological processes in model systems, engineering plant strains for agriculture, or advancing
human cellular therapies to treat diseases. Genomic alterations are most efficient when a
double-strand DNA break is introduced at the loci where the modification is desired.
Different classes of naturally occurring DNA endonucleases, including homing
endonucleases, have therefore been explored as candidates for genome modification studies
as they target long stretches of DNA. Homing endonucleases are mobile genetic elements
whose biological role is to introduce site-specific double-strand breaks into naïve genomes,
ultimately resulting in the selfish propagation of their own genes. Consequently, homing
endonucleases are an ideal enzymatic system whose natural properties can be exploited to
manipulate genes.
In the present studies, I examine the cleavage mechanism of GIY-YIG family homing
endonucleases, as until now the method by which they hydrolyze DNA has remained poorly
understood. Using the GIY-YIG homing endonuclease I-BmoI as a model system, I
investigate the amino acid, nucleotide, and divalent metal ion requirements of the GIY-YIG
nuclease domain to generate a double-strand break in DNA. I specifically test models by
which enzymes with a single active site could nick both strands of DNA, and determine that
I-BmoI functions as a monomer throughout the reaction pathway. Furthermore, I demonstrate
that the nuclease domain itself has weak binding affinity, is tethered to DNA by a high
affinity binding domain, and must reposition across each strand through a series of protein
and substrate conformational changes to facilitate DNA hydrolysis.
To explore the relevance of GIY-YIG homing endonucleases as genome editing reagents, I
fused the nuclease domain of I-TevI to three different re-targetable DNA-binding platforms
utilized in the field. The engineered nucleases developed within the present studies are
mechanistically distinct from established technologies, as they function as monomers and
cleave DNA at a preferred sequence motif. I therefore envision that the engineered GIY-YIG
nucleases may circumvent complications associated with established technologies, and
provide an alternative and potentially safer set of genome editing reagents.
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Chapter 1

1

Introduction

Enzymes that hydrolyze nucleic acids, termed nucleases, are ubiquitous and indispensible
for life. Nucleases are critical components in a variety of cellular processes, including
nucleotide metabolism and scavenging, DNA repair and recombination, restriction
defense systems that protect host genomes, and the mobility of genetic elements (1-3). By
lowering the transition state energy required for phosphodiester bond hydrolysis,
nucleases act as catalysts to hydrolyze DNA or RNA polynucleotide chains. The focus of
this thesis is to characterize the mechanism by which one class of nuclease hydrolyzes
DNA to initiate its own genetic propagation between distinct biological alleles.
Additionally, the derived molecular understanding provided the necessary insight to
engineer this nuclease family for targeted genome editing applications.
Using the GIY-YIG homing endonuclease (GIY-HE) I-BmoI as a model system, I sought
to investigate the mechanism by which GIY-HEs generate double-strand breaks (DSBs)
in DNA. To better understand the structure and function of I-BmoI, we developed an
experimental approach in Chapter 2 that combines bioinformatic, genetic, and structural
techniques to identify non-conserved residues within an enzyme that affect catalysis. In
Chapter 3, I present work that investigates the divalent metal ion and base pair
requirements of the I-BmoI nuclease domain to efficiently cleave its cognate target site.
After gaining insight into the biology and function of the nuclease domain, I specifically
test models for cleavage by I-BmoI to elucidate the mechanism of hydrolysis in Chapter
4. Finally, in Chapter 5 I present data that demonstrates the GIY-YIG nuclease domain
can be fused to the three common DNA-binding platforms used in the field of genome
editing to create highly active and targetable chimeric nucleases. By understanding the
cleavage mechanism of GIY-HEs prior to designing the chimeric nucleases, we hope to
avoid engineering complications related to other genome editing technologies due to the
inherent biology of the associated nuclease domain (4).

2

1.1 DNA endonucleases
Nuclease nomenclature differs depending on where hydrolysis along the DNA strand
occurs, what type of nucleic acid is being modified, and whether or not both strands are
hydrolyzed. Endonucleases cleave within polynucleotide chains, exonucleases catalyze
the removal of nucleotides from either the 5’ or 3’ end of nucleic acids, and nickases and
cleavases hydrolyze one or both strands, respectively. Additionally, nucleases can
hydrolyze polynucleotides chains in non-specific, structure-specific, or sequence-specific
manners. Non-specific nucleases, such as the Serratia and Anabaena nucleases, act as
extracellular nucleotide scavengers for their prokaryotic hosts (5,6). The Serratia
nuclease has a single active site and hydrolyzes single- and double-stranded DNA and
RNA unless the nucleic acid substrate contains certain polynucleotide tracts (7-9).
Structure-specific nucleases typically recognize abnormal DNA conformations and are
common within DNA-repair and recombination pathways. AP endonucleases nick
adjacent to sites of mismatched or damaged bases to initiate base-excision repair (10-12),
and T7 endonuclease I recognizes branched DNA to resolve holiday junctions (13-15).
Finally, examples of sequence-specific (or site-specific) nucleases include endonucleases
that are involved in host restriction/modification (RM) defense systems (16-18), or
enzymes that initiate the mobility of selfish genetic elements (19,20).

1.1.1 Restriction defense systems
First discovered in the mid 1950’s (21-23), RM systems have revolutionized molecular
biology as purified recombinant restriction endonucleases (REs) are indispensible for
many scientific disciplines (18,24). REs constitute half of the RM systems employed by
prokaryotes to prevent invasion by foreign DNA (18,25). In addition to REs, RM systems
also encode DNA methyltransferases that utilize S-adenosyl-methionine as a co-factor to
methylate adenine or cytosine residues, protecting host DNA from self-degradation
(26,27). Both endonuclease and methyltransferase components of the RM system bind
the same 3-8 base-pair sequence, with some organisms encoding upwards of 20 RM
systems that target different sites (28). Since the initial characterization of type II REs
(29,30), thousands of distinct REs have been identified that bind and cleave unique sites
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by a vast number of mechanisms, necessitating a unified naming convention with distinct
subtypes (24,31-33). Type II REs act independently of their associated methyltransferases
and can be further divided into over 14 subtypes, including Type IIP and IIS classes to
specify enzymes that recognize palindromic sequences or those that cleave outside of
their primary recognition site, respectively (24,32). The Type IIP subclass constitutes the
majority of REs utilized for biochemistry, while the nuclease domain of the Type IIS RE
FokI has been used extensively for genome editing applications due to the challenges
associated with reengineering of the natural binding specificities of Type IIP REs (see
also Chapter 1.2.5) (34-37). Detailed studies of RM systems from each subclass have
provided insight into the distinct properties and molecular mechanisms by which REs
hydrolyze DNA (Table 1.1) (38). Interestingly, the conserved motifs that constitute RE
active sites have also been identified in other classes of site-specific DNA endonucleases
that act as selfish mobile genetic elements (39-42), with REs themselves also implicated
to play a role in genome evolution (43,44).

1.1.2 Mobile genetic elements
On an evolutionary timescale, the status of most genomes can be considered fluid and
under selective pressure, a result of normal or aberrant cellular processes, spontaneous
mutations, or the presence of mobile genetic elements (MGEs) (45-47). Initially thought
to be mechanistically selfish and phenotypically neutral with respect to host biology
(48,49), certain classes of MGEs can contribute to essential cellular functions including
mating type switching in Saccharomyces cerevisiae or the maintenance of proper
transcript splicing in bacteriophage T4 (50,51). MGEs often encode relatively small
genes that act to initiate ‘self-mobility’ between host and recipient alleles (49,52), yet the
cumulative presence of multiple MGEs is thought to comprise a significant proportion of
many genomes (53-56). During the mobility process, MGEs have been shown to
influence recipient genome dynamics by inducing genomic rearrangements (57-59),
promoting the spread of antibiotic resistance genes (60-62), or fragmenting formerly
intact genes (63-65).
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Table 1.1: Properties of site-specific nucleases
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Homing endonucleases (HEs) are one class of MGE that are often found encoded within
introns, an arrangement that has been suggested as a mechanism to reduce the impact of
the insertion of MGEs on host gene function (66-68). Within these introns, genes of HEs
(or other classes of DNA endonucleases) can be found that initiate the mobility process
(67,69-71) (Figure 1.1). The first step of intron propagation occurs when the intronencoded endonuclease is translated and generates a double-strand break within a naïve
allele, followed by DNA repair processes within the recipient organism that utilize the
MGE-containing donor allele as a template for repair (20,68). Other than HEs, a number
of classes of endonuclease are known to initiate similar non-mendelian gene conversion
events, including transposons, retrotransposons, and REs (44,71-74). Accordingly, the
mechanisms by which various MGEs mobilize their encoding genes have been exploited
for targeted genome editing applications (75-79).

1.1.3 Strategies to hydrolyze DNA
Site-specific endonucleases vary considerably in their oligomeric assembly on DNA,
target site recognition, and method of DNA hydrolysis (Table 1.1) (18,80). Extensive
studies have revealed an assortment of catalytic mechanisms utilized by REs and HEs to
generate DSBs (Table 1.1, Figure 1.2). Many Type IIP REs, such as EcoRI, stably
oligomerize on DNA to provide two active sites to hydrolyze each DNA strand (81).
Alternatively, the Type IIP REs BcnI and MvaI bind DNA as monomers and ‘hop’ across
the phosphate backbone between nicking reactions (82,83). Some Type IIS REs have also
been shown to transiently dimerize or sequentially nick both strands via a conformational
change mechanism (Figure 1.2, see also Chapter 1.2.5) (84,85). Yet another DNA
hydrolysis mechanism has been proposed for the phospholipase D RE BfiI, where a
single composite active site is formed at a dimer interface prior to hydrolysis through a
covalent protein:DNA intermediate (86). A similar catalytic mechanism has been
observed for the single active site Tn10 transposase, where successive phosphoryl
transfer reactions contribute to DNA hydrolysis via an intra-strand DNA hairpin
intermediate (87). The mechanisms by which HEs generate double-strand breaks to
initiate their mobility have also been studied, and are discussed below.
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Figure 1.1: Mobility pathway of selfish intron-encoded endonucleases
The expression of an endonuclease gene embedded within an intron results in the lateral
transfer of the intron sequence from the donor allele to an intronless recipient allele.
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Figure 1.2: Mechanisms of DNA hydrolysis by site-specific endonucleases.
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1.2 Homing and Type IIS restriction endonucleases
Like other MGEs, HEs catalyze the ‘selfish’ propagation of their genes to naïve
chromosomal sites through a process termed homing (Figure 1.1) (3,66). HEs were
discovered when non-mendelian inheritance was observed for an intron in the
mitochondrial large rRNA gene of Saccharomyces cerevisiae (88,89). It was later shown
that the unidirectional gene conversion event was dependent on the intron-encoded open
reading frame that expressed the ω factor, now known as the LAGLIDADG HE I-SceI
(90,91). HEs share mechanistic and structural similarities with REs (Table 1.1), yet they
differ by targeting extended recognition sites (14-36 base pairs) in a sequence tolerant
manner (REs are generally intolerant to substitutions within their relatively short 3-8 base
pair binding sites) (18,80). While Type IIS REs also bind short sequences, they are
mechanistically similar to certain types of HEs by cleaving at a distance from their
primary binding site, unlike canonical REs (Table 1.1) (92,93).
Homing endonuclease genes have been identified in organisms within all kingdoms of
life and constitute six different classes based on conserved structural and catalytic motifs
(the LAGLIDADG, H-N-H, His-Cys, GIY-YIG, PD-(D/E)xK, and EDxHD families)
(Figure 1.3) (94). The H-N-H and His-Cys box families contain highly similar active site
structures (ββα-Me family), while the PD-(D/E)xK and EDxHD classes contain catalytic
motifs analogous to those found within orthodox REs (79,95). The relatively small ISsp6803I (150 amino acids) was the first identified HE gene that contains the PD(D/E)xK motif and is distinct from its RE counterparts as it binds a long 23 base pair
target site in a tetrameric configuration (41,96). HEs are generally small proteins (<50
kDa) that have mostly adopted two distinct strategies to target extended allelic sites:
acquiring multiple DNA-binding elements to bind elongated asymmetric sites in a
sequence tolerant manner, or dimeric assembly of comparatively globular folds to
double-up their binding capacity on pseudo-palindromic sequences (Figure 1.3) (79,80).
The structures and DNA hydrolysis mechanisms utilized by the three major families of
HEs and Type IIS REs are further discussed below.

9

Figure 1.3: Structures of homing and restriction endonucleases
Active site secondary structure elements are shown in orange, magnesium ions in red,
and zinc ions in cyan. For simplicity, only the active site structures of the units directly
involved in DNA hydrolysis for I-Ssp6803I are highlighted. HE, homing endonuclease;
RE, restriction endonuclease; I-HmuI PDB:1U3E; I-TevI PDB:1MK0 & 1I3J; I-PpoI
PDB:1A73; I-OnuI PDB:3QQY; I-Ssp6803I PDB:2OST; FokI PDB:1FOK.
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1.2.1 GIY-YIG homing endonucleases
Characterization of GIY-YIG HEs began when it was demonstrated that the mobility of
the intron associated with the thymidylate synthase (td) gene of bacteriophage T4 was
dependent on an encoded endonuclease (97). It was later discovered that the
endonuclease, named I-TevI, comprised a two-domain structure with an N-terminal
domain that contains a GIY-YIG nuclease motif and a C-terminal DNA-binding domain
(Figure 1.4A) (3,98). The structural modularity of the endonuclease is also reflected in its
target site, as cleavage and DNA-binding regions are present within I-TevI’s cognate
substrate (99). Furthermore, mutagenesis and interference assays of the intronless td
substrate revealed that I-TevI’s minor groove interactions with substrate are highly
tolerant to nucleotide substitutions (100,101). Results from randomized cleavage motif
selections and hydrolysis site mapping experiments revealed that I-TevI nicks the
bottom- and top-strands of substrate within a CnnnG motif 25 and 23 base pairs upstream
of the intron insertion site, respectively (Figure 1.4A) (101,102). Moreover, biochemical
assays demonstrated that I-TevI binds DNA as a monomer and induced significant bends
in its substrate near the cleavage site (103).
Independent NMR and X-ray crystallography studies of the nuclease and DNA-binding
domains of I-TevI provided high-resolution images of the enzyme’s modular structure
(Figure 1.4C) (104-107). The catalytic domain structure revealed a tightly packed ~90
amino acid core with a ββααβα fold, where the GIY and YIG motifs are encoded by the
first two β-strands within a single active site (104,106,108). Additionally, the C-terminal
domain/substrate co-crystal confirmed the sequence-tolerant minor groove interactions by
I-TevI, and also identified NUMOD3 α-helix (nuclease associated modular) and helixturn-helix DNA-binding elements similar to those identified in ββα-Me HEs (Figure
1.4A, see also Chapter 1.2.4) (105,109-111). Rather unexpectedly, the C-terminal
structure of I-TevI revealed a non-canonical zinc-finger module that does not specifically
contact DNA (105). It has been speculated that the I-TevI zinc-finger, along with the
mostly-unstructured inter-domain linker, acts as a flexible distance determinant to
position the GIY-YIG domain on substrate for cleavage (104,107,112,113).
Unfortunately, the extraordinarily high specific activity of I-TevI leads to cytotoxicity

11

Figure 1.4: GIY-YIG homing endonucleases I-TevI and I-BmoI
Schematic representations highlighting the protein and substrate modularity of (A) I-TevI
and (B) I-BmoI. Both enzymes bind asymmetric sequences that span the intron-insertion
site (IS) of their respective intronless thymidylate synthase alleles. Intron insertion
renders the intron-containing alleles resistant to cleavage by altering critical base pairs at
the cleavage site (shown in bold uppercase font). Bottom- and top-strand nicking sites are
shown by filled and open triangles, respectively. (C) Composite structural representation
of I-TevI displaying the independent N-terminal GIY-YIG domain and C-terminal DNAbinding domain crystal structures.
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when expressed in bacteria, precluding purification of the wild-type enzyme (114).
Detailed biochemical studies to investigate the cleavage mechanism of I-TevI were
therefore prohibited, though a conformational change model of cleavage was proposed
where the monomeric nuclease domain sequentially nicks both DNA strands (Figure 1.2)
(103).
Fortuitously, an additional GIY-HE similar to I-TevI, named I-BmoI, is encoded within
an intron that interrupts the thymidylate synthase gene (thyA) of Bacillus mojavensis
(115). The thyA sequence that I-BmoI hydrolyzes is homologous to the td allele targeted
by I-TevI, with I-BmoI preferring only a guanine nucleotide at its cleavage site in an
analogous position to the G of the CnnnG motif observed for I-TevI (Figure 1.4B)
(102,116). This preference renders the post-homing intron-containing allele immune to
cleavage, as intron insertion disrupts the cognate I-BmoI cleavage site without affecting
binding along the asymmetric recognition site (115). I-BmoI is also a modular enzyme
where a flexible linker connects the N-terminal GIY-YIG domain to a DNA-binding
domain that contains three predicted NUMOD3 α-helices and a helix-turn-helix domain
(Figure 1.4B) (115,116). To generate a DSB, I-BmoI nicks the bottom-strand prior to the
top strand (non-coding before coding) with multiple distinct DNA-distortions observed
surrounding the cleavage site (117). As such, I-BmoI appears to operate via a comparable
catalytic mechanism to I-TevI, where substantial protein and substrate conformational
rearrangements facilitate cleavage by the GIY-YIG domain. Unlike I-TevI, however, IBmoI is easily overexpressed and purified from bacteria due to a ~750-fold reduced
specific activity (116), allowing us to perform detailed biochemical examinations of
protein:DNA interactions and specifically test DNA-hydrolysis models (Chapters 2-4).
Additionally, because a major consideration of this thesis is the mechanism by which
GIY-HEs hydrolyze DNA, the distribution, modularity, and mechanisms of other
enzymes that contain the GIY-YIG motif are described below.

1.2.2 Properties of other GIY-YIG family endonucleases
First discovered within intron-encoded ORFs in bacteriophage and filamentous fungi
(118), the GIY-YIG motif is distributed amongst nucleases with diverse structures and
functions (104,119,120). Variations of the GIY-YIG consensus are found in HEs and REs
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(GIY-REs) (40,97,115,121-126), non-LTR retrotransposons (127-129), non-specific
nucleases (130), structure-specific nucleases involved in DNA-repair and recombination
(131-136), and the recently described human and C. elegans LEM associated nucleases
(137,138). Independent crystallographic studies revealed that the GIY-YIG domain is
composed of a structurally conserved and tightly packed core that contains three βstrands surrounded by at least two α-helices (Figure 1.5A) (106,139-143). The central
GIY-YIG domain has a single active site and has acquired distinct context specific
adaptations either within or surrounding the conserved fold to expand its functional
diversity.
Prior to studies that solved two separate GIY-RE:substrate co-crystals (142,143),
functional roles of conserved tyrosine, histidine, arginine, and asparagine residues
remained speculative, other than a metal binding role established for a conserved
glutamate residue (E75 in α-helix 3 of I-TevI, residue numbering hereafter for I-TevI).
The crystal structures subsequently suggested a concerted single-step cleavage reaction
that utilizes a single magnesium ion for hydrolysis (143). The tyrosine residues of the
GIY and YIG motifs (Y6 and Y17), found within β-strands 1 and 2, respectively,
potentially act interchangeably as the primary general base to activate a water molecule
(though Y6 is most likely). Additionally, the imidazole ring of H31 in α-helix 2 is within
hydrogen bonding distance of both Y6 and Y17 and may assist in proton abstraction to
initiate hydrolysis. The active site divalent metal ion, coordinated primarily by E75 in αhelix 3 and to some extent by N90, is thought to simultaneously stabilize the reaction
intermediate and 3’ leaving group. Interestingly, the role of R27 in α-helix 1 remains
somewhat ambiguous, as it is found in different rotameric conformations between the
dimer subunits in the structure of the GIY-RE Eco29kI structure (142). Roles have been
proposed for the conserved arginine to contact the phosphate backbone, interact with the
neighboring ribose, or to directly participate in catalysis (142,143). Furthermore, it is
highly likely that additional contextually distinct functional residues within separate GIYYIG architectures are unidentifiably by conservation alone, and I present data in Chapter
2 that identifies non-conserved yet functionally relevant residues of the I-BmoI catalytic
domain (120).
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Figure 1.5: GIY-YIG domain structures
(A) Structures of six GIY-YIG nuclease domains. Secondary structure elements that
contain the active site residues are shown in orange, and catalytic residues are shown in
red for I-TevI. For the remaining five structures, only residues homologous to Y17 and
R27 are shown. (B) DNA-bound structures of dimeric GIY-YIG REs Hpy188I and
Eco29kI, with dimer half-units shown in cyan and green, and active site structures shown
in orange. Views along the DNA axis or perpendicular to the plane of DNA are shown
(left and right panels, respectively). Slx1 PDB:1ZG2; I-TevI PDB:1MK0; UvrC
PDB:1YCZ; Hpy188I PDB:3OQG; T4 endo II PDB:2WSH; Eco29kI PDB:3NIC.
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The conserved amino acids of GIY-YIG endonucleases are found within a structurally
similar active site (Figure 1.5A), yet individual family members employ distinct
architectures and function by a number of mechanisms (reviewed in reference 142). For
example, GIY-REs have acquired supplementary protein folds that supply base-specific
and backbone contacts necessary to bind 5 or 6 base pair target sites in a specific manner
(142,143). The additional folds also assist in oligomerization as a mechanism for DSB
formation, where Eco29kI and Hpy188I assemble as dimers (Figure 1.5B) and Cfr42I
forms a tetramer upon DNA binding (126,143,144). Similarly, bacteriophage T4
endonuclease II, which degrades host DNA during infection, forms a tetrameric structure
that nicks both strands of a single substrate or synapses between multiple targets to nick
one strand of each substrate (145). Alternatively, the bacterial nucleotide excision repair
proteins UvrC and Cho employ single GIY-YIG domains as nickases to hydrolyze one
DNA strand 3’ to DNA lesions of different sizes (132,133). These endonuclease also
typically encode a secondary nuclease module to nick upstream of the damaged DNA
base to fully excise the lesion (119). While it has been speculated that GIY-HEs
hydrolyze DNA via a sequential nicking and conformational change mechanism
(103,117,146), cleavage by I-TevI or I-BmoI has remained poorly understood. Both
characterized GIY-HEs lack the supplementary catalytic domain folds necessary for
dimerization and no additional putative nuclease motifs or active sites have been
predicted. Therefore, I specifically test models for DNA hydrolysis by single active site
enzymes in Chapters 4 and 5 (for I-BmoI and engineered I-TevI nucleases, respectively)
towards understanding the GIY-HE cleavage mechanism.

1.2.3 LAGLIDADG homing endonucleases
LAGLIDADG homing endonucleases (LHEs) have a broad phylogenetic distribution and
target sequences of moderate length from 16 to 26 base pairs (80,147). As described
above for I-SceI, the discovery of LHEs provided a foundation from which we began to
understand the mobility of selfish MGEs (52). With over 10 solved crystal structures to
date, LHEs are well-characterized structurally and hydrolyze DNA within two active sites
located at the base of the pseudo-dimeric enzyme interface (Figure 1.3) (80,148,149).
Also termed dodecapeptide-nucleases, LHEs encode α-helices within each subunit that
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contain the moderately conserved 10-residue motif and form the major interactions at the
subunit interface. LHEs with a single copy of the motif function as homodimers and
target near-palindromic sites (150,151), while single peptide chain LHEs with two copies
of the motif and are monomers that can target asymmetric sequences (152,153). LHEs
utilize four extended antiparallel β-sheets to bind DNA through the major groove where
interactions from each half-unit span the cleavage site and induce a directed bend in the
substrate (Figure 1.3) (150-154). Each half-unit of either the homodimeric or single chain
enzymes hydrolyzes one strand of DNA, while for some LHEs it is suspected that a
shared divalent metal ion across both active sites can contribute to DNA hydrolysis (80).
As such, the DNA-binding mechanism and unique subunit interface has made LHEs
intriguing candidates for genome editing applications (148,149,154,155). These prospects
will be further discussed in Chapter 1.4.3, and we investigate the utility of a catalytically
inactive LHE as a DNA-binding platform for engineered nucleases in Chapter 5.

1.2.4 ββα-Me homing endonucleases
His-Cys box and H-N-H family enzymes form structurally similar ββα-Me active site
architectures and are found within a selection of endonucleases that perform various
biological functions (80,156). Aside from HEs (109,157), the ββα-Me fold is found
within REs (39,42,158), non-specific bacterial colicins and fungal nucleases (including
the Serratia nuclease) (159-162), structure-specific holiday junction resolvases (163), and
other DNA processing enzymes (164,165). The His-Cys motif is characterized by
histidine and cysteine residues and is found within many HE genes (166-169). I-PpoI, the
most well characterized His-Cys HE family member, dimerizes to bind and cleave a
relatively short pseudo-palindromic 14 base pair recognition sequence (Figure 1.3)
(111,170,171). Crystallographic studies revealed a tertiary structure rich in metal ions
where multiple zinc ions are coordinated by histidine and cysteine residues to stabilize
the protein core, and magnesium ions are coordinated within the ββα-Me active site to
assist in hydrolysis by interacting with the scissile phosphate (157,172). A significant
bend in DNA across the base pairs between the two active sites is observed, facilitated by
NUMOD4 DNA-binding elements within each monomer (110,111). Interestingly, each
subunit positions a hydrophobic leucine side-chain within the minor groove to widen the
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distance between the phosphate backbones prior to hydrolysis, a mechanism that has been
suggested to increase accessibility to the cleavage site prior to hydrolysis (173).
While they share a ββα-Me fold, the H-N-H HEs are structurally dissimilar to I-PpoI as
they target longer recognition sequences (24-40 base pairs) and do not bind DNA as
symmetric dimers (52,79). The crystal structure of the H-N-H HE I-HmuI substratebound complex revealed an extended monomeric configuration with N- and C-terminal
DNA-binding domains flanking either side of the H-N-H active site (Figure 1.3) (109).
Within the context of H-N-H HEs the catalytic motif inherently functions as a nickase, as
I-HmuI and I-BasI bind DNA as monomers to nick only a single strand (174-176), and ITevIII forms an asymmetric dimer to induce a DSB by nicking both strands (177). It is
possible that I-HmuI and related H-N-H HEs nick only a single strand of DNA as a result
of their monomeric assembly on DNA combined with rotational restriction of the active
site by surrounding DNA-binding elements. The I-HmuI N-terminal DNA binding
domain displays high similarity to the NUMOD4 domains observed within I-PpoI, while
the C-terminal domain contains NUMOD3 α-helices and a helix-turn-helix domain
(similar to those observed for I-TevI), sandwiching the active site between elements with
substantial affinity for DNA (109,110,175). Furthermore, the DNA-binding modules of IHmuI span the phosphate backbone twice to induce a 40° bend near the cleavage site, and
like I-PpoI widen the minor groove (80,109).

1.2.5 Type IIS restriction endonucleases
Type IIS REs were the first identified Type II subclass due to their capacity to nick at
least one strand of DNA at a precise distance anywhere from 0 to 21 base pairs from the
primary 4-7 base pair binding site (32,92,93). Like GIY-HEs, many Type IIS REs are
two-domain proteins connected by a flexible linker (178-180), with FokI being the most
highly characterized of any Type IIS RE. A number of catalytic mechanisms have been
described for the four subclasses of Type IIS REs, and FokI binds DNA as a globular
monomeric protein to initiate hydrolysis (180,181). Upon DNA binding, the single active
site nuclease domain of FokI is released from the globular structure allowing extension to
the cleavage site where hydrolysis occurs non-specifically (84,182). Hydrolysis is most
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efficient when dimerization with another substrate bound FokI molecule at a proximal
secondary site occurs, another hallmark of many Type IIS REs (84,180,183). FokI nicks
both DNA strands at 9/13 base pairs away from its primary binding site to generate a
DSB, yet the composition of nucleotides surrounding the cleavage site does not affect
hydrolysis (184,185). Thus, most Type IIS REs are said to non-specifically cleave DNA
while retaining a distance preference for the location of hydrolysis (92,93). The
modularity and non-specific nuclease activity of the FokI nuclease domain has garnered
significant interest in the field of genome editing and has led to its adaptation within
multiple engineered platforms (35,186). The architectures of FokI chimeric nucleases are
discussed in Chapters 1.4.1 and 1.4.2, while the genome editing successes, limitations,
and prospects are discussed in Chapters 1.5 and 6.

1.3 Genome editing
The ability to stably modify genomes has led to the elucidation of the functions of many
genes in model systems and initiated the field of nuclease mediated gene therapy. In the
late 1970’s, the first site-directed homologous gene targeting method demonstrated that
synthetic genes could be stably integrated into Saccharomyces cerevsiae (187). The
seminal study revealed that yeast could heritably acquire a metabolic gene from an
exogenous source through homologous recombination (HR), when a stable leu2- strain
was converted to a LEU2+ strain upon transformation with a bacterial plasmid encoding
the corresponding leucine biosynthesis gene. This technique was subsequently adopted
for many gene knock-in or knock-out studies in yeast (188-191), yet similar efficient
gene conversion was not observed in mice or human cells (192-195). The finding that on
average less than 0.01% of human cells were genetically modified was the due to the
inherent biology of mammalian cells, where nonhomologous end joining (NHEJ) is the
predominant DNA repair pathway at most cell stages versus HR in yeast, precluding the
methodology from relevant human cell therapies (194,196,197).
A shift in the paradigm of genome editing in mammalian cells occurred when traditional
homologous gene replacement methods were coupled with a site-directed DSB (198,199).
When a vector expressing the LHE I-SceI was cotransfected with a donor template for
DNA repair via HR, greater than 100-fold increases in gene conversion events were
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observed versus transfection of the HR template alone (200-202). By generating a
sequence-specific break to initiate DNA repair in the presence of a donor template, the
natural DSB-repair preference in mammalian cells was shifted from NHEJ to HR. The
realization that genomes could be modified at defined locations was encouraging, as early
efforts with high efficiency recombination based approaches using transposons or viral
integrases remained relatively non-specific (203,204). Consequently, much effort has
been devoted to developing site-specific endonuclease architectures for targeted genome
modification, a subset of which are further discussed below.

1.4 Genome editing with engineered nucleases
At the beginning of this century, multiple clinical trials were initiated to treat two forms
of severe combined immunodeficiency (X-SCID and ASA-SCID) using retroviral
integrases (205-207). SCID is a genetic disorder of the adaptive immune system where
the development of both T- and B-lymphocytes is impaired, making it an ideal disease
model for therapy as corrected cells will selectively proliferate over a patient’s intrinsic
population of deficient cells (208,209). Retroviral treatments were conducted on
extracted hematopoietic stem cells to restore a functional immune system to recipients by
stably integrating wild-type copies of their deficient genes (205,206,210). At early stages
in their treatment regimens, patients appeared to recover from their SCID symptoms,
however it was later discovered that in many cases their therapies had promoted the
development of leukemia as a result of non-directed transgene integration adjacent to
proto-oncogenes (209,211,212). Though these and other clinical trials prolonged the life
of most patients, they reinforced the necessity for the development of highly targeted
therapeutic technologies that could function in a site-specific manner.
Around the same time, high frequency gene replacement in mammalian cells using sitespecific nucleases renewed optimism within the field of gene therapy (78,213-215). By
mimicking the natural propagation mechanisms of ‘selfish’ genetic elements, engineered
endonucleases were employed to disrupt or delete genes, correct deleterious singlenucleotide polymorphisms (SNPs), or introduce exogenous corrective genetic cassettes
(Figure 1.6) (216-218). Upon further refinement of engineered nuclease technologies, it
has become possible to modulate the desired gene correction mechanism following a

20

Figure 1.6: Genome editing outcomes from targeted DNA breaks
Site-specific endonucleases initiate DNA repair pathways at endogenous alleles leading
to gene conversion events that differ depending on whether or not an exogenous donor
template is provided.
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DSB (NHEJ vs. HR, elaborated in Chapter 6) (219,220). Though some limitations
associated with current platforms have led to the exploration of alternative nuclease
technologies (221-223), the majority of engineered site-specific endonucleases utilize one
of two architectures: customizable DNA-binding modules fused to the non-specific FokI
nuclease domain, or LHEs whose binding specificities have been reengineered to target
non-native sequences.

1.4.1 Zinc-finger nucleases
As described in Chapter 1.2.5, the Type IIS RE FokI is a bi-partite enzyme that
transiently dimerizes through its catalytic domain to hydrolyze DNA. Accordingly, the
modularity and catalytic mechanism of FokI has been exploited to generate chimeric REs
by fusing the non-specific nuclease domain to targetable zinc-finger DNA-binding
proteins, creating zinc-finger nucleases (ZFNs, Figure 1.7A, B) (34,35,224). The
oligomeric nature of FokI requires a “head-to-head” design of ZFNs and necessitated
optimization of the dimer interface and for efficient cleavage (Figure 1.7B) (225-227). To
expand the genomic space targetable by ZFNs, the re-programmability of zinc-finger
proteins as DNA-binding modules has been extensively explored (228-231). Each zincfinger unit contributes 3-4 base pairs of DNA-binding specificity, where engineered
arrays of six zinc-fingers can theoretically bind an 18 base pair sequence (Figure 1.7B)
(232). The combined optimization efforts have led to ZFN architecture refinements and
the development of high-throughput assembly methods to construct active dimeric ZFN
pairs (217,233-235). ZFNs have been notably successful tools for gene editing studies in
model organisms and human cell lines (214,236-239), yet the limited targeting range,
frequently ambiguous nucleotide recognition, and imperfect assembly of zinc-finger
arrays has reduced the widespread technological potential of ZFNs (240,241).

1.4.2 Transcription activator-like effector nucleases
An alternative highly customizable DNA-binding platform has begun to supplant zincfinger arrays as the preferred targeting module in FokI chimeric nucleases (218,242).
While characterizing the virulence of Xanthomonas strains as plant pathogens, it was
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Figure 1.7: FokI nuclease derived ZFNs and TALENs
(A) Structural representations of a zinc-finger array. Separate zinc-finger units that each
target 3-4 base pairs are coloured in orange, green, and yellow, with zinc ions coloured in
cyan. (B) Schematic of two 3-member ZFNs in a head-to-head orientation, each of which
interacts with a 9 base pair target. (C) Structural representations of a 25-repeat TAL
array, with repeats that each contact a single base pair coloured separately. (D) Schematic
of two 12-repeat TALENs in a head-to-head orientation, each of which interacts with 12
base pairs.
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discovered that transcription activator-like (TAL) effector proteins recognize DNA
through a highly repetitive structure (Figure 1.7C) (243). Uniquely, 2 amino acids within
a repeated and otherwise almost absolutely conserved 33-35 amino acid structure dictate
a single-base pair contact (termed the repeat-variable diresidue, or RVD) (244,245).
Recent crystallographic studies confirmed the predicted 1:1 cipher that governs DNA
recognition, where an array of sequential RVDs within the repeated TAL backbone can
be assembled to bind defined sequences (Figure 1.7D) (246,247). It wasn’t long before
studies emerged demonstrating that TALENs (TAL effector nucleases, where the FokI
nuclease domain is fused to the TAL domain) efficiently target desired loci in yeast,
plants, zebrafish, and mammalian systems (248-254). The early success of this
architecture led to a much more rapid refinement of TALEN development and assembly
compared to ZFNs, due in part to the pre-established knowledge of FokI biology. Within
three years, numerous high-throughput assembly methodologies have been developed
with considerable promise for widespread application of TALENs (249,255-258).
Similarly to ZFNs, however, TALENs are subject to the limitations of the inherent
biology and mechanism of the FokI nuclease domain and must therefore be constructed
in a head-to-head design (4).

1.4.3 Engineered LAGLIDADG nucleases
As the initiators of modern genome engineering, LHEs have continued to drive
innovation within the field. Their relatively small size and robust structural
characterization have made them ideal candidates for application-oriented genome
editing studies (149). Additionally, their natural pseudo-symmetric modularity,
modifiable DNA-binding specificity, and growing number of identified family members
have begun to translate to an almost unlimited targetable sequence space by engineered
LHEs (148,149,154,259,260). Unlike the head-to-head design of FokI derived ZFNs and
TALENs, engineered LHEs are single module enzymes that cleave within their respective
binding sites. Initial studies to engineer the binding specificity of LHEs involved the
generation of I-CreI/I-DmoI chimeras that target novel hybrid DNA sequences. The
engineered ‘E-DreI’ chimeric LHE contained one I-CreI homodimeric subunit that
functionally replaced one half of the single chain LHE I-DmoI (Figure 1.8A) (261,262).
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Figure 1.8: Methods to engineer LAGLIDADG endonuclease specificity
(A) Chimeras are created from left and right units derived from distinct parent enzymes
and cleave a corresponding hybrid target site. (B) Directed evolution of amino acids that
specify DNA interactions. Altered amino acid side chains are space filled in blue, while
mutated base pairs are shown in red. Active site LAGLIDADG motifs are coloured in
orange.
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More recently, a study generated 30 different chimeric LHEs from the I-OnuI subfamily,
14 of which displayed appreciable in vitro activity (155). Yet, the most powerful and
successful directed evolution approaches have involved the semi-rational high-throughput
re-engineering of the LHE DNA-binding interface (Figure 1.8B) (259,263-265). Using
this method, LHEs have been re-targeted to engineer maize genes (266), generate
populations of malaria resistant mosquitoes (267), and target numerous human alleles
(154,268-270). Despite the successes associated with engineered LHEs, each directed
evolution method must be coupled with concurrent (and sometimes challenging) reoptimization of catalytic activity and protein stability, as LHEs are highly dynamic single
module enzymes for which most intra-molecular interactions are not well understood
(271-273).

1.5 Scope of the thesis: can the cleavage mechanism of
the GIY-YIG domain detoxify engineered nucleases?
This thesis continues the story of GIY-HE characterization that began over 24 years ago
when I-TevI was discovered (97). To date, studies with I-TevI have provided biochemical
and structural insight into the roles of the nuclease, linker, and DNA-binding domains of
GIY-HEs, yet were unable to specifically test models for DSB formation. Thus, the DNA
hydrolysis mechanism utilized by GIY-HEs to mobilize their own genes has remained
unknown. Using the related endonuclease I-BmoI, I have revisited this story to
investigate catalytic domain interactions with substrate and specifically test DSB
mechanisms. By understanding the biology of GIY-HE’s, I have been able to exploit the
inherent properties of GIY-YIG nuclease domains to create chimeric enzymes fused to
the three targetable DNA-binding platforms used in the field of genome editing.
As described within this thesis, I propose a monomeric cleavage mechanism for GIYHEs that involves the repositioning of the single active site nuclease domain to perform
sequential nicking reactions. The conformational change mechanism proceeds through
multiple distinct DNA distortions, the first of which is dependent on an identified
protein:DNA interaction that acts as a molecular tether to anchor the nuclease domain on
substrate. Given that I-BmoI requires a GC base pair at its cleavage site for efficient
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hydrolysis (Figure 1.4B), this added preference would imply that a di-nucleotide
targeting rule exists for I-BmoI. Accordingly, an analogous protein:DNA tether for ITevI would lead to an expanded targeting preference from a CnnnG di-nucleotide to a trinucleotide. This inference is plausible, as the functional similarity of the GIY-HE linkers
has previously been demonstrated when chimeric TevBmo and BmoTev nucleases were
shown to cleave corresponding hybrid target sites (113). This study also emphasized that
the I-TevI and I-BmoI nuclease domains retained function in the context of a non-native
DNA-binding platform, a significant result when considering either domain for genome
editing applications.
I envision the monomeric and site-specific cleavage mechanism of GIY-HEs as an
advantageous property to ‘detoxify’ and improve existing genome editing reagents.
Studies have revealed that the inherent non-specific nuclease activity and dimeric
requirement of FokI-derived ZFNs and TALENs has led to high off-target cleavage rates
by established ZFNs that are in clinical trials (274,275). While TALENs have performed
slightly better than ZFNs in terms of genome modification activity at similar loci (276),
the specificity of either platform has not been thoroughly examined and they remain
susceptible to the same non-specific and toxic mechanisms inherent to the FokI nuclease
domain (4). Conversely, the directed evolution of LHE DNA-binding specificity has not
proceeded as readily as had been hoped. While the confinement of DNA-binding and
cleavage properties within a single small architecture has advantages, subtle changes to
the engineered LHE structure can have unforeseen consequences and often necessitates
laborious re-optimization of catalytic activity. Consequently, the difficulties associated
with these technologies have led to the exploration of alternative nuclease platforms that
include chimeras of Type IIP REs to zinc-fingers and inactive LAGLIDADG HEs
(221,277), and synthetic ‘guide’ RNAs that stimulate DNA hydrolysis by the
CRISPR/Cas system (223,278,279). Unfortunately, the efficacy and specificity of either
platform have not been robustly tested.
The work presented within this thesis has directed the development of the first set of
monomeric reprogrammable nucleases. By understanding the fundamental biology and
cleavage mechanism of GIY-HE’s, I have been able to rationally design and test GIY-
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YIG engineered nucleases fused to the zinc-finger, LHE, and TAL DNA-binding
platforms (GIY-ENs). It is possible that the inherent properties of GIY-ENs may
circumvent the drawbacks associated with other technologies, as the requirements to
cleave at a preferred motif and function as a monomer may abolish the promiscuous
activity observed with FokI-derived nucleases. These potentially advantageous properties
are elaborated in Chapter 6, along with future considerations and prospects for GIY-ENs.
Overall, it has been important is to understand the inherent cleavage mechanism,
nucleotide preference, and modularity of the GIY-HE family prior to generating chimeric
and targetable enzymes.
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Chapter 2

2

A unified genetic, computational and experimental
framework identifies functionally relevant residues of
the homing endonuclease I-BmoI

The work presented in this chapter is reproduced (with permission, Appendix S1) from:
Kleinstiver, B.P., Fernandes, A.D., Gloor, G.B., Edgell, D.R. (2010) A unified genetic,
computational and experimental framework identifies functionally relevant residues
of the homing endonuclease I-BmoI. Nucleic Acids Research 38: 2411-2427

2.1 Introduction
The explosion of sequence and structural data has rapidly accelerated the pace of protein
structure and function studies. Bioinformatic approaches that predict function based on
amino acid conservation (1,2), homology modelling studies (3), and identification of coevolving residues (4,5) are among methods commonly used to address structure and
function questions. There are, however, many protein families for which mechanistic
insight is lacking. The GIY-YIG homing endonuclease family is one such example.
Homing endonucleases are site-specific yet sequence-tolerant DNA endonucleases that
are distinguishable from other DNA endonucleases in their ability to bind long target
sequences and tolerate multiple substitutions within their binding site (6). They function
primarily as mobile genetic elements, initiating the movement of their coding sequence
and surrounding DNA by binding and cleaving a target site (the homing site) in genomes
that lack the endonuclease (7). Homing endonucleases are phylogenetically widespread,
and have traditionally been categorized into one of four large families based on
conserved amino acid motifs, the LAGLIDADG, HNH, His-Cys box, and GIY-YIG
families (6). The PE-(DE)-XK and Vsr-like enzymes are only recently described and
have fewer family members (8,9). Much effort has been devoted towards re-engineering
naturally occurring LAGLIDADG endonucleases to cleave novel target sequences with
clinical relevance in the human genome (10-13). Similar studies could in principle be
performed on any endonuclease family, necessitating a detailed understanding of
mechanism.
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Within the four largest endonuclease families, the GIY-YIG endonucleases are the least
understood in terms of mechanism. The prototypical GIY-YIG family endonuclease is ITevI, encoded with the genome of Escherichia coli phage T4 (14). Studies on I-TevI
revealed that the enzyme has a two-domain structure, composed of a N-terminal catalytic
domain containing the class-defining GIY-YIG motif that is connected to a C-terminal
DNA-binding domain by a flexible linker (15). Substantial experimental evidence
suggests that the DNA-binding domain tethers the catalytic domain on its substrate to
perform two sequential nicking reactions that generate a staggered 2-nt 3’ overhang (16).
The catalytic domain has no measurable DNA-binding activity when expressed
independently, and a critical function of the linker region in I-TevI, and its isoschizomer
I-BmoI, is to correctly position the domain on substrate (17-19). Early bioinformatic
studies revealed that the GIY-YIG domain is not exclusive to homing endonucleases
(20), illustrated by the presence of the domain in the UvrC nucleotide excision repair
protein (21), restriction enzymes (22,23), and retrotransposable elements (24). Structural,
biochemical and bioinformatic studies have shown that the GIY-YIG domain is ~90
amino acids with an α/β-fold composed of a central three-stranded antiparallel β-sheet
flanked by three helices (21,25) (Figure 2.1). Four highly conserved residues in the GIYYIG domain, Y17, R27, E74, and N87 (numbered according to the I-BmoI sequence,
Figure 1B) comprise a putative active site cleft (Figure 1C), with a single divalent metal
ion coordinated by the glutamic acid residue in both the I-TevI and UvrC structures.
Mutation of any of these residues abolishes DNA cleavage activity in a number of GIYYIG enzymes (20-22,26,27).
In spite of a wealth of bioinformatic, biochemical, and structural data, the mechanism by
which GIY-YIG homing endonucleases introduce a double-strand break in substrate is
unknown (28). The mechanism must involve repositioning of a (presumably) single
active site within the catalytic domain on substrate to perform two sequential nicking
reactions, with the bottom (non-coding) strand nicked before the top (coding) strand
(27,29). This mechanism is likely to be distinct from other enzymes that contain the GIYYIG domain, including the restriction enzyme Cfr42I that functions as a tetramer (30),
Eco29kI that functions as a dimer (31), or the UvrC proteins that nick only a single-strand
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Figure 2.1: I-BmoI is a modular GIY-YIG homing endonuclease
(A) Schematic representation of I-BmoI interactions with intronless thyA substrate based
on biochemical data (27,32). Top- and bottom-strand nicking sites are shown as open and
filled triangles, respectively, and the critical -2 GC base pair is shown in enlarged, boldtype font. The intron insertion site is indicated by a vertical line, with exon 1 sequence
upstream (-) and exon 2 sequence downstream (+). (B) Homology model of the I-BmoI
catalytic domain (residues 1-88). Highlighted are four highly conserved residues in GIYYIG alignments that are critical for function, and secondary structure elements of the
domain. Subsequent illustrations of the catalytic domain will be shown from this view
(front) or a 180-degree rotation (back). (C) Surface representation of a front view of the IBmoI homology model highlighting the putative catalytic cleft. The sidechains of Y17,
R27, E74, and N87 are surface exposed, lie along the base of the cleft, and are situated in
close proximity to one another. Patches of charge are shown in color, blue being positive,
red being negative, and green being hydrophobic.
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adjacent to a damaged base (21). In an effort to gain insight into the mechanism by which
GIY-YIG homing endonucleases introduce a double-strand break, we have been studying
I-BmoI (Figure 2.1), an isoschizomer of I-TevI (32). Like I-TevI, I-BmoI is a twodomain endonuclease with an extended recognition sequence. Both enzymes cleave at the
same positions within their respective intronless substrates, but I-BmoI requires only a
critical G-C base pair at position -2 of intronless substrate for cleavage (33). As a model
GIY-YIG homing endonuclease, I-BmoI has a number of advantages over I-TevI,
including the fact that the wild-type (WT) enzyme can be overexpressed and purified in
quantities that are difficult to obtain with I-TevI. Moreover, I-BmoI is ~750-fold less
active than I-TevI, suggesting that early steps in the reaction pathway are more amenable
to in vitro analysis (27,33).
Here, we present a unified experimental framework that will provide a platform on which
to base future structure and function studies of GIY-YIG homing endonucleases, and
other GIY-YIG-containing enzymes. Our framework, which we term MUSE, synthesizes
data from three distinct experimental approaches; mutual information analyses that
identify co-evolving residues in the GIY-YIG domain, a unigenic evolution strategy that
uses a functional genetic selection to identify hypo- and hyper-mutable residues, and
interpretation of the data using paralog-specific sequence alignments and structural
models of the GIY-YIG domain. While none of the approaches used in our study are
individually novel, the synthesis of data from all three methods facilitated the
identification of residues that are unlikely to have been identified as important for
function using any one of the approaches in isolation. Mutational analyses of the
positions revealed phenotypic differences relative to WT I-BmoI in functional assays,
validating that MUSE can successfully identify previously unrecognized residues with
the GIY-YIG domain as relevant for function.

2.2 Materials and methods
2.2.1 Strain and plasmid construction
Strains and plasmids used in this study are listed in Supplementary Table S2.1, and
oligonucleotides are listed in Supplementary Table S2.2. To construct strain
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BW25141(λDE3) for use in unigenic evolution experiments, E.coli BW25141 was
lysogenized using the λDE3 lysogenization kit (Novagen). The toxic plasmid backbone,
p11-lacY-wtx1 (38), was used to construct pToxBmoHS and pToxBmoIn+ by inserting
the corresponding intronless homing site (HS) and intron-containing target site (In+),
respectively. To construct pToxBmoHS, oligonucleotides DE-395 and DE-396 were
annealed and ligated into the XbaI and SphI sites of p11-lacY-wtx1. The 51bp intronless
homing site corresponds to positions -10 to +41 of the exon1-exon2 junction relative to
the intron insertion site (32). To construct pToxBmoIn+, oligonucleotides DE-429 and
DE-430 were annealed and ligated into the XbaI and SphI sites of p11-lacY-wtx1. The 51
bp intron-containing site corresponds to the final 10 bp of the 3’ end of the intron plus the
first 41 bp of the 5’ end of exon 2 (32). pIBmoIE, which is a pUC57 derivative containing
a codon optimized I-BmoI gene (IDT DNA), was used as a template for cloning the IBmoI gene (optimized I-BmoI sequence is presented in Supplementary Figure S2.1).
Primers DE-331 and DE-384 were used to amplify and clone the codon optimized IBmoI into the NdeI and XhoI sites of pACYCDuet-1 to generate pACYCIBmoI. This
plasmid was subsequently used as a template to generate pACYCR27A using the
Quikchange XL site-directed mutagenesis kit (Stratagene) with primers DE-419 and its
reverse complement, DE-420. All plasmid constructs were verified by sequencing.

2.2.2 Genetic selection
To

generate

strains

harbouring

the

toxic

plasmid

for

unigenic

evolution,

BW25141(λDE3) was transformed with one of the 3 toxic (reporter) plasmids (p11-lacYwtx1, pToxBmoHS, or pToxBmoIn+) and plated on LB plates containing 100 µg/ml
ampicilin and 0.2% glucose. For each strain, a single colony was picked to inoculate 500
ml LB plus 100 µg/ml ampicilin and 0.2% glucose to generate electrocompetent cells.
Typically, 50 µl of electrocompetent cells were transformed with 100 ng of the
expression plasmid (pACYCIBmoI or pACYCR27A). The transformations were allowed
to recover in 500 µl of SOC media at 37oC for 5 minutes, then diluted into 2 ml 37oC
SOC and shaken at 37oC for 75 minutes. We found that addition of IPTG was not
necessary to induce I-BmoI expression, as an IPTG concentration of 0.1 mM led to toxic
effects. After incubation, transformations were diluted 1000-fold in SOC, and 100-µl
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aliquots were spread on plates containing LB plus 25 µg/ml chloramphenicol to estimate
number of transformants, or plates containing LB plus 25 µg/ml chloramphenicol and 10
mM arabinose to observe the number of colonies surviving the selection. Survival rate
was calculated by dividing the number of colonies observed on chloramphenicol plus
arabinose plates by colonies observed on chloramphenicol only plates.

2.2.3 Construction of mutagenized I-BmoI libraries
I-BmoI mutant libraries were generated by error-prone PCR from pACYCIBmoI using
primers DE-490 and DE-491. The forward primer (DE-490) was designed such that only
the ATG start codon was included in the primer, and the reverse primer (DE-491) was
designed such that no part of the I-BmoI gene was present in the primer. Three mutagenic
libraries were generated using identical PCR conditions in parallel 50-µl reactions
containing 80 ng of pACYCIBmoI as template, 20 pmol of each primer (DE-490, DE491), 0.2 mM dATP, 0.2 mM dGTP, 1 mM dCTP, 1 mM dTTP, 0.5 mM MgCl2, 0.5 mM
MnCl2, and 2.5 units of Taq polymerase (NEB) in the presence of 1x PCR buffer (10 mM
KCl, 10 mM (NH4)2SO4, 20 mM Tris-HCl pH 8.8, 2 mM MgSO4, 0.1% Triton X-100).
A total of 30 PCR cycles were run as follows: 94oC for 60s, 46.5oC for 60s, and 72oC for
60s. Mutagenic PCR products were digested with NdeI and XhoI and ligated into
pACYCR27A (used as a ligation target due to the fact that re-ligated singly cut R27A IBmoI would be non-functional in the selection). The ligated pools were independently
transformed into DH5α, grown in 3 ml LB plus 25 µg/ml chloramphenicol for16 hours at
37oC, and miniprepped (QIAGEN) to generate the mutant I-BmoI libraries.

2.2.4 I-BmoI unigenic evolution and selection of variants
The three mutagenic libraries were subjected to unigenic evolution to determine survival
percentage and to obtain clones required for sequence analysis. We sequenced a total of
167 selected clones picked from LB plus chloramphenicol and arabinose plates, of which
87 independent clones (36, 34, and 17 clones from pools 1, 2, and 3 respectively) were
identified (the rest discarded due to redundancy of DNA or amino acid sequence). These
clones contained a total of 460 nucleotide substitutions corresponding to 271 amino acid
substitutions. We also sequenced 62 unselected clones from LB plus chloramphenicol
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only plates. The unselected clones harboured a total of 760 nucleotide substitutions, 577
amino acid substitutions, and were used to establish baseline mutation frequencies. The
EoS value was calculated as described (40).

2.2.5 Construction and purification of site-directed mutants
We created a library of site-directed mutants using the Quikchange® XL Site-Directed
Mutagenesis Kit (Stratagene) to generate point mutants in the pACYCIBmoI backbone.
For purification purposes, a subset of these mutants were sub-cloned into the
pTYB1vector and were expressed and purified as previously described with one change
to the protocol (27). Once the clarified lysate has been loaded, the five column volume
wash with buffer A now contains a final concentration of 1mM ATP (Bioshop Canada
Inc.) to help remove bound chaperones. The concentrations of purified WT I-BmoI and IBmoI mutants were determined by a standard Bradford assay in duplicate using an
Ultrospec 2100 pro (Biochrom Ltd).

2.2.6 Characterization of I-BmoI variants
A set of I-BmoI variants identified from the unigenic evolution study and the library of
site-directed mutants were run through the genetic selection (as described above) to
determine their survival versus WT. Cleavage assays were subsequently performed with
I-BmoI mutants that were amenable to purification. The cleavage activities of WT and IBmoI mutants were determined using titrations with 10 nM pBmoHS and 2-fold serial
dilutions of I-BmoI from 700 nM to 1.37 nM in 10-µl volumes for 5 min at 37oC in 50
mM Tris pH 7.9, 50 mM NaCl, 2 mM MgCl2, and 1 mM DTT. Reactions were stopped
by addition of 4 µl stop dye (100 mM EDTA pH 8.0, 25% glycerol, and 0.2%
bromophenol blue) and heated at 90oC for 5 minutes. Stopped reaction were run on 1%
agarose gels, stained with ethidium bromide (OmniPur) and analyzed on an
AlphaImager™3400 (Alpha Innotech). Percent linear DNA is defined as the percentage
of total DNA (circular, nicked, and linear) converted to linear product. Nicking assays
were conducted as above, with a standard protein concentration of 175 nM and 10-µl
aliquots of a reaction pool were stopped at 15 s, 30 s, 45 s, 1 min, 1min 30 s, 2 min, 3
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min, and 5 min. The rate constants for the first strand (circular to nicked) and second
strand (nicked to linear) steps were calculated as described in Supplementary Figure S2.3.

2.2.7 Structure based alignment
Sequences similar to the endonuclease domain of I-TevI (GI: 29345254) were identified
by BLAST in the nonredundant protein database and in the metagenomic protein
database at NCBI. All proteins with an E value less than 0.1 were aligned to the I-TevI
catalytic domain structure (PDB ID: 1LN0) using the block align feature of Cn3D
(http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml). The defaults of this feature
were changed to not perform global alignments and to allow changes to the block
structure of existing alignments. Long gaps were not allowed. One hundred and seventyfour full-length sequences were identified. Partial sequences, sequences that required
large gaps or that were missing the presumed catalytic residues (R27, E75, and N90, ITevI numbering) were excluded from the alignment. The alignment included the I-BmoI
sequence (GI: 12958590). The alignment contained 4 bacteriophage sequences, 97
sequences from the marine metagenome, 23 bacterial sequences and 50 eukaryotic
sequences. The sequences were culled to remove the shorter member of a redundant pair
with a threshold of 90% using JalView (49), leaving 146 sequences. To test the quality of
the alignment and for contamination by paralogous GIY-YIG sequences, the UvrC
sequence from Thermotoga maritima (GI: 8134799) was included in the initial alignment.
Using the Cn3D block align method, the sequences were sorted by matches to the
position sensitive scoring matrix. The T. maritima UvrC sequence was the third worst
scoring protein by this measure, suggesting that UvrC proteins were effectively excluded
from the alignment. Second, we examined the alignment for an excess of local
covariation that can detect as little as 10% contamination of the alignment (35). This
often results when paralogous gene families are incorporated into one alignment. No
excess local covariation was identified, suggesting that contamination by UvrC or other
parologous GIY-YIG type endonuclease domains was rare. Based on the alignment, we
built a homology model of the I-BmoI GIY-YIG domain (residues 1-88) using
MODELLER (50) and SWISS-MODEL (51) with the I-TevI structures (1MK0 and
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1LN0) as templates. There was no significant difference between the two structural
models.

2.2.8 Co-variation analyses
Three semi-independent methods, MIp (34), ∆Zp and ∆Zpx (35), were applied to the
multiple sequence alignment to identify pairs or small groups of positions that showed
non-independent evolution in the GIY-YIG domain, using scoring cutoffs of 4.5 (MIp),
3.5 (∆Zpx) and 1.5 (∆Zp), respectively. Mutual information values were assigned to
residues using the I-BmoI reference sequence. Distances were calculated using the closest
non-hydrogen atom of co-evolving residues in the I-BmoI homology model.

2.3 Results
2.3.1 Improved alignment of the GIY-YIG domain
Previous multiple sequence alignments of the GIY-YIG domain have included sequences
of proteins with diverse functions, diluting the phylogenetic signal from GIY-YIG
domains specific to homing endonucleases (20,23). To gain better insight into residues
that are conserved amongst potential GIY-YIG homing endonucleases, we collected
sequences by BLAST and aligned them to the I-TevI catalytic domain structure with
Cn3D. BLAST searches were dominated by matches to the nucleotide excision repair
protein UvrC, all of which were subsequently discarded. In addition, sequences that
contained obvious insertions and deletions, or sequences that lacked residues equivalent
to the functionally critical R27, E74 and N87 (I-BmoI numbering), were removed
resulting in a final alignment of 146 sequences.
The GIY-YIG domain has previously been separated into 5 conserved regions that are
characterized by highly conserved residues, termed motifs A through E (20). In our new
alignment (Figure 2.2A), the information content associated with the highly conserved
residues has not changed significantly, with the exceptions of increases associated with
the tyrosine residues of motif A (Y6 and Y17) and the phenylalanine residue of motif C
(F57). There are, however, differences outside of the highly conserved residues that are
apparent in our alignment. In particular, there are obvious increases in the information

59

Figure 2.2: Alignment of the GIY-YIG domain
(A) Multiple sequence alignment of 146 sequences represented as a sequence logo (52).
Positions are numbered according to the I-BmoI sequence that is shown below the
alignment (conserved functionally critical residues are shown in green). Predicted
secondary structure elements of the I-BmoI GIY-YIG domain are indicated on the
sequence by shading, and motif assignments are identified on the alignment with shaded
boxes. (B) Front (left) and rear (right) views of the homology model with the degree of
conservation mapped onto the structure. Conserved positions are shown in dark green,
with the side chains of highly conserved residues indicated. Variable positions are shown
in white.
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content of positions that intervene the GIY and YIG elements of motif A (I8, N10, and
K15), and the stretch of residues (S48, K51, H52, G53) that precede the phenylalanine
(F57) of motif C. In contrast, there is a decrease in the information content of the proline
(P84) that precedes the conserved tyrosine (Y86) and asparagine (N87) residues of motif
E (Figure 2.2A), attributable to the removal of UvrC sequences from the alignment that
predominantly possess a proline at this position.
To display sequence conservation within the GIY-YIG domain, the entropy for each
position in the alignment was calculated and subsequently displayed on the I-BmoI
homology model, with conserved positions (low entropy, high information content)
coloured green and non-conserved positions (high entropy, little information content)
coloured white (Figure 2.2B). As expected, the highly conserved residues that
characterize the GIY-YIG domain (Y6, Y17, R27, E74, and N87) all surround the
proposed catalytic surface. Of particular interest is H31 that displays high information
content, and lies in close proximity to the essential R27 in α-helix1, with both residues
stacked against each other and orientated towards the presumed catalytic surface (Figure
2.2B). In general, the majority of conserved residues are similarly positioned, with the
exception of a block of moderately conserved residues spanning positions 47-53 (located
in α-helix 2, orientated away from the catalytic surface). Strikingly, many of the nonconserved residues occupy positions distinct from the proposed catalytic surface,
including residues in α-helix 1 and the loop connecting α-helix 1 and α-helix 2.
Collectively, these data highlight the conservation of residues that surround the proposed
catalytic surface of the GIY-YIG domain, whereas non-conserved residues tend to be on
the periphery of the domain.

2.3.2 Identification of co-evolving positions in the I-BmoI catalytic
domain
Additional insight into functionally important residues of the I-BmoI catalytic domain
was obtained by applying mutual information analyses to detect amino acid positions that
co-evolve, or co-vary, with each other. Such analyses can detect non-independent
evolution of residues that co-vary with other residues because of functional constraints.
Indeed, most residues that co-vary tend to be within contact distance of each other (4,34).
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We applied three different methods to analyze co-variation in the GIY-YIG domain
alignment, MIp, ∆Zpx, and ∆Zp (35), and found that the highest scoring amino acid pair
by all methods was S20-I71 (Table 2.1). While S20 and I71 are not within predicted
contact distance (6.3Å) in the homology model of the I-BmoI GIY-YIG domain, they
occupy a surface of the domain that can be envisioned as a gateway to the catalytic cleft
formed by the C-terminal end of β-sheet 2 and the N-terminal end of α-helix 3 (Figure
2.3). In addition, we identified a set of four residues, L35-H40-N46-F49, that co-evolve
with each other (Table 2.1). This set of residues was of interest because the H40Y
mutation in I-TevI reduces catalytic activity relative to the WT protein (36), and the
interaction between these residues may be required to position the H40 residue
appropriately within the active site (Figure 2.3). Another intriguing residue identified by
mutual information analyses was K7 that coevolves with three other residues, T9, F16
and E60 (Table 2.1). All four residues lie in adjacently positioned β-sheets (Figure 2.3),
suggesting that interaction between these residues is critical for folding of the GIY-YIG
domain. Similarly, other sets of coevolving residues such as K51-H52, and H63-K73W76 (Table 2.1), are all within contact distance of each other and likely have roles in
folding or stability of the domain.

2.3.3 Unigenic evolution identifies mutable positions in I-BmoI
The above results provided a phylogenetic and structural framework for the identification
and analysis of potential functionally critical residues in the catalytic domain of I-BmoI.
To gain experimental insight into residues that are functionally relevant across the full
length of I-BmoI, we adapted the unigenic evolution method (37). In this method, a
genetic selection is used to isolate functional variants of I-BmoI after random
mutagenesis, facilitating identification of amino acid positions that were either tolerant
(hypermutable) or intolerant (hypomutable) of substitutions. The selection utilizes a twoplasmid system that relies on I-BmoI expression from one plasmid (pExp) to cleave a
second, toxic plasmid (pTox) that contains the cognate I-BmoI homing site (38) (Figure
2.4). Cells survive plating on selective media only if the toxic plasmid has been cleaved
by a functional I-BmoI. As shown in Figure 2.4, we observed a survival ratio of 0.95
when WT I-BmoI was expressed from pExp, and pTox contained the I-BmoI homing site
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Table 2.1: Co-evolving residues in the I-BmoI GIY-YIG domain
Pair

MIp

S20-I71
H63-K73
K51-H52
K7-E60
L35-N46
K7-F16
K73-W76
K7-T9
Q75-D79
L35-F49
N10-S48
L35-H40

8
4.8
4.7
4.1
5.2
3.9
6
3.2
3.8
3.5
4.6
4.7

ΔZpx
5.7
3.8
4.3
3.6
3.4
3.7
4.6
3
4.1
3.2
3.9
3.4

ΔZp
5.5
3.5
2
2
1.8
1.8
1.8
1.8
1.8
1.7
1.6
1.5

Distance (Å)
6.3
3.1
1.3
3
3.7
4.2
3.3
3.8
3.1
3.6
3
3.5
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Figure 2.3: Co-evolving residues of the I-BmoI catalytic domain
Position of four sets of co-evolving residues mapped onto the I-BmoI homology model,
color-coded by co-evolving residues (yellow, L35, H40, N46, F49; red S20, I71; blue K7,
T9, F16, E60; orange K51, H52). Front (left) and rear (right) views are shown, with
functionally critical residues highlighted in light green.
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Figure 2.4: The two-plasmid genetic selection
(A) Schematic of the expression plasmid (pExp) and toxic (reporter) plasmid (pTox). (B)
Verification of the genetic selection using variants of pExp and pTox. Survival rates are
expressed as the ratio of colonies on chloramphenicol + arabinose plates to colonies on
chloramphenicol only plates. WT I-BmoI, pExp expressing WT I-BmoI; R27A I-BmoI,
pExp expressing an inactive R27A I-BmoI; randomized I-BmoI, library of I-BmoI
variants; p11-lacY-wtx1, parental pTox without I-BmoI target site; ND, not determined.
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(pToxBmoHS). In contrast, survival ratios of 0 were observed when WT I-BmoI was
used with the pTox backbone (p11-lacY-wtx1) containing no homing site, and when a
catalytically inactive I-BmoI variant, R27A, was used in combination with pToxBmoHS.
Furthermore, the survival ratio was <0.0001 when pTox contained the intron-containing
I-BmoI substrate (pToxBmoIn+), which I-BmoI cleaves poorly (33). These results
validate the genetic selection system, showing that cells survive only when I-BmoI can
cleave the toxic plasmid that contains the I-BmoI homing site.
We used error-prone PCR to generate three independent libraries of I-BmoI variants in
pExp, mutagenzied over the entire I-BmoI coding region. The libraries were transformed
into the selection strain carrying pToxBmoHS, and survivors identified by plating on
selective media with an average survival ratio of ~0.01 for the three pools. We identified
and sequenced 87 independent I-BmoI variants that survived the selection, containing an
average of 5.28 nucleotide substitutions (or 3.11 amino acid substitutions) per clone
(Supplementary Figure S2.2). To determine the mutation frequencies inherent to the
error-prone PCR, we sequenced 62 independent clones plated on non-selective media,
which contained an average of 12.26 nucleotide substitutions per clone (Supplementary
Figure S2.2). As expected, the average number of substitutions in the pool of unselected
clones was much greater than the number in the selected pool, and the distribution of the
number of changes between the selected and unselected clones differed.
By mapping the mutable positions from the selected clones onto the I-BmoI sequence, we
found that amino acid positions tolerant to substitutions were distributed throughout the
length of the coding region (Figure 2.5). To gain further insight into tolerated mutations
within the GIY-YIG catalytic domain, the mutable residues from positions 1-88 were
mapped onto a homology-based 3D model of the I-BmoI catalytic domain (Figure 2.6).
Interestingly, the majority of the mutations mapped to the periphery or the backside of
the catalytic domain (opposite the proposed catalytic surface). Also, few mutations were
observed near the proposed catalytic surface and no substitutions were observed in the
four functionally critical residues (Y17, R27, E74, and N87). Some positions tolerated the
same substitution more than once, as evidenced by the appearance of the same mutation
in independent clones that contained an alternate set of accompanying mutations (Table
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Figure 2.5: Unigenic evolution analysis of I-BmoI
Shown is a summary of the mutations found in the 87 selected clones and the EoS value
for each position. Non-synonymous substitutions found at each position are indicated
beneath the corresponding I-BmoI sequence over the entire length of the protein (multiple
independent occurrences of the same mutation are shown in subscript). Shown above
each line of sequence is a graph of the evidence of selection (EoS) at each amino acid
position of I-BmoI. Regions of modelled or predicted secondary structure are indicated
by grey rectangles, and bold residues indicate the GIY and YIG motifs, functionally
critical residues, or residues that are identical between I-BmoI and I-TevI in the linker
domain.
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Figure 2.6: Mapping positions that tolerate non-synonymous substitutions and EoS
data onto the I-BmoI homology model
For the left of each panel, amino acid positions that tolerate non-synonymous
substitutions are shown in red and positions where no change was found are in white. On
the right of each panel, the EoS score is shown as gradient. Positions with high EoS
values are blue, and low EoS values are white. (A) Ribbon representations of a front view
of the catalytic domain, with functionally critical residues identified by the present and
previous studies indicated. (B) Surface representation of a front view of the I-BmoI
catalytic domain, with the putative catalytic cleft bounded by white dashed lines. (C)
Surface representation of a rear view of the catalytic domain.
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S2.3). For example, residue N12 tolerated 10 amino acid substitutions (five to aspartate,
four to threonine, and one to tyrosine) in different clones, indicating that the position is
highly mutable. The significance of mutations in positions outside of the I-BmoI catalytic
domain were difficult to interpret due to the absence of similarity between the DNAbinding domain of I-BmoI and that of I-TevI, for which there is an available structure.
However, the I-BmoI and I-TevI linker regions, encompassing residues 95-112 of IBmoI, show some degree of similarity (18). In particular, alanine-scanning mutants in
this region of I-TevI functionally divided the linker into deletion intolerant and deletion
tolerant regions (17,20). The equivalent deletion intolerant region of the I-BmoI linker
appeared to contain few mutations among the selected clones (Figure 2.5), with some
amino acid positions exhibiting high statistical confidence that the lack of mutation was
not due to random chance (see below).

2.3.4 Statistical analysis of unigenic evolution data reveals residues
of potential functional importance
More rigorous interpretation of the unigenic evolution data to identify hypo- and hypermutable residues requires statistical analyses to determine the probability that any codon
will undergo a synonymous or non-synonymous change, taking into account the expected
substitution frequencies based on the bias of the mutagenic PCR and the base
composition of individual codons. Previous methods utilized a statistic, H, varying
between -1 and 1, to determine the mutability of an individual amino acid position
(37,39). We found that H both over- and under-estimates the mutability of positions
because it lacks the power to determine if a significant difference exists between the
selected and unselected clones at each position (40). For instance, the number of
hypomutable residues in a given protein was vastly overestimated by assigning a value of
-1 for any residue that had no non-synonymous changes, whereas there will be many
positions that do not contain sequence changes simply because the mutagenic method is
not saturating.
To take this, and other issues into consideration, we developed a new method for
analyzing unigenic evolution data called EoS (Evidence of Selection) (40). The EoS
value assesses whether the observed frequency of substitutions for any given codon in the
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selected clones is statistically different from the expected frequency of mutations based
on data for the same codon from the unselected pool of clones. Importantly, the EoS
value explicitly represents both selection and the power to detect selection for each
residue, and is plotted as the log2 ratio of the probability of non-random changes per
codon versus the probability of random changes per codon. Thus, an EoS value of 8
represents a 1 in 256 probability that the observed spectrum of mutations occurred at
random. Moreover, the fact that some residues possess low EoS scores does not
necessarily indicate that these residues are not of potential functional significance, only
that the sample size is insufficient to determine their significance.
For example, A/T rich codons are more likely to be mutated due to the bias of Taq
polymerase, whereas G/C rich codons are less likely to be mutated. Under the EoS
method, a lysine codon (AAA) for which there were no non-synonymous changes in the
selected clones would be flagged as significant only if substitutions were observed at the
same codon in the unselected clones. As an example, consider position K130. Six nonsynonymous substitutions were present in the unselected clones at this position, whereas
no substitutions were observed in the selected clones at this position (Supplementary
Table S2.3). Because the spectrum of observed substitutions in the selected clones was
significantly different from the observed and expected spectrum of mutations in the
unselected clones, K130 is assigned a high EoS value of 8.03, thus providing strong
evidence that the position is intolerant to substitution. In contrast, K171 has a low EoS
value of -0.65 because a similar spectrum of mutations was observed in the both the
selected and unselected clones at this position (Supplementary Table S2.3).
Using the EoS value as a guide, many positions throughout the length of I-BmoI appear
to have potential functional importance (Figure 2.5). Of particular interest were residues
in the catalytic domain that have a high EoS value. For example, K29, N42, N50, K51,
F57, I67, I71, N80, and Y82 all have EoS values greater than 6. Apart from F57, none of
these positions have been implicated by previous studies to be of potential functional
importance. We mapped the EoS values of residues onto the I-BmoI homology model,
and compared this representation to that of the mutable amino acid residues mapped onto
the model (Figure 2.6). Residues that line the catalytic surface were refractory to
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mutation in the selected clones (Figure 2.6A and 2.6B, and coloured white), whereas the
EoS values indicate that the majority of these residues are predicted to be functionally
critical (Figure 2.6A and 2.6B, and coloured blue). Many residues with high EoS scores
were located away from the active site surface (Figure 2.6B and 2.6C), consistent with
structural roles (for instance, K51, which strongly co-evolves H52; Table 2.1). Again, it
is important to note that residues with a low EoS value (coloured white in Figure 2.6) do
not imply that this position is not of potential significance, only that we lack the statistical
power to draw such a conclusion given the observed spectrum of mutations (for example,
R27).
Inspection of EoS values for the remainder of the I-BmoI sequence revealed that many
residues in the linker and C-terminal region appear to be of potential functional
significance (Figure 2.5). For instance, two residues in the linker region that are identical
between I-TevI and I-BmoI, K105 and K111, possesses EoS values >8. These residues in
I-BmoI are excellent candidates for future mutagenic studies because they correspond to
the deletion intolerant region of the I-TevI linker, where mutations drastically reduced or
abolished cleavage activity (17,20).

2.3.5 Genetic analysis of site-directed mutants
The data generated by mutual information and unigenic evolution facilitated the
identification of amino acids of potential functional importance that could be tested
through mutational analyses. We focused on amino acids positions within the N-terminal
catalytic domain, because these positions could be interpreted within the context of
known and modelled GIY-YIG domain structures and previous mutagenic studies, and
because mutations in the catalytic domain would not affect the DNA-binding activity of
I-BmoI (15,32). Thus, we could be confident that any phenotype we observed for sitedirected mutants was due to a defect related to the function of the catalytic domain. We
selected amino acid positions for mutagenesis based on one of the following criteria: (1)
the position had a high EoS value, (2) the residue(s) was identified as co-evolving with
another residue, or (3) the residue possessed high information content in the alignment
and had not been previously analyzed by mutational studies. For instance, H31 was
chosen for mutagenesis because it possessed high information content, had a moderate
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EoS value of 3.52, and has not previously been targeted by mutagenesis studies of GIYYIG homing endonucleases. In contrast, position 71, an isoleucine in I-BmoI, displayed
very low information content, yet had a high EoS value of 6.37. Furthermore, I71 coevolves with S20, thus both residues were chosen for further analyses. The rationale for
choosing other amino acid positions for mutagenesis is provided in Supplementary Table
S2.4. In addition to generating site-specific mutants, we chose two clones identified in the
unigenic evolution study that contained single mutations within the catalytic domain
(N12D and H52R) for further analyses. These clones are representative of amino acid
positions within the catalytic domain that are tolerant to change.
To determine if the identified residues were indeed critical for I-BmoI function, we
individually analyzed the mutants using the genetic selection, allowing us to calculate a
survival ratio that could be directly compared to that for WT I-BmoI. As shown in Table
2.2, the mutants could be divided into four classes. Class I mutants, Y17F, Y17H, S20A,
H31F, H31Y, N42D, and N42A, showed the most dramatic effect as none survived the
selection. Class II mutants were severely compromised in their survival, with ratios
<0.07, and included H31A, and I67N. Class III mutants, S20Q, H52R, I71N, and I71A,
exhibited moderate survival ratios of between 0.14 and 0.43. The class IV mutants,
N12D, S48A, K51L, H52Y, and Y86F all showed survival ratios essentially equivalent to
WT I-BmoI, and thus were considered to have little effect on I-BmoI activity. We
considered the possibility that a lack of survival in the selection could be due to the
generation of a hyperactive mutant or an altered specificity mutant, resulting in a toxic
endonuclease that would cause cell death. For all mutants, however, we observed no
reduction in viable cells when cultures were plated on non-selective media during the
selection protocol, suggesting that none of the mutants were toxic. Furthermore, we
purified the H31A and N42D mutants and found by in vitro cleavage assays that both
mutants were severely compromised for cleavage activity (see below and Figure 2.7),
suggesting that the lack of survival in the genetic selection was due to loss of
endonuclease activity.
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Table 2.2 Survival ratios of I-BmoI variants with mutations in the catalytic domain
Mutant
Class I

Survival ratio relative to WT1

Y17F
0
Y17H
0
S20A
0
H31F
0
H31Y
0
N42A
0
N42D
0
Class II
H31A
0.003 +/- 0.002
I67N
0.06 +/- 0.04
Class III
S20Q
0.12 +/- 0.02
2
H52R
0.43 +/- 0.04
I71A
0.22 +/- 0.03
I71N
0.20 +/- 0.03
Class IV
N12D2
1.06 +/- 0.03
S48A
1.02 +/- 0.03
K51L
0.86 +/- 0.10
H52Y
0.96 +/- 0.05
Y86F
0.99 +/- 0.04
1
Values shown represent averages and standard deviation of at least three independent
trials, normalized against the survival ratio for a WT I-BmoI selection performed in
parallel.
2
The H52R and N12D mutants were isolated from the pool of selected clones.
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Figure 2.7: Cleavage activity of WT I-BmoI and site-directed mutants
(A) Shown are representative cleavage assays using 2-fold serial dilutions of the WT and
mutant I-BmoI proteins, from 700 nM on the right to 1 nM on the left. The first lane of
each gel from the left is unreacted substrate. For the R27A, H31A and N42D mutants,
only the three highest protein concentrations were tested. In the bottom panel, substrate
linearized by EcoRI is shown in the leftmost panel. Circular (C), linear (L), and nicked
(N) plasmid forms are indicated to the right of each gel.
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2.3.6 Cleavage assays with key site-directed mutants
To better understand the effect of individual mutations on endonuclease activity, we next
purified key site-directed mutants (N12D, S20Q, H31A, N42D, I67N, and I71N) for use
in in vitro cleavage assays (Figure 2.7 and Figure 2.8). The H31Y and I71A mutants were
insoluble and not studied further, and apart from the N12D mutant, mutants with similar
survival ratios to WT I-BmoI in the genetic assay were not purified for cleavage assays
(Table 2.2). We first analyzed the activity of the mutant proteins relative to WT I-BmoI
over a wide range of protein concentrations in cleavage assays using a circular substrate
that contained a single I-BmoI site. As shown in Figure 2.7, the N12D, S20Q, I67N and
I71N mutants exhibited a range of activities relative to WT I-BmoI. The N12D mutant
was as active as WT I-BmoI, whereas I61N and I71N displayed intermediate cleavage
activities. The S20Q mutant was the least active, and we estimate that this mutant
retained ~30% cleavage activity of WT I-BmoI. In contrast, the H31A and N42D mutants
were severely compromised for cleavage activity, with no linear product visible at the
highest protein concentrations tested (Figure 2.7).
To gain additional insight into the observed phenotypes, we performed time-course
cleavage assays with WT and mutant proteins to detect the appearance of a nicked
intermediate as well as the linear product (Figure 2.8). These assays were performed with
limiting metal ion, as we have previously shown that this reaction condition can
effectively distinguish the two sequential nicking reactions that generate a double-strand
break (27). With circular plasmid substrates used in this assay, the first nicking reaction
generates a nicked intermediate with slow mobility, and the subsequent nicking reaction
generates a linear product. The profile of the nicking assays suggested that the I-BmoI
cleavage reaction followed the reaction scheme shown in Equation (1):
𝐶

!!

𝑁

!!

𝐿

(1)

where C, N, and L are intact plasmid substrate, nicked intermediate, and linear product
resulting from a double-strand break. The rate constant for the first nicking reaction is k1,
and k2 is the rate constant for the second nicking reaction.
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Figure 2.8: Nicking assays with WT and mutant proteins
Shown are representative agarose gels of time-course assays, with time points in seconds
indicated above the gels. The first lane of each gel contains unreacted substrate (-).
Circular (C), linear (L), and nicked (N) plasmid forms are indicated to the right of each
gel. Beside each gel image is a graphical representation of the disappearance of substrate
and appearance of products formed over time. Data points from three independent
experiments are plotted, with a continuous line drawn through the average.
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As shown in Figure 2.8 and Table 2.3, the reaction profiles and rate constants of the WT
protein and N12D mutant were very similar, with conversion of the nicked intermediate
to linear product complete by ~120 seconds. The reaction profiles of the S20Q and I67N
mutants were very different from WT and N12D, with k1 constants indicative of a slower
first nicking reaction. Under conditions used in these assays, neither reaction was
complete at the end of the time course, making it difficult to determine k2 for the S20Q
and I67N mutants using Equation 1 (Supplementary methods S2). In contrast, Figure 8
illustrates that the I71N mutant displayed a similar first nicking step to the WT and N12D
proteins, but that the conversion to linear product was slower as indicated by kinetic
analysis (Table 2.3), consistent with a nicked intermediate accumulating over an
extended period of time relative to WT protein. Consequently, conversion to linear
product was delayed, but still complete by the end of the time course. Collectively, these
results clearly implicate residues identified by MUSE as functionally important, as
mutation of these residues generates phenotypes that are distinct from the WT protein.

2.4 Discussion
Detailed insight into protein structure and function can be obtained by synthesizing data
from multiple experimental, computational and structural approaches. Here, we elaborate
an experimental framework to identify previously unknown functionally relevant residues
of the GIY-YIG endonuclease I-BmoI that takes into account evidence other than strict
conservation of residues in a multiple sequence alignment. Our goal was to use MUSE to
identify key amino acids in I-BmoI for proof-of-principle experiments, highlighting the
utility of the MUSE framework. We anticipate that our data will form a platform on
which to pursue future structure and function studies of GIY-YIG homing endonucleases
and other proteins containing the GIY-YIG domain, and that the MUSE approach will be
generally applicable to a broad range of proteins.

2.4.1 Application of MUSE to GIY-YIG homing endonucleases
Past studies on GIY-YIG enzymes have utilized alignments and structural data to identify
a set of absolutely conserved residues, subsequent mutation of which abolished cleavage
activity. The residues were chosen for mutational analyses on the assumption that
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Table 2.3: DNA cleavage by WT I-BmoI and variants identified by MUSE
protein

k1 (s-1)a

k2 (s-1)b

WT
N12D
I71N
S20Q
I67N

0.080 ± 0.0033
0.073 ± 0.0045
0.045 ± 0.0028
0.012 ± 0.003
0.036 ± 0.0005

0.034 ± 0.00069
0.024 ± 0.00081
0.015 ± 0.00051
N.D.
N.D.

a

k1 is the rate constant for the first nicking step that generates nicked intermediate from
circular substrate. For S20Q and I67N, k1 is valid only at the initial time point
(Supplementary Figure S2.4).
b

k2 is the rate constant for the second nicking step that generates a linear product
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conserved residues are important for function, and likely are components of the enzyme’s
active site. Such approaches, however, provided limited mechanistic insight and would
miss residues that are not universally conserved amongst GIY-YIG enzymes, but
nonetheless may be functionally critical. Furthermore, alignments of GIY-YIG
containing proteins are dominated by the nucleotide excision repair protein, UvrC, which
has a different set of functional constraints than GIY-YIG homing endonucleases. Thus,
one aspect of the MUSE approach was to assemble an alignment of GIY-YIG proteins
that closely resembled known homing endonucleases, with the goal of enhancing the
information specific to GIY-YIG homing endonucleases. For instance, it is known that
~140 well-aligned sequences will provide sufficient information for covariation analyses
to detect co-evolving residues (4). As discussed below, the strongest co-evolving amino
acid pair detected by covariation analyses was S20-I71. One of these residues, I71, has
not previously been identified for mutational analyses because this position is highly
variable in multiple sequence alignments, yet our data indicate that I71 is a functionally
significant residue.
That I-BmoI is a site-specific endonuclease was another critical factor in this study,
facilitating the use of a genetic selection where survival in the assay was dependent on
endonuclease function. Survival could also be influenced by the solubility or stability of
I-BmoI variants. We found, however, that very low levels of I-BmoI expression were
required for survival in the selection, suggesting that solubility was not likely a factor.
Furthermore, use of a functional genetic selection allowed us to screen through a large
population of I-BmoI variants mutagenized over the entire coding region, thus avoiding
biases introduced by localized mutagenesis of specific residues or regions of the protein.
Using the EoS method for analysis of unigenic evolution data, we obtained sufficient
power to identify residues of potential functional significance for a protein the length of
I-BmoI (266 residues) by sequencing a relatively small number of selected (87) and
unselected (62) clones. In addition to identifying residues of potential importance, MUSE
is also expected to identify positions that are tolerant to mutation (hypermutable). For
instance, N12 was mutated 10 times in the selected clones as opposed to 7 times in the
unselected clones, clearly implying a tolerance to mutation that is not expected to
drastically affect I-BmoI function. Indeed, our in vitro analyses of the N12D mutant (the
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most common mutation at that position) indicate essentially WT levels of activity,
validating that the MUSE framework has the power to distinguish between residues in IBmoI the catalytic domain that are functionally important and those that are not.

2.4.2 Residues within the GIY-YIG domain of I-BmoI that are
important for function
The proposed catalytic mechanism for the GIY-YIG domain is based on the predicted
function of a set of conserved residues (Y17, R27, E74 N87), each with distinct roles
(21,25). Y17 is thought to act as a general base to activate a nucleophilic water; R27 may
stabilize the 5’ phosphate of the cleavage intermediate, or contact substrate; E74
coordinates a divalent metal ion that likely functions as the Lewis acid; and N87 is
thought mainly to have a structural role in maintaining the active site architecture.
Mutation of any of these residues to alanine abolishes cleavage activity, an uninformative
phenotype as limited mechanistic insight is gained from catalytically inactive mutants.
Hence, many unanswered questions remain regarding the catalytic mechanism of the
GIY-YIG domain. For instance, the path of substrate DNA has only been inferred from
the position of the conserved residues in the catalytic domain. In this regard, it is worth
noting that an I-BmoI R27A mutant displayed a loss of hypersensitivity in footprinting
experiments compared to WT protein (27), suggesting that the R27A mutant possesses a
DNA contact defect that would not be expected if R27 functioned as a catalytic residue.
Thus, additional types of evidence other than structural data are needed to definitively
assign functional roles to the presumed set of catalytic residues. Moreover, the
significance of residues that lie very close to the proposed active site of I-TevI and UvrC
are unknown, and have largely been ignored because they are not conserved in multiple
sequence alignments. In the following sections, we discuss the potential structural and
functional significance of residues identified by MUSE for which subsequent
mutagenesis revealed effects on I-BmoI cleavage activity.

2.4.3 S20 and I71
The S20-I71 pair was chosen for further study because this pair was the highest scoring
set of co-evolving residues (Table 2.1 and Supplementary Table S2.4). In the GIY-YIG

80

domain alignment, S20 and I71 are both poorly conserved positions (but are conserved
between I-BmoI and I-TevI), and are most commonly varied to glutamine and asparagine
residues, respectively. In the I-BmoI homology model and the I-TevI structure, the
residues are located in the proposed catalytic surface (Figure 2.9). In the I-TevI structure,
S20 lies within hydrogen-bonding distance of the metal-coordinating residue E75, and
could potentially position E75 or stabilize the interaction of E75 with divalent metal ion.
Intriguingly, I71 can be structurally aligned with L116 of the His-Cys box homing
endonuclease I-PpoI, where the residue is inserted into the minor groove of its homing
site substrate (41,42). Further evidence for significant roles of S20 and I71 stemmed from
the unigenic evolution data, as S20 possessed an EoS score of 3.25 and I71 possessed a
score of 6.37. Neither position was mutated in the selected clones, whereas both positions
were mutated in the unselected clones (Supplementary Table S2.3). We made S20A and
S20Q mutations and found that the S20A mutant did not survive the genetic selection,
whereas S20Q had a survival ratio of 0.063. Cleavage assays with S20Q revealed that at
high protein concentrations the enzyme retained ~30% activity of WT protein, and a
similar reduction in cleavage activity was observed when the equivalent residue in UvrC
(K32) was mutated (21).
Both I71 mutants (I71A and I71N) survived the genetic selection, but with reduced ratios
relative to WT I-BmoI. We purified the I71N mutant for further analysis, and found that
it had slightly reduced activity relative to WT protein. Importantly, time-course cleavage
assays revealed that the nicked plasmid intermediate persisted longer than for WT protein
(Figure 2.8). Because I-BmoI generates a double-strand break by two independent and
sequential nicking reactions (27), the phenotype of the I71N mutant implies a defect in
the second nicking reaction. While the mechanistic basis of this defect will require future
study, it is possible that I71 functions in substrate recognition, and that the I71N mutation
greatly reduces substrate interactions that effect the second nicking reaction.
One intriguing question regarding the S20 and I71 residues is why do they co-evolve? It
is worth noting that the predicted distance separating the residues (~6Å) could reflect a
limitation of the homology model of the I-BmoI catalytic domain, as these residues are
~3.5Å apart in the I-TevI structure. In the 146 sequences used for mutual information
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Figure 2.9: Summary of functionally relevant residues identified by MUSE
Shown are ribbon (left) and surface (right) representations of the I-BmoI catalytic domain
with the residues identified by MUSE (S20, H31, N42, I67, and I71) highlighted in green,
and previously identified functionally critical residues (Y17, R27, E74 and N87) shown
in black. The catalytic cleft is highlighted as in Figure 2.1C.
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analyses, position 20 is most commonly a serine, and position 71 is most commonly an
isoleucine. However, there are almost equal occurrences of Q20-N71, Q20-D71, and
S20-L71 pairs among the sequences. We attempted to rescue the S20Q mutant by making
a second site mutation in position I71, generating a S20Q/I71N double mutant, reasoning
that this double mutant represented a tolerated amino acid pairing at positions 20 and 71.
However, the S20Q/I71N double mutant did not survive the genetic selection, suggesting
that this combination of residues is not tolerated in the I-BmoI background, and that
changes at other positions would be required to restore activity. Both S20 and I71 are in
close proximity to the proposed metal binding residue, E74 (E75 in I-TevI), implying that
certain combinations of residues may be favoured for correct positioning of the metalbinding residue within the active site (Figure 2.9).

2.4.4 H31
H31 was chosen for further analysis due to its high information content in the alignment,
the observation that this position has a relatively high EoS score of 3.52, and a lack of
mutations in the selected clones (but multiple mutations were present in the unselected
clones; Supplementary Table S2.3). H31 is well conserved amongst GIY-YIG
endonucleases, but is replaced by a tyrosine in the equivalent position in UvrC (Y43). In
the homology model and I-TevI structure (Figure 2.9), H31 packs against the side chain
of R27 and is within hydrogen bonding distance of both H40 and Y6, but no potential
functional role was assigned to H31 based on the I-TevI structure. In the UvrC structure,
Y43 was proposed to act as a general base to deprotonate a nucleophilic water molecule
(21). To test the importance of H31 in I-BmoI, we made three mutations, H31A, H31F
and H31Y, reasoning that the H31F would be structurally similar but chemically inert,
while H31Y might retain limited function. Intriguingly, the H31F and H31Y mutants did
not survive the genetic selection, while the H31A mutation had a very low survival ratio
(Table 2.3). Unfortunately, the H31Y mutant proved to be insoluble and could not be
studied in vitro, whereas no cleavage activity could be detected in vitro with the H31A
mutant using plasmid-based cleavage assays. The H31A mutant may retain an extremely
low level of activity that is difficult to detect using non-radioactive substrates, but that
may be sufficient to permit very a low level of survival in the genetic selection. These
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data provide the first evidence that H31 may play an important role in the active site of IBmoI and other GIY-YIG endonucleases, either functioning as a base, by stabilizing the
active site architecture by forming a hydrogen bond network with Y6 and H40, or by
contacting substrate.

2.4.5 N42
N42 was chosen for mutational studies because it possessed a high EoS score of 6.49
(Figure 2.5 and Supplementary Table S2.4). In the GIY-YIG domain alignment, position
42 has little information content, although there is a tendency for this position to be a
polar residue. N42 is located in a loop connecting α-helix1 and α-helix2, and is
orientated so that the side chain points towards the predicted active site surface (Figure
2.9). Interestingly, the amino group of N42 is within hydrogen bonding distance of the
hydroxyl group of the functionally critical Y17. We made two mutations that would
disrupt this interaction, N42A and N42D, and found that both mutants did not survive the
genetic selection, and that the N42D mutant displayed no cleavage activity in vitro. N42
may be critical because it functions to correctly position Y17 within the active site of the
enzyme.

2.4.6 I67
Like I71, I67 is not conserved amongst GIY-YIG endonucleases, with this position
displaying no information content (Figure 2.2, Supplementary Table S2.4). In the
homology model of the I-BmoI catalytic domain, I67 is positioned in a loop connecting
α-helix 3 and β-sheet 3, with its side chain pointed towards the active site surface (Figure
2.9). Mutation to asparagine reduced in vitro cleavage activity to approximately half that
of WT I-BmoI, with defects in both the first and second nicking reactions (Figure 2.8).
We envision that I67 may be involved in substrate interactions, similar to a role for I71.

2.4.7 Residues outside of the catalytic domain predicted to be critical
for function
GIY-YIG homing endonucleases are modular proteins, with the N- and C-terminal
domains connected by a flexible linker. Past studies on the I-TevI linker have revealed
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that the linker is required to correctly position the N-terminal GIY-YIG domain on
substrate for efficient cleavage (17,19,43). Remarkably, the linker can extend or retract to
correctly position the catalytic domain on substrates that contain insertions or deletions
that move the preferred cleavage sites from their WT position. This property of the linker
has led to the proposal that I-TevI, and perhaps other GIY-YIG endonucleases, generates
a DSB by a conformational change mechanism, whereby the linker is a critical
component in repositioning the catalytic domain between the bottom- and top-strand
nicking reactions. Interestingly, I-BmoI can also reposition the catalytic domain to cleave
substrates with +5 and +10 insertions (18), suggesting that the I-BmoI linker functions
analogously to the I-TevI linker in spite of limited amino acid similarity between the two
proteins in the linker region. Intriguingly, our unigenic evolution data revealed that many
residues within the I-BmoI linker region are predicted to be functionally significant.
Notably, K105 and K111, conserved between I-TevI and I-BmoI, have EoS scores
greater than 8. These residues correspond to the deletion intolerant region of the I-TevI
linker, where 2- or 3-amino acid deletions abolish cleavage activity, although the
functional basis for this phenotype is unknown (17,19). Furthermore, two additional sets
of residues in the I-BmoI linker, centered on Y120 and K130, also have high EoS scores.
Our data clearly implicate the I-BmoI linker as important for function, and identify a set
of residues for future mutagenesis and functional studies.
Apart from a repeated nuclease-associated modular DNA-binding domain motif
(NUMOD3) (44), I-BmoI shares little amino acid similarity with I-TevI in the C-terminal
DNA binding domain, even though the enzymes are isoschizomers and bind the same
stretch of thymidylate synthase sequence in Bacillus mojavensis and phage T4,
respectively (32). The NUMOD3 motif corresponds structurally to a minor-groove
binding α-helix that was first identified in the co-crystal of the I-TevI DNA-binding
domain with its homing site substrate (45), and later in the structure of an unrelated HNH
endonuclease, I-HmuI (46). In the I-TevI structure, the α-helix is positioned along the
minor groove of its DNA substrate, and only one residue in the α-helix (S191) makes a
single hydrogen bond contact to the phosphate backbone. Immediately preceding the αhelix, however, is H182 that makes two base-specific hydrogen bonds. Based on
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sequence predictions, I-BmoI possesses three NUMOD3 motifs, with H147, H175 and
H202 corresponding to the critical H182 of I-TevI. The EoS scores for the three histidine
residues in I-BmoI are extremely low (Figure 2.5), and each position had multiple
substitutions in the selected clones (Supplementary Table S2.3), suggesting that these
residues perform different functions than the equivalent H182 of I-TevI. Similarly,
residues that comprise the predicted I-BmoI helix-turn-helix (HTH) motif at the Cterminal end of the DNA-binding all have low EoS scores (Figure 2.5). In I-TevI, the
analogous HTH motif makes extensive hydrophobic contacts with thymine residues in
the substrate, providing specificity to the I-TevI substrate interaction. The tolerance of the
I-BmoI HTH to mutation implies that it may function differently than the analogous HTH
motif of I-TevI, and a detailed study of the sequence requirements for DNA binding by
both HTH motifs would provide an intriguing comparative study.

2.4.8 Conclusion
Using a unified experimental approach that synthesizes three distinct types of data, we
have identified previously unknown functionally relevant residues in the GIY-YIG
homing endonuclease I-BmoI. Our results will form a platform for future studies of IBmoI and other GIY-YIG-domain containing proteins because residues identified by
MUSE, when mutated, generate distinct phenotypes that will provide mechanistic insight.
Many of the positions identified by MUSE are non-conserved, and have escaped
detection by traditional analyses such as strict conservation in multiple sequence
alignments, providing a cautionary tale against using only a single methodology for
structure and function studies. We anticipate that the MUSE framework will be generally
applicable to a wide range of protein families, requiring ~140 well-aligned paralogous
sequences, an enzymatic activity that forms the basis for a genetic selection and, although
not essential, a structural model on which to interpret the MUSE data. For instance, the
MUSE framework can be applied to any homing endonuclease or DNA endonuclease
without difficulty, and would greatly aid in the re-design of endonucleases against novel
target sequences. Unigenic evolution screens have been applied to eukaryotic proteins,
including human Pin1 (a prolyl isomerase) and yeast TFIIB (47,48), and each of these
proteins could be also analyzed within the MUSE framework.
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Chapter 3

3

Divalent metal ion differentially regulates the sequential
nicking reactions of the GIY-YIG homing endonuclease
I-BmoI

The work presented in this chapter is reproduced (with permission, Appendix S1) from:
Kleinstiver, B.P., Bérubé-Janzen, W., Fernandes, A.D., Edgell, D.R. (2011) Divalent
metal ion differentially regulates the sequential nicking reactions of the GIY-YIG
homing endonuclease I-BmoI. PLoS One 6(8):e23804.

3.1 Introduction
Homing endonucleases are DNA endonucleases that primarily function as mobile genetic
elements by introducing double-strand breaks or nicks at specific homing sites in naïve
genomes (1,2). DNA repair, recombination and replication pathways repair the doublestrand break (or nick) using the endonuclease-containing genome as a template, resulting
in the mobilization of the homing endonuclease gene and surrounding DNA to the
recipient genome (1). In model laboratory systems, the efficiency of endonucleasemediated homing is extraordinary, reaching 80-100% in some cases (3-5), implying that
homing endonucleases can quickly spread through populations of naïve genomes. The
rapid accumulation of genome sequence data has revealed an abundance of homing
endonuclease genes in bacterial, archaeal, viral, and organellar genomes, including the
mitochondrial and nuclear genomes of eukaryotes (6,7). Five distinct homing
endonuclease families, defined by conserved amino acids, have been characterized to
date. They are the LAGLIDADG, HNH, His-Cys box, GIY-YIG, and PD-(D/E)xK
families (8,9).
Homing endonucleases have attracted much interest as potential reagents for
manipulating complex genomes, and substantial effort has been devoted to
reprogramming the specificity of a select few LAGLIDADG endonucleases to cleave
clinically relevant targets (10-14). Understanding the mechanism of DNA hydrolysis by
homing endonucleases is critical for their utilization as reagents for targeted manipulation
of complex genomes. From a mechanistic perspective, the least understood of the homing
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endonuclease families are the GIY-YIG enzymes. GIY-YIG homing endonucleases are
modular in nature and contain an N-terminal cleavage domain of ~100 amino acids that
includes the class-defining GIY-YIG motif, and a C-terminal DNA-binding domain that
is composed of distinct modules (Figure 3.1) (15,16). The N- and C-terminal domains are
connected by a flexible linker that functions as a molecular ruler to position the catalytic
domain at the correct distance on substrate from the DNA-binding domain (17-20). Two
well-studied GIY-YIG endonucleases are the isocaudomers I-TevI and I-BmoI, encoded
within group I introns interrupting the thymidylate synthase genes of bacteriophage T4
and Bacillus mojavensis, respectively (21-23). I-TevI and I-BmoI introduce a staggered
double-strand break by two independent and sequential nicking reactions at the same
positions of their substrates, with the bottom (non-coding) strand of substrate nicked
before the top (coding) strand (24,25). DNA bending assays and in-gel footprinting
demonstrated that significant DNA distortions on the bottom strand occur independently
of the first nicking reaction (24,25). Interestingly, studies with mutant DNA substrates
revealed distinct sequence requirements for efficient double-strand break formation by
each endonuclease. In particular, I-BmoI absolutely requires a GC base pair at position -2
immediately 3’ to the top-strand nicking site (26), yet displays no sequence preference for
bases flanking the bottom-strand nicking site, while I-TevI requires an additional CG
base pair 5’ to the bottom-strand nicking site for cleavage activity (27).
The GIY-YIG nuclease motif is not unique to homing endonucleases, as the domain is
found in a variety of protein scaffolds (28), including DNA repair proteins (29),
retrotransposable elements (30), and restriction endonucleases (31-33). Structural studies
of diverse GIY-YIG domains have revealed a compact α/β-fold composed of a central
three-stranded antiparallel β-sheet flanked by three α-helices (29,34-38). A set of
conserved residues comprise the single active site that uses a one-metal ion mechanism to
catalyze DNA hydrolysis (36,37). The function of the GIY-YIG nuclease domain varies
in a scaffold-dependent manner, as the domain has acquired additional structural units
that are interspersed within the GIY-YIG domain to direct oligomerization or DNA
binding. For instance, the GIY-YIG restriction enzyme Eco29kI utilizes additional folds
to function as a dimer (39), with each monomer nicking one strand of substrate. In the
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Figure 3.1: Model of I-BmoI interactions with intronless and intron-containing
substrates based on DNA footprinting experiments
Shown is a schematic of the modular interaction of I-BmoI with the intronless thyA allele
(upper), and the resultant changes to the target site upon intron insertion that generates
the intron-containing allele (lower). Top- and bottom-strand nicking sites are indicated by
open and filled triangles, respectively. The critical GC-2 base-pair is shown in enlarged
bold-type font, and the intron insertion site (IS) is indicated by a vertical line with exon 2
downstream and either exon 1 or the intron (red) upstream.
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case of the UvrC nucleotide excision repair protein, the single GIY-YIG domain nicks 3’
to a lesion site to initiate a repair event (40). The homing endonucleases are distinct from
other GIY-YIG family members, as they have an extended structure and bind DNA as
monomers (25). They are believed to successively use the single active to generate a
double-strand break (38), but how the active site is reorganized to accommodate different
DNA strands for the sequential nicking reactions is unknown.
Here, we investigate the contributions of divalent metal ion and DNA sequence to the
sequential nicking reactions of I-BmoI. We show that cleavage by I-BmoI is sensitive to
the identity and concentration of divalent metal ion, and that the second-strand nicking
rate is affected to a greater extent by low metal ion concentrations than the rate of the
first nicking reaction. DNA substrate mutations at key positions within the cleavage site
of I-BmoI can differentially attenuate or completely abolish first- and second-strand
nicking. Furthermore, we show that the GC-2 base pair is crucial for generating bottom
strand minor-groove distortions that are a necessary prerequisite to cleavage.

3.2 Materials and methods
3.2.1 Bacterial strains and plasmids
E.coli strains DH5α and ER2566 (New England Biolabs) were used for plasmid
manipulations and protein expression, respectively. pTYBmoI was used to over-express a
wild-type, codon-optimized version of I-BmoI for purification as previously described
(41). pBmoHS is a pBS derivative that contains an insert corresponding to 49 bp of the
intronless thyA substrate (26). A complete description of all plasmids used in this study is
found in Supplementary Table S3.1.

3.2.2 Oligonucleotides
Oligonucleotides used in this study can be found in Supplementary Table S3.2.

3.2.3 Cleavage assays on plasmid substrates
Single time-point cleavage assays to examine metal dependence were performed in 10-µl
volumes containing 20 mM Tris-HCl pH 8.0, 250 mM NaCl, 2.5% glycerol, 10 nM wild-
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type or G-2T pBmoHS, and various concentrations of MgCl2, CaCl2, CuCl2, MnCl2,
NiCl2, and ZnCl2. Reactions were started by the addition of I-BmoI to final a
concentration of 175 nM, allowed to proceed for 90 seconds at 37°C, and stopped by the
addition of 4 µl stop dye (100 mM EDTA, 25% glycerol, 0.2% bromophenol blue).
Stopped reactions were heated for 5 minutes at 95°C, cooled on ice for 5 minutes,
electrophoresed on a 1% agarose gel, and stained in a 1xTAE solution containing
ethidium bromide (Caledon) prior to analysis on an AlphaImager™3400 (Alpha
Innotech). Time course cleavage reactions to determine Mg2+ dependence were
performed on supercoiled pBmoHS in 115-µl volumes with conditions similar to those
listed above, with either 0.5 mM, 1 mM, 2 mM, 5 mM, 7 mM, or 10 mM MgCl2. A 10-µl
aliquot was removed prior to the addition of wild-type I-BmoI to final a concentration of
175 nM, and subsequent 10-µl aliquots were removed at ten time points into 4 µl stop
dye. Stopped reactions were visualized as indicated above. Reaction progress was
determined by the relative amount of circular substrate, nicked intermediate, and linear
product. At least 3 independent trials were conducted for each MgCl2 concentration.
Time course cleavage reactions with mutant pBmoHS substrates were performed in 65-µl
volumes with conditions similar to those listed above, with either 2 mM or 10 mM
MgCl2. A 10-µl aliquot was removed prior to the addition of wild-type I-BmoI to final a
concentration of 175 nM, and subsequent 10-µl aliquots were removed at 15, 30, 60, 120,
and 180 seconds into 4 µl stop dye. Mutant substrates were classified as follows: class I
substrates displayed a reaction progress similar to wild-type intronless substrate, class II
substrates displayed defects for both bottom and top-strand nicking reactions at 2 mM
MgCl2 and ‘rescue’ of cleavage to near WT levels after 180 seconds in 10 mM MgCl2,
and class III substrates showed severe to complete defects in 2 mM MgCl2 and no
appreciable rescue of activity in 10 mM MgCl2 after 180 seconds. Cleavage assays for
class I, II, and a selection of class III substrates (G-2T, C-3G/C-5A, T-1G/C-3G/C-5A, C3G/C-4A/C-5A, and In+) were conducted as described above. For the remainder of class
III substrates, only the accumulation of nicked intermediate or linear product above
background levels was measured after a 180 second incubation with I-BmoI in 2 mM or
10 mM MgCl2. Three independent reactions were performed for substrates that gave
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measurable rate constants, and two independent trials were performed for class III
substrates that displayed minimal or no cleavage. Rate constants for the reaction
𝐶

!!

𝑁

!!

𝐿

were estimated for the two-constant irreversible kinetic model using Prism5 (GraphPad
Software) or via the Bayesian bootstrap (61). The time-course data were fit to the three
following equations
𝐶 = 𝐶! exp  (−𝑘! 𝑡)
𝑁 = 𝐶!

!!
!! !!!

[− exp −𝑘! 𝑡 + exp −𝑘! 𝑡 ]

!
𝐿 = 𝐶! [1 + !!!!
(𝑘! exp −𝑘! 𝑡 − 𝑘! exp −𝑘! 𝑡 )]
!

(equation 1)
(equation 2)
(equation 3)

where C0 is the initial concentration of circular substrate (in nM), N is the concentration
of nicked DNA (in nM), L is the concentration of linear product (in nM), k1 is the first
nicking rate constant (in s-1), k2 is the second nicking constant (in s-1), and t is time (in
seconds). For each bootstrap replicate, parameters were optimized for minimal
discrepancy with the data under the half-taxi metric (62). This procedure was found to be
more robust than a standard least-squares estimation due to the constraint that the total
amount of circular, nicked, and linear DNA is constant. Posterior parameter medians and
95% confidence intervals are reported in Supplementary Table S3.3. The ratio of k1/k2 at
various MgCl2 concentrations was reported as the value of the log10k1 – log10k2 to
minimize over-weighting the end points if plotted on a linear scale.

3.2.4 OP-Cu in-gel footprinting
1,10-phenanthroline copper (OP-Cu) footprinting experiments were conducted as
previously described (24). Substrates used included a 74-mer duplex oligonucleotide
substrate corresponding to the intronless thyA target site (DE-116/DE-117), the intronless
74-mer with G-2T (DE-446/DE-447), G-2A (DE-459/DE-460), or G-2C (DE-461/DE462) substitutions, the intron-containing 74-mer (DE-444/DE-445), and the introncontaining 74-mer with A-2G substitution (DE-463/DE-464) (see Supplementary Table
S3.2). Gel images were analyzed using ImageQuant 5.2 (GE Healthcare Life Sciences).
To quantify hypersensitive sites observed in the OP-Cu footprint, two bands outside of
the I-BmoI protection region were selected to normalize phosphorimager units (positions
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+9 and +10 for intronless substrates, and +11 and +12 for intron-containing substrates,
relative to the intron insertion site). Hypersensitivity to OP-Cu at positions -1 and -2 was
calculated by expressing the ratio of normalized phosphorimager units at sites in the
shifted footprint (UC, upper complex) to the units in the unbound substrate reaction
(UNB, unbound) (24).

3.2.5 Molecular modeling
The I-BmoI GIY-YIG domain homology model was built as previously described (41),
and alignments to annotated structures were performed using MacPyMOL v1.2r.
Residues 6-10 of the homology model were aligned to residues 47-51 of the solution
structure of E142Q Eco29kI (3MX1) (Figure 6A) (36). A subsequent alignment was
performed with the I-BmoI homology model and a single subunit of the Y49F/L69K
Eco29kI structure in complex with its 18 base pair substrate (3NIC) (36). For illustration
purposes, only nucleotides (-4)-CCCGCGGGC-(+5) of the Eco29kI substrate were
shown. Additional alignments were performed using structures of the I-TevI GIY-YIG
domain (1KM0 and 1LN0) in place of the I-BmoI homology model (38), and of Hpy188I
in complex with substrate (3OQG) in place of the Eco29kI structure (37), yielding nearly
identical results.

3.3 Results
3.3.1 Magnesium is the preferred divalent metal ion for efficient and
specific cleavage
To determine the divalent metal ion preference for cleavage by I-BmoI, we tested various
metals across a range of concentrations in assays with a supercoiled plasmid (pBmoHS)
containing the I-BmoI intronless thyA target site (Figure 3.2). I-BmoI reaction progress
can be visualized using supercoiled substrate, as the first nicking reaction generates a
nicked plasmid intermediate and the second nicking reaction converts the nicked
intermediate to linear product (41). Cleavage assays were performed under single
turnover conditions (protein excess) with a range of MgCl2, CaCl2, CuCl2, MnCl2, NiCl2,
and ZnCl2 concentrations (Figure 3.2). Reactions with CoCl2 did not yield any products.
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Figure 3.2: Magnesium is the preferred divalent metal ion for efficient and specific
cleavage by I-BmoI
(A) Representative gel images of time-point cleavage assays with I-BmoI performed on
supercoiled substrate containing the intronless thyA target site. Reactions contained
increasing concentrations of MgCl2, CaCl2, CuCl2, MnCl2, NiCl2, and ZnCl2. Lanes that
lack I-BmoI (-) have 10 mM metal (1 mM for ZnCl2), and nicked (N), linear (L), and
circular (C) plasmid forms are indicated to the right of each gel image. (B)
Representative gel images of I-BmoI cleavage assays performed on supercoiled substrate
containing a mutation at the critical GC-2 basepair (G-2T). Reactions were performed in
the presence of MgCl2 or MnCl2.	
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The overall divalent metal ion preference of I-BmoI was Mn2+ > Mg2+ > Ni2+ > Ca2+ >
Zn2+ >> Cu2+ = Co2+. In particular, cleavage was extremely efficient in the presence of
MnCl2 for all concentrations tested, while reactions in MgCl2 displayed a second strand
defect at 0.25 mM MgCl2, near complete conversion of nicked intermediate to linear
product at 2 mM MgCl2, and complete conversion to product at 10 mM MgCl2 (Figure
3.2A). NiCl2 appeared to be inhibitory at 10 mM, yet similar levels of cleavage were
observed at 0.5 mM NiCl2 and MgCl2. Cleavage was observed in the presence of CaCl2
(albeit greatly reduced versus MgCl2), whereas ZnCl2 and CuCl2 were inhibitory at most
concentrations tested, with the exception that 0.05 mM ZnCl2 supported nicking only.
These findings correlate well with the typical roles of divalent metal observed for the
majority of site-specific DNA endonucleases, including the tetrameric GIY-YIG
restriction enzyme Cfr42I, apart from the observation that cleavage by Cfr42I was most
efficient in CoCl2-containing buffers (31,42-44).
Site-specific endonucleases have been shown to exhibit increased activity in the presence
of manganese, but at the cost of fidelity (45,46). To determine if I-BmoI displayed a
similar loss of fidelity in the presence of MnCl2 relative to MgCl2, we performed
cleavage assays on a plasmid substrate with a G-2T mutation, against which I-BmoI is
known to retain only limited activity (Figure 3.2B) (26). We observed minimal nicking of
the pBmoHS G-2T substrate by I-BmoI in the presence of 10 mM MgCl2, while 2 mM
and 10 mM MnCl2 were condusive for cleavage (but reduced versus intronless thyA
substrate). Collectively, these data suggested that the observed increase in efficiency in
the presence of MnCl2 is partly due to decreased fidelity, allowing I-BmoI to cleave noncognate sites. Furthermore, based on these results we determined that of the divalent
metal ions tested, a selection of magnesium concentrations would provide the optimal
level of efficiency and specificity.

3.3.2 Limiting divalent metal ion has a more pronounced regulation of
second strand nicking
To gain insight into the substrate conversion process by I-BmoI, we selected a range of
MgCl2 concentrations to dissect reaction progress as previous data indicated that the
sequential reactions have distinct metal requirements (24). We performed time-course
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cleavage assays with the thyA supercoiled substrate and determined rate constants based
on the following reaction scheme:

  𝐶
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𝑁

!!

𝐿

where k1 is the rate constant for conversion of supercoiled plasmid (C) to nicked
intermediate (N), and k2 is the rate constant for conversion of nicked intermediate to
linear product (L). Representative time course experiments in 0.5 mM and 10 mM MgCl2
are shown in Figure 3.3, with k1 and k2 rate constants for all MgCl2 concentrations tested
summarized in Table 3.1. We observed a 5.2-fold reduction in k1 when MgCl2 was
reduced from 10 mM to 0.5 mM MgCl2, while a 12.2-fold decrease was observed for k2.
The distinct metal requirements for each nicking reaction is represented in the log10k1 log10k2 versus MgCl2 concentration plot, which shows a more pronounced decrease in k2
as the concentration of MgCl2 is reduced (Figure 3.3C). These data suggest that divalent
metal ion regulates the rate of both nicking reactions, but that the second strand nicking
reaction has a more stringent requirement for divalent metal than the first nicking
reaction.

3.3.3 Assays with mutant substrates reveal three distinct cleavage
phenotypes
To further probe the contribution of divalent metal ion and DNA sequence to the
sequential nicking reactions by I-BmoI, we performed time-course cleavage assays with
various supercoiled mutant substrates at 2 mM and 10 mM MgCl2. We took advantage of
a series of previously constructed substrates (26), whereby positions -6 through -1 of
intronless thyA substrate were individually and in combination changed to the
corresponding intron-containing sequence (Figure 3.1 and Table 3.2), which I-BmoI does
not cleave. End-point assays with these substrates highlighted the importance of the GC-2
base pair in the generation of a DSB by I-BmoI (26). The previous assays, however, were
incapable of distinguishing defects in each independent nicking reaction because they
were performed on linearized plasmid substrates in 10 mM MgCl2. Time-course assays
using mutant cleavage site plasmids revealed that the substrates segregated into three
distinct classes (Figure 3.4 and Table 3.2). Class I mutants were defined as substrates that
behaved essentially as intronless thyA substrate, showing slightly reduced nicking and
slower conversion of nicked intermediate to linear product at 2 mM versus 10 mM MgCl2
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Figure 3.3: Limiting divalent metal ion has a greater effect on second strand than
first strand nicking
	
  
Shown are representative images of time-course cleavage assays with supercoiled
substrate containing the intronless thyA target site and I-BmoI in (A) 0.5 mM MgCl2 and
(B) 10 mM MgCl2, as well as progress curves for each condition. Circular substrate (C),
nicked intermediate (N) and linear product (L) are indicated on the gel images. Individual
data points from three independent replicates are shown in the progress curves, and the
solid continuous lines are the best fit of the data to equations 1 and 2. (C) Plot of the
log10k1 - log10k2 value for MgCl2 concentrations tested.
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Table 3.1: Rate constants for first- and second-strand nicking reactions in different
MgCl2 concentrations

a

[MgCl2] (mM)

k1 (s-1)a

k2 (s-1)

10
7
5
2
1
0.5

0.10 ± 0.007
0.10 ± 0.005
0.079 ± 0.004
0.056 ± 0.001
0.037 ± 0.0006
0.019 ± 0.0002

0.078 ± 0.008
0.060 ± 0.003
0.050 ± 0.002
0.036 ± 0.001
0.013 ± 0.0004
0.0064 ± 0.0002

k1 and k2 rate constants are reported as the best fit value of three independent
experiments with standard error.
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Table 3.2: Summary of cleavage data for intronless and mutant substrates
Rate constants (s-1) a
Substrate
(intronless)

Class I
(like wild-type)
Class II
(rescue)

2mM MgCl2

-6

-5

-4

-3

-2

-1

k1

G

C

C
A

C

G

T

0.057
0.05
0.057
0.031
0.01
0.0095
0.0082
0.0044
0.011
0.0045
0.00027
n.d.
n.d.
n.d.
n.d.
0.00037
n.d.
0.00016
n.d.
n.d.
0.0002
n.d.
n.d.

T
G
G
A

T
T

A
A
A

A
A

G

A

Class III
(no rescue)
G
A
A
A
A
T

(intron-containing)
a

b

T

A
A
A

A
A
A
A
A

G
G
G
G
G
G
G

T
T
T
T
T
T

G

G
G

T
T
T
T

G

k2

c

0.026
0.028
0.024
0.0095
0.0084
0.016
0.0091
0.015
0.017
0.015
n.d.d
n.d.
n.d.
n.d.
n.d.
0.00053
n.d.
n.d.
n.d.
n.d.
0.0017
n.d.
n.d.

10mM MgCl2
k1

k2

0.11
0.1
0.087
0.065
0.025
0.031
0.024
0.014
0.028
0.014
0.00061
n.d.
n.d.
n.d.
n.d.
0.0013
n.d.
0.00035
n.d.
n.d.
0.00052
n.d.
n.d.

0.074
0.057
0.058
0.025
0.025
0.042
0.022
0.043
0.048
0.047
n.d.
n.d.
n.d.
n.d.
n.d.
0.014
n.d.
0.0026
n.d.
n.d.
0.0091
n.d.
n.d.

Rate constants were determined from three independent experimental trials for all substrates.
k1, the rate constant for the first nicking reaction that generates nicked intermediate from
circular substrate (expressed as the median of a 95% confidence interval, see Supplementary
Table S3.3)
c
k2, the rate constant for the second nicking reaction that generates the linear product (expressed
as the median of a 95% confidence interval, see Supplementary Table S3.3)
d
n.d. not determined.
b
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Figure 3.4: Magnesium concentrations reveal three distinct classes of substitutions
Cleavage assays with I-BmoI were conducted on supercoiled plasmid substrates
containing substitutions at positions -6 to -1 in the presence of 2 mM or 10 mM MgCl2
(see also Table 2). Mutant substrates were arranged into three classes. (A) Substrates that
showed a phenotype similar to wild-type intronless thyA substrate (class I); (B) substrates
that demonstrated poor cleavage in 2 mM MgCl2 and rescued cleavage in 10 mM MgCl2
(class II); (C) substrates with significantly reduced or no cleavage (class III). Shown are
representative gel images of time-course cleavage assays, where the second lane from the
left contains unreacted plasmid substrate (-). Nicked (N), linear (L), and circular (C)
plasmid forms indicated to the right. Beneath each gel image is a graphical representation
of reaction progress over time in 2 mM and 10 mM MgCl2 using dashed and solid lines,
respectively. Data points representing three independent experiments for class I and II,
and two experiments for class III are shown.
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(Figure 3.4A). The substrates were those with substitutions C-4A or G-6T, and the rate
constants for the first and second strand nicking reactions in low and high MgCl2 were
very similar to those obtained for intronless thyA substrate (Table 3.2 and Supplementary
Table S3.3).
Class II mutants were defined as substrates that exhibited a greater impairment of first
and second strand nicking in low versus high MgCl2 conditions. This class included the
singly mutated substrates T-1G, C-3G, and C-5A, as well as the multiply substituted C3G/C-4A, C-4A/C-5A, C-5A/G-6T and C-4A/C-5A/G-6T substrates (Table 3.2). The
general characteristics of substrates in this class were the accumulation and persistence of
the nicked intermediate in 2 mM MgCl2 (which resulted in impaired double-strand break
formation), and the rescue of cleavage in 10 mM MgCl2 resulting in the near complete
conversion to linear product by 180 seconds (Figure 3.4B and Table 3.2). Rate constant
analysis indicated a further segregation of substrates within class II by differential basespecific effects on first and second strand nicking reactions (Table 3.2). The T-1G
substitution decreased the first (k1) and second (k2) strand rates by roughly 2- and 3-fold
versus intronless thyA substrate in the presence of 2 mM and 10 mM MgCl2, respectively,
suggesting a more profound modulation of second-strand nicking. The C-3G substitution,
which displayed similar defects in the presence or absence of a C-4A substitution,
generated approximately 5- and 3- fold reductions in k1 and k2 versus intronless substrate,
regardless of MgCl2 concentration. Interestingly, the C-5A substitution, alone or in the
context of a G-6T substitution, decreased k1 by roughly 6- and 3-fold in the presence of 2
mM and 10 mM MgCl2, respectively. The addition of a C-4A substitution to the C-5A
template exacerbated the k1 defect to 12- and 9-fold in the presence of 2mM and 10 mM
MgCl2. Surprisingly, the C-5A substitution showed less of an influence on the secondstrand nicking rate (k2), evidenced by a 1.5-fold rate reduction in both MgCl2
concentrations. This result was observed with the C-5A substitution alone or in the
context of the double mutation with C-4A.
Class III mutants were defined as substrates with drastically reduced reaction rates that
displayed little or no cleavage in either low- or high-metal ion conditions (Figure 3.4C
and Table 3.2). All substrates with mutations at the -2 position fell into this category, in
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addition to substrates with mutations at both the -5 and -3 positions. Interestingly, we
observed that the G-2T substitution alone, and in combination with substitutions at
positions -1 or -4 and -6, demonstrated limited accumulation of nicked intermediate at
180s in high metal. First strand nicking rates (k1) for class III substrates were 84- to 314fold reduced as compared to intronless thyA substrate, indicating a substantial first strand
defect. Additionally, we observed that the substrates containing a combination of C-3G
and C-5A mutations retained low levels of double-strand break formation after 180s in 10
mM MgCl2, and that the addition of a T-1G or C-4A mutation did not abolish the low
amount of cleavage. Importantly, the intron-containing substrate showed no evidence of
nicking or cleavage after 180 seconds under either condition tested (Table 3.2).
Collectively, the cleavage assays indicated that substrates with individual mutations at
positions -4 or -6 had little effect on first- or second-strand nicking in either low or high
metal ion conditions. Additionally, substrates with single mutations at positions -1, -3 or 5 exhibited defects in both first- and second-strand nicking in low metal conditions and
an observable rescue of cleavage by high divalent metal ion. Substrates with mutations at
both the -3 and -5 positions were not significantly rescued by high metal ion, and those
with mutations at position -2 were defective for cleavage under all conditions tested.

3.3.4 In-gel footprinting reveals multiple minor groove distortions
dependent on GC-2
The cleavage data suggested that divalent metal ion and the GC-2 base pair are required
for efficient double-strand break formation. To gain further insight into the role of the
GC-2 base pair in the cleavage pathway, we performed in-gel footprinting with the minor
groove-specific reagent 1,10-copper phenanthroline (OP-Cu). I previously used in-gel
footprinting to show that significant OP-Cu hypersensitive sites were localized to
positions -2 and -1 of the bottom strand of the I-BmoI-thyA complex (24), consistent with
protein-induced DNA distortions that make the minor groove more accessible to OP-Cu.
The distortions were also present in I-BmoI-substrate complexes formed with the
catalytic mutants R27A and E74A, implying that the distortions precede first-strand
nicking and do not require the presence of a metal ion bound by E74 (24). Previous
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footprinting studies, however, did not explore the requirement of the GC-2 base pair in
formation of OP-Cu hypersensitive sites.
We performed in-gel footprinting with a 74-mer duplex oligonucleotide substrate
corresponding to the intron-containing substrate (In+), which contains an alternative
sequence upstream of the insertion site relative to the intronless substrate and notably has
a G-2T substitution (Figure 3.5). As shown in Figures 3.5B and 3.5C, the OP-Cu
hypersensitive sites at positions -2 and -1 on the bottom strand were significantly reduced
in the UC consisting of I-BmoI-In+ substrate as compared to UC formed with intronless
thyA substrate. We next mutated the GC-2 base pair within the context of the intronless
substrate to TA-2, AT-2 or CG-2, and measured the extent of the OP-Cu hypersensitive
sites at positions -2 and -1 on the bottom strand. These three mutations reduced the OPCu hypersensitive sites to the same extent as was observed with intron-containing
substrate (Figure 3.5B and 3.5C), indicating the GC-2 base pair is critical for inducing
DNA distortions that result in enhanced OP-Cu sensitivity. To provide further evidence
for this model, we tested a T-2G substitution within the context of the intron-containing
substrate (Figure 3.5A), reasoning that this mutation should restore the OP-Cu
hypersensitivity if contacts to the GC-2 base pair are required for minor-groove
distortions. Indeed, footprinting reactions on the T-2G intron-containing substrate
revealed a restoration of OP-Cu hypersensitivity at positions -2 and -1 to approximately
half of those observed on thyA intronless substrate. Products seen at the -4 position are
indicative of bottom-strand nicks observed when I-BmoI-thyA complexes were formed
in-gel in the absence of exogenously added metal (24), as Cu2+ is not a productive
divalent metal ion for cleavage (Figure 3.2A).

3.3.5 Modeling of an I-BmoI-substrate complex
To gain insight into the role of divalent metal ion and substrate contacts in the I-BmoI
reaction pathway, we used the recently solved co-crystals of the GIY-YIG restriction
enzymes Eco29kI and Hpy188I with their respective substrates to model an I-BmoIsubstrate complex (36,37). Eco29kI and Hpy188I function as dimers to cleave
palindromic sites, with each GIY-YIG monomer nicking one strand of the
substrate(37,39). We first generated a homology model of residues 1-92 of I-BmoI based
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Figure 3.5: The GC-2 base pair is required for minor-groove distortions near the
bottom-strand nick site
(A) Illustration of base pairs -6 to +7 of the intronless (In-), intron-containing (In+), and
mutant 74-mer substrates used for in-gel 1,10-phenanthroline copper (OP-Cu)
footprinting reactions. First- and second-strand nicking sites are indicated by open and
filled triangles, respectively. (B) Representative denaturing gel image of OP-Cu
footprinting reactions on bottom-strand labeled In-, In+, and mutant substrates. Nicked
products at -4 and minor groove distortions at positions -2 and -1 are indicated using
filled triangles, asterisks, and greater-than symbols, respectively. Sequence upstream of
the intron insertion site (IS) varies whether the intronless or intron-containing substrate
was used as a template. (C) Graphical representation of the minor groove sensitivity to
OP-Cu at positions -2 (asterisk, blue) and -1 (greater than symbol, purple) for In-, In+,
and mutant substrates, expressed as the ratio of normalized phosphorimager units of the
upper complex (UC) and unbound substrate (UNB).
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on the closely related I-TevI GIY-YIG domain structure (38). Next, we superimposed the
I-BmoI model on a monomer of the dimeric Eco29kI and Hpy188I structures by aligning
residues 6-10 of I-BmoI with the structurally analogous amino acids of Eco29kI (residues
47-51) and Hyp188I (residues 61-65) (which included key structural resides of the βsheet 1). We observed that the position of the I-BmoI active site residues (Y6, Y17, R27,
H31, E74 and N87) aligned well with the homologous residues in both restriction
enzymes (Figure 3.6A and data not shown), as was observed in two other structure
superposition studies (36,37). To model the position of the substrate in the I-BmoI active
site, we included the substrate DNA from the Eco29kI structure, and similar results were
obtained using the DNA from the Hpy188I structure. As shown in Figure 3.6, the path of
the DNA follows a previously hypothesized catalytic cleft that is lined by the active site
residues of I-BmoI (41), with the metal ion coordinated by E74 positioned in close
proximity to the bottom-strand scissile phosphate at position -4. Of particular interest are
the OP-Cu hypersensitive sites at positions -2 and -1 of the bottom strand that result from
a widening of the minor groove. These distortions could place the base edge of the
bottom strand C of the critical GC-2 base pair within hydrogen bonding distance of a
number of side chains, highlighting the importance of this base pair in the cleavage
pathway. The model also reinforces the notion that the role of divalent metal ion in
promoting second-strand nicking must be in repositioning of the substrate-DNA complex
rather than by directly participating in DNA hydrolysis.

3.4 Discussion
Enzymes that function as DNA endonucleases almost always require the presence of
active site divalent metal ions (8,42,44). In general, the preferred ion is magnesium,
which acts to catalyze reaction progress by stabilizing negative phosphoanion transition
states, or by acting as Lewis acids to modulate the pKa of coordinated water molecules
(42,44). Metal-activated water molecules can function as catalytic agents by adopting the
roles of nucleophiles and general bases, or by protonating leaving groups (44,47).
Families of site-specific DNA endonucleases have distinct metal ion requirements, and
generally function by either a one- or two-metal ion mechanism (44,47). The metal ion
requirements for homing endonucleases are best understood for the LAGLIDADG family
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Figure 3.6: Model of I-BmoI GIY-YIG domain interactions with substrate
(A) Cartoon representation of the I-BmoI GIY-YIG domain homology model (gray) (41)
aligned with the solution structure of related GIY-YIG restriction enzyme Eco29kI
(3MX1, blue) (36). The side chains of the conserved and catalytically relevant residues
Y6, Y17, R27, H31, E74, and N87 of I-BmoI are shown in black, and equivalent Eco29kI
residues in orange (Y49, Y76, R104, H108, E142, and N154). The position of divalent
metal coordinated by Eco29kI is represented by the red sphere. (B) Cartoon
representation of the I-BmoI homology model aligned with a segment of the DNA from
the substrate-bound Eco29kI structure (3N1C, -4C to +5C). The top strand of the
Eco29kI substrate is labeled according to the nucleotides of the I-BmoI intronless allele (8G to +1A). The phosphate of the bottom strand nick site is highlighted in blue, the
bottom strand distortions at positions -2 and -1 are shown in green, and the -2GC base
pair is shown as a stick model in red. (C) Surface representation of the GIY-YIG domain
for the model shown in panel (B). (D) Similar to panel (C), with a 90° rotation of the
model on the horizontal axis, and a 180° rotation around the vertical axis.
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that have an active-site preference for magnesium, and can uniquely function by a twometal mechanism where a third divalent metal ion is shared between two active sites
(8,48,49). The H-N-H homing endonuclease I-HmuI, which generates single-stranded
nicks in DNA substrates, functions optimally at 1 mM MgCl2 or MnCl2 and nicks via a
one-metal ion mechanism (43). Studies of the related H-N-H colicin E9 revealed different
divalent metal ion requirements for cleavage of distinct nucleic acid substrates, with
magnesium promoting cleavage of dsDNA and zinc being more effective for nicking of
ssDNA (50). I-PpoI, a His-Cys box homing endonuclease, functions by a one-metal ion
mechanism and requires zinc and magnesium for folding and cleavage, respectively
(8,51). The focus of this paper, the GIY-YIG homing endonucleases, have traditionally
been studied in the presence of magnesium that structural studies indicate is coordinated
by a conserved active site glutamate (E74 in I-BmoI) (38). GIY-YIG enzymes likely use
a single-metal ion to promote DNA hydrolysis (36,37), and our data agrees with studies
of the tetrameric GIY-YIG restriction enzyme Cfr42I that revealed a broad tolerance to
divalent-metal ion (31).
Among the GIY-YIG family of enzymes, there is tremendous diversity in how the GIYYIG nuclease domain is utilized to hydrolyze DNA. For instance, the restriction enzymes
Eco29kI and Hpy188I function as dimers (37,39), with each GIY-YIG monomer nicking
one strand, whereas the UvrC nucleotide excision repair protein uses a single GIY-YIG
domain to nick 3’ to a mutagenic lesion (40). In this respect, GIY-YIG homing
endonucleases differ from characterized GIY-YIG enzymes that make a DSB in that a
single catalytic domain is used in two ordered and sequential nicking reactions to
generate a DSB (24,25). How the single active site of the GIY-YIG nuclease domain is
reorganized on substrate between nicking reactions is unknown, but previous studies
suggested an involvement of divalent metal ion in this process (24). Our current study
more accurately defines the roles of divalent metal ion and DNA substrate bases in this
process as evidenced by reaction conditions that differentially affect k1 or k2. Not
surprisingly, substrates that contained a mutation in the critical GC-2 base pair displayed
drastically impaired rate constants, indicating a severe defect in first-strand nicking and
an inability to form a DSB. Interestingly, bases surrounding the bottom-strand nicking
site at positions -4 and -5 also resulted in reduced nicking rates when mutated. This
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observation was somewhat surprising as previous studies had not revealed a critical role
of these positions for cleavage by I-BmoI (26), likely because past studies examined only
linear product formation under high metal conditions rather than employing reactions
conditions that could temporally dissect base-specific nicking effects. The I-BmoIsubstrate model predicts that multiple amino acid side chains within the catalytic cleft
project into the major groove near positions -4 and -5, implying that base pair
substitutions result in altered contacts that consequently reduce k1. The observation that
k1 defects associated with these substrates were significantly rescued in the presence of
10 mM MgCl2 suggests that magnesium can compensate for lost I-BmoI-substrate
interactions by promoting alternative conformations of protein or substrate within the
catalytic cleft that facilitate cleavage. Additionally, substitutions near the bottom strandnicking site had a comparatively insignificant effect on the top strand-nicking rate (k2),
which is in agreement with the bottom strand contacts being necessary only for k1.
A crucial aspect of the I-BmoI cleavage pathway is the introduction of a significant minor
groove distortion in thyA substrate (24); similar DNA-bending was also observed in ITevI-td substrate complexes (25). These protein-dependent DNA distortions are observed
in the absence of exogenous magnesium, and the precise role of these distortions in the
cleavage pathway is unknown. Parallels can be drawn with other site-specific
endonucleases, as large DNA distortions have been shown to bring opposite strand
scissile phosphates into close proximity (52). Conversely, the natural curvature of nucleic
acids is highly sequence dependent and can be influenced by the presence of divalent
metal ions (53-55). Interestingly, magnesium ions have been shown to induce much
greater changes in the curvature of GC- versus AT-rich DNA (53). In this respect, it is
noteworthy that the DNA distortions introduced by I-BmoI and I-TevI occur in stretches
of GC-rich DNA (24,25), suggestive of distinct metal dependent and protein induced
distortions that promote substrate conformational changes between nicking reactions. It is
possible that aside from directly participating in catalysis, magnesium may induce a
secondary substrate conformation that is distinct from the distortion resulting from
contacts to the GC-2 base pair. Reduced rate constants observed for I-BmoI on mutant
substrates can therefore be rationalized by lack of base-specific contacts to the GC-2 pair
and to other positions, as well as the sequence-dependence of DNA distortions induced
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by magnesium. Decreased fidelity of I-BmoI on the G-2T substrate in the presence of
manganese can alternatively be explained by different protein-DNA conformations
promoted by manganese ions relative to magnesium, as they have differential effects on
natural DNA curvature (56).
Similar roles for metal ions in promoting protein-DNA interactions and conformational
changes required for efficient catalysis have been dissected in other enzyme systems
where a single active site is used sequentially to perform multiple reactions (57). Notably,
sub-optimal magnesium concentrations can uncouple excision and strand transfer events,
and manganese can reduce target site specificity of the Tn10 transposase (57). However,
the modular structure of I-BmoI and other GIY-YIG homing endonucleases resembles
that of Type IIs restriction enzymes, including the well-characterized FokI that is a
monomer in solution but transiently dimerizes to generate a DSB (58,59). The FokI
cleavage mechanism has been suggested as a solution to how the single active site of
GIY-YIG homing endonucleases is used to affect a double-strand break (38).
Interestingly, divalent metal ion has been shown to stabilize the FokI dimer/substrate
complex (59), and it is possible that a reduction in the k2 rate constant we observe in low
magnesium conditions reflects a defect in transient dimerization between I-BmoI
monomers. No obvious dimer interface was evident in the structure of the I-TevI catalytic
domain (38), which shares high identity with that of I-BmoI, but it is possible that
dimerization determinants lie outside of the catalytic domain. Interestingly, the type IIs
enzyme Eco31I also has a modular structure but binds and cleaves DNA as a monomer
(60), suggestive of mechanistic similarities to I-BmoI and I-TevI.
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Chapter 4

4

The monomeric GIY-YIG homing endonuclease I-BmoI
uses a molecular anchor and a flexible tether to
sequentially nick DNA

The work presented in this chapter is reproduced from (with permission, Appendix 1) the
accepted version of:
Kleinstiver, B.P., Wolfs, J. W., Edgell, D.R. (2013) The monomeric GIY-YIG homing
endonuclease I-BmoI uses a molecular anchor and a flexible tether to sequentially
nick DNA. Nucleic Acids Research, doi: 10.1093/nar/gkt186

4.1 Introduction
Site-specific DNA nucleases are central to many cellular processes, including DNA
recombination and repair, restriction defense systems, and the mobility of selfish genetic
elements (1,2). A number of nuclease active sites have evolved that are characterized by
conserved amino acid motifs and operate via distinct catalytic mechanisms to generate
nicks or double-strand breaks (DSBs) in DNA (1-3). There is often little correlation
between the identity of the nuclease active site motif and cellular function, as conserved
catalytic cores from individual nuclease families are found within diverse protein
scaffolds (1,4). As such, a fundamental understanding of the mechanisms by which each
nuclease family generates a DSB is required, as several families have been exploited for
genome engineering purposes (5-9).
One such nuclease family contains the GIY-YIG catalytic motif, consisting of a compact
domain of ~100 amino acids that is characterized by at least two α-helices that surround a
three-stranded β-sheet (10-14). The catalytic core includes a number of conserved amino
acids that are essential for DNA-hydrolysis via a one-metal ion mechanism (14). The
minimal GIY-YIG nuclease domain is often found associated with protein scaffolds that
function to anchor the GIY-YIG domain in close proximity to DNA, implying that the
GIY-YIG domain itself has weak DNA-binding activity (15-20). Included in this
category is the nucleotide excision repair protein UvrC that has acquired distinct binding
domains and uses a single GIY-YIG domain to nick 3’ to DNA lesions (11).
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Alternatively, the restriction enzymes Eco29kI and Hpy188I have acquired
supplementary units of structure that are intertwined within the conserved GIY-YIG
domain to promote oligomerization and assembly on DNA, with each GIY-YIG
monomer nicking one strand (13,14,19,21). The GIY-YIG nuclease domain is also found
within homing endonucleases (GIY-HEs) as an N-terminal fusion to sequence-tolerant
DNA-binding domains that target extended asymmetric binding sites (22,23).
GIY-HEs function as mobile genetic elements by introducing DSBs at a defined site
within naïve genomes to promote mobility of their own genes (2,24,25). I-TevI and IBmoI, encoded within introns interrupting the td and thyA thymidylate synthase (TS)
genes of bacteriophage T4 and Bacillus mojavensis, remain the best-characterized GIYHEs to date, however sequencing efforts have identified additional putative GIY-HEs
(26-28). I-BmoI and I-TevI bind a homologous target site in their respective TS genes
and consist of N-terminal GIY-YIG domains connected by linkers to C-terminal domains
that contact 30-35 base pairs of substrate (Figure 4.1A) (15,23,29). Studies of I-TevI
indicate that the inter-domain linker is flexible (29,30), supported by its ability to position
the catalytic domain on substrate. The modularity of GIY-HEs is also evidenced in their
cognate target sites, as the asymmetric target sequences contain distinct motifs for DNA
binding and cleavage (15). The I-BmoI and I-TevI target sites share 48% identity and
previous in vitro substrate selections identified a conserved G-C base pair that flanks the
I-BmoI and I-TevI cleavage sites as critical for cleavage (Figure 4.1A) (31,32). Contacts
to the G-C base pair are essential for both GIY-HEs to perform the sequential and
independent nicking reactions to generate a DSB with a 2-nt 3’ overhang (23,33,34).
Previous studies with I-TevI showed that the two-domain enzyme bound DNA as a
monomer and induced significant substrate bending near the cleavage site (35), while
chimeric enzymes with the I-TevI nuclease domain fused to the ryA zinc-finger generated
a DSB in a non-cooperative manner (9).

Kinetic analyses of the two-step nicking

reaction using I-BmoI showed that the first-strand nicking reaction proceeds
approximately 2-fold faster than the second nicking reaction (28). Moreover, divalent
metal ion and DNA sequence at the cleavage site influences I-BmoI activity, likely by
modulating local DNA structure and promoting sequential protein interactions with bases
in the cleavage site region (36). However, the central question of how the single active
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Figure 4.1: I-BmoI interactions with substrate and monomeric cleavage models
(A) Schematic of the modular structure of I-BmoI interacting with intronless thyA
substrate. Bottom- and top-strand nicking sites are indicated by filled and open triangles,
respectively. IS, intron-insertion site. NUMOD; nuclease-associated modular DNAbinding domains. (B) Models for double-strand break formation by monomeric nucleases
with single active sites. For transient dimerization, the secondary enzyme molecule can
dimerize with the primary DNA-bound molecule from solution or via synapsis as a
substrate-bound molecule at an additional target site.
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site of GIY-HEs is utilized to successively nick each DNA strand has not been rigorously
addressed. Based largely on studies with I-TevI, a conformational change model was
proposed whereby the GIY-YIG nuclease domain and substrate undergo substantial rearrangements between nicking reactions to reposition the active site (Figure 4.1B) (35).
However, the extreme cytotoxicity of I-TevI precluded detailed kinetic studies that could
rule out alternative mechanisms of DSB formation by monomeric nucleases, including
transient dimerization between catalytic domains, synapsis of two enzymes bound to
separate target sites, or cleavage through sequential transesterification reactions (Figure
4.1B) (37-39).
Here I capitalize on the ability to purify wild-type I-BmoI to explicitly test models of
DSB formation. Significantly, we show that I-BmoI functions as a monomer at all stages
of the reaction pathway and does not use a hairpin mechanism for DNA cleavage. The
data are consistent with a model where the monomeric GIY-YIG domain rotates between
nicking sites to generate a DSB, with the I-BmoI DNA-binding domain functioning to
anchor the linker and nuclease domain to substrate. I envision that a better understanding
of the catalytic mechanism will provide insight into the ability of GIY-HEs to invade a
diverse range of biological alleles, as well as enhance ongoing efforts to utilize the GIYYIG nuclease domain as a genome-editing tool.

4.2 Materials and methods
4.2.1 Strain and plasmid construction
A complete description of strains and plasmids used in this study are found in
Supplementary Table S4.1. E.coli strains DH5α, ER2566, and BW25141(λDE3) were
used for plasmid manipulations, expression studies, and genetic selections, respectively.
Sequences and details of oligonucleotides are in Supplementary Table S4.2. Full-length IBmoI, R27A I-BmoI, and N- and C-terminal truncations were expressed and purified as
previously described (28). Codon optimized N- and C-terminal I-BmoI domain
truncations were cloned by PCR using Phusion (N.E.B.) into the NdeI and KpnI sites of
pTYB1. To construct plasmid pLBmo, the PvuII fragment of pBmoHS was subcloned
into the PvuII site of LITMUS28i (N.E.B.). A duplex 49mer oligonucleotide containing
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the I-BmoI thyA target site (DE-906/907) was ligated into the SwaI site of pLBmo in the
opposite or same orientation as the primary I-BmoI target site to generate the 2-site
plasmids pLBmo2a and pLBmo2b, respectively. Quikchange (Stratagene) reactions were
performed on pLBmo to generate pLBmoNa and pLBmoNb by introducing Nt.BbvCI
sites 1082 or 60 base pairs from the I-BmoI top-strand nick site, respectively. Both
Nt.BbvCI sites were introduced into pLBmo to generate pLBmo2N.
To create the pTox plasmid, Quikchange was performed (DE-1171/1172) to remove the
EcoRI site from p11-lacY-wtx1 (40) and an oligo cassette containing an EcoRI site (DE1173/1174) was ligated into XbaI/SphI. The kanamycin-resistant pKox plasmid was
generated by cloning the kanamycin resistance gene into the ScaI site of pTox. The
vectors pKoxBmoHS and pKoxBmoIn+ were similarly generated from their respective
pTox precursors (28). pTox and LITMUS28i plasmids containing variant I-BmoI homing
sites with G+7A, G+7C, or G+7T mutations were generated by ligating the appropriate
duplex oligos into XbaI/EcoRI of either vector. Plasmid constructs with nucleotide
insertions in the I-BmoI homing site were generated by ligating the appropriate oligos
into XbaI/EcoRI of LITMUS28i. All plasmid constructs were verified by sequencing.

4.2.2 Identification of I-BmoI domains
Limited proteolysis trials were conducted in reactions containing 1X binding buffer (50
mM Tris-HCl pH 8.0, 50 mM NaCl, 1mM DTT), 5 µM I-BmoI, and 5.5 µM intronless
thyA (DE-116/117), intron-containing (DE-444/445), non-specific (DE-144/144GC), or
mutant (see below) 74-mer duplex oligonucleotide substrates. Reactions were incubated
at room temperature for 5 minutes and an aliquot (‘0’ time-point) was extracted prior to
the addition of either 50 ng trypsin, 100 ng chymotrypsin, 5 ng substilisin A, or 1 µg
elastase in 1X protease dilution buffer (20 mM Tris-HCl pH 7.9, 50 mM KCl, 10 mM
MgSO4). Aliquots were removed from the digest, added to stop buffer (100 mM EDTA
pH 8.0, 150 mM Tris-HCl pH 6.8, 4.8 % SDS, 24% glycerol), and boiled at 95oC prior to
electrophoresis on 15% SDS-PAGE gels. Coomassie stained bands of stable domains
were excised prior to in-gel trypsin digestion at the London Regional Proteomics Facility.
Recovered peptides were subjected to MALDI-TOF mass spectrometry and the results
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analyzed using the UCSF MS-Bridge webpage. To delineate the boundary of the trypsinand elastase-stable catalytic domain, LC mass spectrometry was performed on a 3Q mass
spectrometer (Micromass) equipped with a Z-spray source and run in positive ion
nanospray mode. Results were analyzed using MassLynx 4.0.

4.2.3 Biophysical characterization of I-BmoI
Differential scanning calorimetry was performed using a VP-DSC MicroCalorimeter
(MicroCal) equilibrated with buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 5%
glycerol) in a 500 µl cell at the Biomolecular Interactions and Conformations Facility at
the University of Western Ontario. Trials consisted of 5.2 µM I-BmoI in the presence or
absence of 5.9 µM thyA 74-mer duplex oligonucleotide substrate, with a heating rate of
1°C/minute from 10-100°C. Data were analyzed with MicroCal Origin 7 software
(including corrections for buffer baseline and protein concentration) using a two-state
model that assumes a single independent unfolding transition (41).

4.2.4 DNA-binding affinity of I-BmoI domains
Binding reactions contained 250 mM NaCl, 50 mM tris pH 8.0, 2.5 mM EDTA, 1 mM
DTT, 5 ng/µl poly dIdC, 5% glycerol, and 0.25 nM of intronless thyA, intron-containing,
or randomized 74-mer substrates radio labeled on the top strand with γ-32P. Serial
dilutions of the I-BmoI domain truncations were added to the reaction mixture prior to
incubation at room temperature for 15 minutes and the addition of loading buffer.
Reaction were loaded on 10% native polyacrylamide (19:1) and visualized using a
Phosphorimager (GE Healthcare). Data were fit to the equation
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4.2.5 Gel filtration chromatography
I-BmoI and I-BmoI:thyA complexes (DE-130/131) were incubated at room temperature
for 10 minutes, spun for 10 minutes at 9300x g, applied to a Superose 12 10/300 GL
column (Amersham Biosciences) pre-equilibrated with dialysis buffer (25mM Tris-HCl
pH 8.0, 500mM NaCl and 5% glycerol), run at 4°C at a flow rate of 0.5 ml/min. Fractions
of 0.25 ml were collected and run on a 12% SDS-PAGE gel (29:1 (w/w) acrylamide to
bis-acrylamide) and a 1% agarose gel. Protein standards used to calibrate the column:
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carbonic anhydrase, 29 kDa; albumin, 66 kDa; β-amylase, 200 kDa; and apoferritin, 443
kDa. The calibration curve was used to calculate the molecular masses of I-BmoI, thyA
substrate, and the I-BmoI:thyA complex by interpolating elution volumes onto the curve.

4.2.6 Cleavage assays with plasmid substrate
The dependence of the initial reaction velocity on protein concentration was determined
by cleavage reactions containing 20 mM Tris-HCl pH 8.0, 250 mM NaCl, 2 mM MgCl2,
2.5% glycerol,10 nM pBmoHS, and I-BmoI (5.5 nM to 175 nM). Aliquots were removed
at time points into stop dye (100 mM EDTA, 25% glycerol, 0.2% bromophenol blue),
heated for 5 minutes at 95°C, electrophoresed on a 1% agarose gel, and stained in
ethidium bromide (Caledon) solution prior to analysis on an AlphaImagerTM3400 (Alpha
Innotech). Rate constants were calculated as best fit value of at least three experiments, as
previously described (9). Initial reaction velocities were determined by calculating the
slope of the line for the early time points of product formation. All subsequent plasmid
cleavage assays were conducted as described above with exceptions indicated below.
Two-site plasmid cleavage assays were performed on the single-site pLBmo plasmid and
two-site pLBmo2a and pLBmo2b plasmids. Reactions were supplemented with either 2
mM or 10 mM MgCl2, and I-BmoI was added to a final concentration of 22.1 nM, 54.3
nM, or 87.5 nM. Domain addition assays were performed on pBmoHS with 10 mM
MgCl2. I-BmoI was added to 11 nM or 22 nM in reactions containing 11 µM N111 IBmoI, N130 I-BmoI, or BSA (1000- or 500-fold excess domain, respectively). Assays on
plasmids with nucleotide insertions or G+7 substitutions were performed on pLBmo,
pLBmo+5T, pLBmo+5C pLBmo+3Ta, pLBmo+3Tb, pLBmo+3Ca, pLBmo+3Cb,
pLBmoG+7A, pLBmoG+7C, and pLBmoG+7T. Reactions were supplemented with 0.5
mM, 2 mM, or 10 mM MgCl2, and 87.5 nM I-BmoI.

4.2.7 Gel-mobility shift assays with pre-nicked substrates
Binding reactions were assembled in the presence of 10 mM EDTA or 10 mM MgCl2 and
run as previously described (34). To generate the 3 substrates required, the top strand
74mer (DE-116) was 5’ labeled with γ-32P prior to annealing with the complement full-
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length bottom-strand oligo (DE-117) to generate the thyA substrate (WT). The substrate
with the 3’-OH -5/-4 bottom strand nick was generated with a 3’-23mer (DE-125) and 5’51mer (DE-123) (-4 nick). To create the -5/-4 bottom strand nick substrate with a 3’-H (4 ddGTP), the 3’-23mer (DE-125) and 5’-50mer (DE-124) that had been extended with
ddGTP by terminal transferase (N.E.B.) were used. To ensure addition of a single ddGTP
nucleotide to DE-124, we analyzed the product of the terminal transferase reaction by
denaturing electrophoresis that revealed only a single nucleotide addition as compared to
an unreacted DE-124 oligonucleotide.

4.2.8 thyA cleavage site and spacer selection
The 4 bp upstream and 9 bp downstream of G-2 in the thyA substrate were randomized to
generate the pKoxRCS library (DE-1228, GCGGAATTCGANNNNGNNNNNNNNNCATGGCCTTGGGAAATCCCTTCAATGTATTCCGGCATG).

A 5’-phosphorylated primer (DE-1229) complimentary

to the underlined sequence was annealed to leave a 4-nt 3’ SphI overhang. The library
was made double stranded by extension with 3’5’ exo- Klenow Fragment (N.E.B.),
digested with EcoRI, and ligated into EcoRI/SphI cut pKox. The potential complexity of
the library was estimated to be approximately 1.6 x 104 based on the number of
independent transformants.
To screen pKoxRCS for cleavable target sites, 60 µl of BW25141(λDE3) cells harboring
pACYCIBmoI were transformed with 200 ng of pKoxRCS. Transformations were
allowed to recover in 500 µl SOC at 37°C prior to plating on non-selective media (LB
plus 25 µg/ml chloramphenicol, 50 µg/ml kanamycin, and 0.2% glucose). 2400
transformant colonies, representing ~15% of the library, were replica-gridded on nonselective and selective media (LB plus 25 µg/ml chloramphenicol and 10 mM L-(+)arabinose). Colonies containing cleavable substrates survived on both media, whereas
those with non-cleavable substrates survived only on non-selective media. 86 colonies
were verified as cleavable by replica-gridding in triplicate, and 96 clones were verified as
non-survivors. The survivors and non-survivors were grown in separate 96-well plates in
1 ml LB + 50 µg/ml kanamycin and 0.2% glucose, and 200 µl from each well was pooled
prior to DNA extraction to generate survivor and non-survivor plasmid libraries.
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Samples were prepared for Ion Torrent sequencing at the London Regional Genomics
Centre by PCR amplifying the survivor, non-survivor, and pKoxRCS libraries with PWO
(Roche) for 25 cycles with barcoded PCR primers. Custom Perl scripts were used to
interpret the sequencing results, revealing 9982 unique sequences in the input library with
an approximately equal distribution of all four nucleotides at each position. Sequences
that occurred greater than 10 times in the survivor and non-survivor pools were retained
for further analyses only if the sequences were also present in the input library.
Nucleotide proportions at each position in the input and survivor datasets were used to
calculate a Position-Specific Scoring Matrix (PSSM), and used to display relative
enrichment by calculating the differences in proportions for each nucleotide at each
position between the datasets.

4.2.9 in vivo survival assays
Two plasmid in vivo substrate activity assays were performed as previously described
(28), with toxic (reporter) plasmids containing the wild-type thyA I-BmoI target site or
variants with G+7 mutations. Briefly, the in vivo I-BmoI cleavage efficiency for each
substrate was calculated by dividing the number of colonies observed on selective plates
(LB plus 25 µg/ml chloramphenicol and 10 mM L-(+)-arabinose) by those on nonselective plates (LB plus 25 µg/ml chloramphenicol).

4.2.10

OP-Cu in-gel footprinting

1,10-phenanthroline copper (OP-Cu) footprinting experiments were performed using 10
pmol of the catalytically inactive R27A variant of I-BmoI, as previously described (34).
Duplex 74-mer substrates (0.1 pmol) used include: thyA, or thyA with G+7A (DE1356/1357), G+7C (DE-1358/1359), or G+7T (DE-1360/1361) substitutions. Hypo- and
hyper-sensitivity to OP-Cu was calculated as the pixel density ratio between bands in the
protein:DNA complex (UC) and unbound substrate lanes. Traces were normalized using
bands outside of the footprinting region (C-12 and A-11).
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4.3 Results
4.3.1 I-BmoI is partially disordered in the absence of substrate
Previous bioinformatic and experimental studies have suggested that I-BmoI is a modular
protein composed of distinct N- and C-terminal domains connected by a linker
(23,42,43). To investigate domain structure changes in the presence of substrate, we
performed limited proteolysis experiments with I-BmoI or I-BmoI in complex with its
cognate thyA substrate, derived from the intronless version of the B. mojavensis thyA
gene (22). Trypsin, elastase, and chymotrypsin digests of I-BmoI revealed a pattern of
proteolysis converging on a single stable domain of ~10 kDa (Figure 4.2A,
Supplementary Figure S4.1A). Solution mass-spectrometry, as well as in-gel trypsin
digest followed by mass spectrometry identified the stable domain as the N-terminal
GIY-YIG domain consisting of residues 1-92. Strikingly, protease digests of I-BmoI in
complex with its cognate 74-mer thyA substrate under identical conditions revealed a
different pattern of protease sensitivity. For all three proteases, substrate-bound I-BmoI
was far more resistant to proteolysis (Figure 4.2A, Supplementary Figure S4.1A).
Additional stable domains of ~18-20 kDa were also observed and subsequently identified
by in-gel trypsin digestion followed by mass spectrometry as peptides that mapped Cterminal to residue 130. Western blot analyses using an antibody raised against residues
1-111 of I-BmoI (N111) confirmed the identities of both stable domains (Supplementary
Figure S4.1B). Digests of I-BmoI with all 3 proteases in the presence of a non-cognate
oligonucleotide substrate revealed a pattern of protease sensitivity similar to that
observed for I-BmoI without substrate (data not shown). No change in protease
sensitivity was observed under cleavage conditions with 10 mM MgCl2. The protease
digestion patterns of the I-BmoI:thyA complex revealed a stable two-domain structure
resulting from specific DNA binding where the inter-domain linker remains moderately
accessible to proteases.
An exception was observed when digests were performed with intron-containing thyA
substrate. I-BmoI binds the intron-containing substrate with similar affinity to the cognate
intronless allele, however nucleotide differences upstream of the intron insertion site
within the intron-containing target abolish the I-BmoI cleavage site (23). Trypsin digests
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Figure 4.2: Identification of stable I-BmoI domains
(A) Images of coomassie stained SDS-gels of trypsin limited proteolysis time-course
experiments performed on I-BmoI and I-BmoI pre-incubated with intronless thyA
substrate. Aliquots were removed at the indicated time points. In-gel trypsin digest
followed by mass spectrometry was performed to identify the peptide products indicated
with an asterisk (*). M, protein marker (sizes in kDa indicated to the left). (B) (top panel)
Coomassie stained SDS-gel of trypsin limited proteolysis time-course experiments of IBmoI in complex with intronless or intron-containing substrates. (bottom panel) Plot of
the fraction of full length I-BmoI remaining or increase of the catalytic domain peptide
over time. Fraction of total protein is calculated after normalization to the untreated lane,
with error bars representing the standard deviation of two replicates. (C) Enthalpy of
transition curves for differential scanning calorimetry of I-BmoI or I-BmoI pre-incubated
with substrate.
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of the I-BmoI:intron-containing substrate complex showed a loss of protection of fulllength protein, revealing a ~25% greater degradation after 20 minutes into N- and Cterminal domains (Figure 4.2B). A ~4 fold increase in the presence of the catalytic
domain fragment was also observed, suggesting that nucleotide changes at the cleavage
site disengage the catalytic domain from substrate resulting in increased protease
sensitivity of the I-BmoI linker. These results are consistent with previous results where
I-BmoI was unable to distort the intron-containing substrate as a prerequisite to bottom
strand nicking, suggesting a loss of catalytic domain contacts at the cleavage site (36).
Additional insight into the stability of I-BmoI was gained through differential scanning
calorimetry analyses that revealed a broad denaturation profile with an observed Tm of
45.1 °C. In the presence of thyA substrate, we observed a ~5-fold increase in the
enthalpy of transition versus that observed for I-BmoI in solution, consistent with an
increase in protein stability (Figure 4.2C) (44). Collectively, these data suggest that only
the N-terminal catalytic domain of I-BmoI is stable in the absence of substrate and that
the C-terminal domain becomes structured upon DNA binding.

4.3.2 N-terminal domains have weak but specific DNA-binding affinity
To investigate the solubility and DNA-binding activity of the N- and C-terminal domains
of I-BmoI, we expressed and purified a number of truncations. N-terminal constructs that
contained the GIY-YIG nuclease domain were soluble and expressed very well (N92,
N111, N130, and N154), while C-terminal constructs were generally insoluble, with the
exception of 130C (Figure 4.3A). Binding assays with full-length I-BmoI and soluble
domain

truncations

showed

stable

complex

formation

with

thyA

substrate

(Supplementary Figure S4.2A), and quantitative DNA-binding assays were performed to
determine dissociation constants of each of the N-terminal domain truncations for thyA
intronless substrate. Binding reactions with intron-containing substrate were also
performed to determine whether the N-terminal truncations possessed affinity for the
cleavage site region of thyA substrate. The dissociation constants for the N92, N111, and
N130 truncations were in the 10 µM range, while the N154 truncation had a KD of ~500
nM for both intronless and intron-containing substrates indicating that the cleavage site
region is not a major determinant for DNA binding (Figure 4.3B, Supplementary Figure
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Figure 4.3: I-BmoI domains have distinct affinities for DNA
(A) Schematic of I-BmoI truncations and image of a coomassie stained SDS-page gel
containing 1.5 µg of each soluble construct (left and right panels, respectively). FL, full
length I-BmoI; N92, residues 1-92 of I-BmoI; N111, 1-111; N130, 1-130; N154, 1-154;
92C, 92-266; 106C, 1- 266; 130C, 130-266. (B). Images of native gel-shift experiments
for N154 binding reactions performed on labeled intronless, intron-containing, and nonspecific substrate. The left lane contains substrate only, and lanes 1 through 16 contain
serial dilutions of N154 from 52.3 µM to 1.60 nM. (C) Graph of the binding curves of
N154 I-BmoI on intronless thyA or intron-containing substrate, with data from three
replicates plotted (see also Supplementary Table S4.3).
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S4.2B, and Supplementary Table S4.3). Discrete complex formation with the N-terminal
truncations in the presence of a non-specific substrate was not observed under our
binding conditions, apart from N154 which aggregated at a concentration that increased
the KD by over 100-fold (Supplementary Table S4.3, Supplementary Figure S4.2B). The
dissociation constants for the full-length protein and 130C DNA-binding domain were
~10 nM for both intronless and intron-containing thyA substrates, consistent with
previous data (23,31). Collectively these data show that I-BmoI possesses two functional
domains connected by a protease-sensitive linker, where the N-terminal catalytic domain
has weak affinity for DNA and the C-terminal domain contributes the majority of the
DNA-binding energy.

4.3.3 I-BmoI binds DNA as a monomer
One model that has been proposed for DNA cleavage by GIY-YIG homing
endonucleases requires the formation of a transient or stable dimer, with each monomer
nicking one DNA strand (36). The ability to purify wild-type I-BmoI allowed us to
determine the oligomeric status of I-BmoI and I-BmoI:substrate complexes in solution
using gel filtration analyses (Figure 4.4). The elution profile of I-BmoI alone (35 kDa)
matched very well with the calculated mass of an I-BmoI monomer (32 kDa), indicating
that in solution I-BmoI is monomeric. The 46-mer thyA DNA substrate eluted at an
observed mass of 99 kDa, well above that of its calculated mass of 29 kDa, due to
aberrant migration of cylindrical DNA through the gel-filtration column. The observed IBmoI:thyA complex, assembled at a 5:1 protein:DNA ratio, eluted with a size (133 kDa)
consistent with an monomeric I-BmoI:DNA substrate complex. Changing the protein to
DNA ratio to 1:2 did not change the elution profile of the I-BmoI:thyA complexes,
suggesting that I-BmoI does not synapse between two DNA molecules. The gel-filtration
results were confirmed by protein cross-linking experiments using two different reagents
with I-BmoI and I-BmoI:thyA complexes (Supplementary Figure S4.3). No cross-linked
products were observed under binding or cleavage conditions (without exogenous metal
or with 10 mM MgCl2, respectively) by gel electrophoresis or Western blot analyses,
even at µM concentrations of protein. Thus, I-BmoI is monomeric and does not form
stable higher order complexes in solution or when in complex with substrate.
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Figure 4.4: I-BmoI is a monomer in solution and in complex with thyA substrate
Graph of gel filtration elution profile of I-BmoI, 46-mer thyA substrate, or IBmoI:substrate complex, with observed molecular weights indicated. Standards used to
generate the elution volume standard curve are shown. Gel filtration analyses were
performed in duplicate. Ve, elution volume; Vo, void volume.
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4.3.4 The oligomeric status of I-BmoI does not change during
cleavage
To specifically test whether the oligomeric status of I-BmoI changes during cleavage, we
performed in vitro kinetic assays to 1) examine the dependence of initial reaction velocity
on protein concentration, 2) determine whether synapsis by two endonuclease monomers
in a two target site plasmid can enhance cleavage rate, and 3) investigate whether adding
excess catalytic domain can stimulate cleavage (37,38). Prior to performing the in vitro
kinetic assays, we sought to examine whether DNA topology influenced the rate of
substrate cleavage by I-BmoI. To accomplish this, we used a plasmid containing a thyA
target site into which we introduced restriction sites for the Nt.BbvCI nickase at two
positions. The same plasmid could therefore be used as a supercoiled, relaxed, or linear
substrate depending on whether the plasmid was relaxed with Nt.BbvCI or linearized
with SwaI. As shown, no significant difference was observed for the rate of product
formation on supercoiled, relaxed plasmid, or linear substrates at 0.5 mM, 2 mM, or 10
mM MgCl2 (Supplementary Figure S4.4), and no difference in rate was observed on
relaxed plasmids that were nicked at either or both Nt.BbvCI sites (data not shown).
Subsequent in vitro cleavage assays were performed on supercoiled plasmid substrate
unless otherwise indicated, as this allowed us to observe and determine rate constants for
all steps of the reaction.
Insight into the oligomeric status of I-BmoI during cleavage was obtained by establishing
the relationship between enzyme concentration and initial reaction velocity. Singleturnover cleavage reactions with eight concentrations of I-BmoI were performed on
plasmid substrates containing a single thyA target-site where product formation was
measured by the appearance of linear DNA (Figure 4.5A). The initial rate of product
appearance for each I-BmoI concentration was calculated and plotted against I-BmoI
concentration, yielding a linear dependence (Figure 4.5B). These data suggest that IBmoI-catalyzed DNA hydrolysis is first order with respect to protein concentration,
indicative of non-cooperative cleavage.
Additional cleavage assays were performed on substrates containing two target sites to
address whether the cleavage rate could be enhanced by synapsis of two I-BmoI

135

Figure 4.5: I-BmoI functions as a monomer
(A) Graph of initial reaction progress for cleavage assays with eight I-BmoI
concentrations expressed as percent linear product. (B) Plot of initial reaction velocity
versus I-BmoI concentration. (C) Graph of reaction progress for cleavage assays with IBmoI and 1- or 2-site substrate plasmids (left and right panels, respectively). L1+L2,
linear products from 2-site plasmid cleavage. (D) Domain addition experiments. Graph of
linear product formation for cleavage assays with 22 nM I-BmoI and 10 nM plasmid.
Reactions were supplemented with 500-fold molar excess of N111, N130, or BSA. All
cleavage assays were performed in triplicate. BSA, bovine serum albumin.
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monomers bound to distinct target sites within a single plasmid. Reaction progress was
examined on plasmids that contained a primary target site alone, or those that contained
an additional secondary target site in the opposite or same orientation relative to the
primary site (Figure 4.5C and Supplementary Figure S4.5). No rate enhancement was
observed for either nicking reaction by I-BmoI on plasmids containing secondary target
sites relative to plasmids with a single site, suggesting that synapsis is not required for
cleavage. To further address a cooperative or synaptic cleavage mechanism, biotintagged/radiolabeled oligonucleotides were immobilized on streptavidin-coated magnetic
beads prior to the addition of I-BmoI (Supplementary Figure S4.6A). After the beads
were stringently washed to remove unbound I-BmoI, cleavage was induced by the
addition of magnesium and product liberation was measured by quantification of
radiolabel released into solution. Cleavage levels were similar regardless of whether or
not excess I-BmoI was added to the pre-formed I-BmoI:substrate complexes during the
magnesium cleavage step (Supplementary Figure S4.6B).
Next, we tested whether transient interactions between catalytic domains could stimulate
cleavage by performing cleavage assays with I-BmoI in the presence of excess Nterminal domain truncations. Cleavage assays with I-BmoI and 500-fold molar excess
N111 or N130 did not stimulate cleavage rate relative to the addition of BSA (Figure
4.5D). Assays with a 500-fold molar excess of N154 led to non-specific cleavage, as the
concentration of the domain added approached the KD of non-specific binding for N154
(Supplementary Table S4.3). A similar pattern of non-specific substrate degradation was
observed for reactions containing the same concentration of N154 alone (data not
shown). Given that I-BmoI exists as a stable monomer in solution and in complex with
substrate, these data demonstrate that I-BmoI acts as a monomer at all stages of the
cleavage pathway and rules out transient dimerization through the catalytic domain as a
potential cleavage mechanism.

4.3.5 I-BmoI does not function via a substrate hairpin mechanism
As a monomeric nuclease, I-BmoI could employ a substrate ‘hairpin’ mechanism to
hydrolyze DNA, where the liberated 3’-OH from the primary nick in DNA acts as the
nucleophile to attack the scissile phosphate bond of the opposite strand. The intra-strand
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transesterification mechanism has been demonstrated for the Tn10 transposase, the
retroviral HIV-1 DNA intergrase, and V(D)J recombinases(45-47). Alternatively, I-BmoI
could form a covalent protein-DNA intermediate, as is the case with the phospholipase D
superfamily enzyme BfiI (48). We tested this hypothesis by generating substrates that
contained pre-nicked bottom strands with either a 3’-OH or 3’-H at the bottom strand
nick site. If I-BmoI uses an intra-strand transesterification reaction, the second nicking
reaction of the top strand should be greatly reduced with the 3’-H substrate. Both prenicked substrates were bound and cleaved equivalently to the intact thyA substrate,
demonstrating that the primary 3’-OH product is not required for resolution of the DSB
and that I-BmoI does not function via an intra-strand substrate hairpin mechanism (Figure
4.6).

4.3.6 The I-BmoI target site is modular
Since I-BmoI acts as a monomer throughout all steps of the cleavage pathway, a potential
mechanism for DSB formation involves dynamic conformational changes within the
enzyme:substrate complex leading to the reorientation of the single I-BmoI active site.
This model implies that the thyA substrate should also be modular and contributes to the
DNA distortions observed during cleavage (34). Previous results indicated that the G-2
base is critical for cleavage and that other bases surrounding the cleavage site can
modulate cleavage efficiency (31,36). Additionally, nucleotide insertions downstream
from the intron insertion site between positions A+8/C+9 alter cleavage by I-BmoI (42).
To delineate functional regions of the thyA substrate and examine the effect of nucleotide
insertions on the first- and second-strand nicking rates, we generated a series of plasmid
substrates that contained target sites with 3-nucleotide insertions between A+4/A+5 or
A+8/C+9, and substrates with 5-nucleotide insertions between A+8/C+9 (Figure 4.7A).
Substrates containing TTT and CCC insertions between A+4/A+5 attenuated cleavage by
~5-fold under standard conditions with 10 mM MgCl2, leading to second-strand rate
constants (k2) of 0.0084 ± 0.0006 s-1 and 0.0051 ± 0.0003 s-1, respectively (Figure 4.7B).
Also evident from the reaction progress curves is the lack of accumulation of a nicked
intermediate, consistent with first-strand nicking being rate limiting (k1 < k2). Assays
performed on the same substrates with 2 mM or 0.5 mM MgCl2 showed low levels of

138

Figure 4.6: I-BmoI does not function via an intra-strand hairpin mechanism
Image of I-BmoI binding reactions performed with dual labeled thyA substrate (WT),
bottom-strand pre-nicked substrate between -5/-4 (-4 nick), and bottom strand pre-nicked
substrate lacking the 3’-OH at the nick site (-4 ddGTP). Reactions were performed with
10 mM EDTA or 10 mM MgCl2. Schematic and naming of complexes are as previously
described (34). Reactions were performed in duplicate showing similar results.
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Figure 4.7: Insertions in the I-BmoI substrate spacer reduce or abolish cleavage
(A) Schematic of the wild-type thyA I-BmoI substrate and the substrates generated
containing 3- or 5-nucleotide insertions. Filled and open triangles represent the bottomand top-strand nicking sites, respectively. (B) Progress curves for cleavage reactions on
thyA, Ins1, and Ins2 substrates in 10 mM MgCl2. Curves are generated from reactions
performed in triplicate. The x-axis has been manipulated so that reaction progress for all
substrates can be visualized.
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cleavage (Supplementary Figure S4.7). Cleavage assays on the four substrates with target
sites containing 3 or 5 nucleotide insertions between A+8/C+9 showed only minimal
nicking activity after prolonged incubations under standard reaction conditions with 10
mM MgCl2 (data not shown). These substrates allowed us to identify the sequence
upstream of A+5 as tolerant to insertions and the sequence downstream of A+8 as
intolerant to insertions. One interpretation of this data is that specific bases in the
A+5/A+8 region may act as anchor points to position the I-BmoI linker or DNA-binding
domain on substrate.
To determine if individual bases in the G-6 to A+8 region of thyA substrate were
important for function in vivo, we adapted an in vitro substrate selection that previously
identified G-2 to be critical for cleavage by I-BmoI (31). We generated a target site with
randomized nucleotides between G-6 and A+8, while maintaining G-2 fixed, to create a
library of target site toxic reporter plasmids (pKoxRCS) to be screened in vivo (Figure
4.8A). The pKoxRCS library was transformed into cells harboring the I-BmoI expression
plasmid (pACYCIBmoI) and transformants were replica-gridded in triplicate onto
selective and non-selective plates (Figure 4.8B), where control toxic plasmids containing
the thyA intronless target site survived on selective media and plasmids encoding the
intron-containing target did not. We identified 86 robustly cleaved reporter plasmids and
sequenced their target site regions, as well as the input library of randomized sites using
barcoded PCR products on an Ion Torrent platform. A plot of the relative change in
nucleotide proportions at each position between the survivor sequences and input pool, as
well as a position-specific scoring matrix (PSSM), identified the wild-type guanine
nucleotide as highly preferred at position +7 (Figure 4.8C, Supplementary Figure S4.8A).
Consistent with previous results, positions within the G-6 to T-1 cleavage motif did not
show strong nucleotide preference (31,36). Positions that displayed slight nucleotide
preference identified the wild-type nucleotide as preferred at that position. A plot of the
relative change in nucleotide proportion between the survivor sequences and a pool of
non-cleavable (‘dead’) clones showed similar results, identifying +7 as the only position
with a strong preference for any nucleotide (Supplementary Figure S4.8B).
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Figure 4.8: An in vivo screen identifies I-BmoI nucleotide preference at G+7
(A) (top) Schematic representation of the randomized cleavage site from -6 to +8 with G2 fixed (in bold enlarged font). (bottom) The pKoxRCS library and I-BmoI expression
plasmids. Filled and open triangles represent the bottom- and top-strand nicking sites,
respectively. IS, intron-insertion site. (B) Work flow to select for cleavable target sites.
(C) Sequencing results from cleavable targets represented as the difference in nucleotide
proportion from the clones in the survivor pool versus the input library.
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4.3.7 Contacts to G+7 facilitate cleavage by I-BmoI
To better understand the preference for guanine at position +7, we designed plasmid
substrates that contained G+7A, G+7C, and G+7T target site substitutions for in vitro and
in vivo assays. Cleavage assays on the G+7T substrate with 0.5 mM MgCl2 showed a
~2.5 fold decrease in both k1 and k2 versus the wild-type G+7 substrate (Figure 4.9A,
Table 4.1). The G+7A substrate displayed kinetics similar to the wild-type target site,
while G+7C showed a slight first-strand nicking defect (Table 4.1). Metal-dependent
rescue of cleavage defects on mutant substrates in vitro was observed in reactions with 2
mM or 10 mM MgCl2, consistent with previous results (36).
The observed cleavage defects on the G+7 substitution substrates were exaggerated when
the same target sites were examined by the in vivo two-plasmid survival assay, possibly
due to low levels of in vivo protein expression versus excess protein to DNA ratios in
vitro (28,40). Briefly, the cleavage efficiency of I-BmoI on non-cognate substrates can be
assessed by the degree to which a target site embedded within a toxic reporter plasmid is
cleaved and survival percentage is reported as the ratio of colonies on selective versus
non-selective plates (28). We observed ~90% survival by I-BmoI on the wild-type thyA
target site and decreasing survival on G+7A > G+7C > G+7T substrates (Figure 4.9B).
The correlation of reduced in vitro cleavage and poor in vivo survival for transversion
substitutions at G+7 suggests that a purine at position +7 acts as a critical anchor point
for I-BmoI on thyA substrate.
To establish a physical basis for the observed defect associated with substitutions at G+7,
we performed in-gel footprinting with the minor groove specific reagent 1,10phenanthroline copper (OP-Cu) on oligonucleotide substrates containing G+7 mutations.
OP-Cu was selected as a footprinting reagent because minor groove distortions of
substrate are identified as hypersensitivity to OP-Cu (49), and because it has previously
been used to identify DNA distortions surrounding the I-BmoI cleavage site that are
dependent on contacts to G-2 (34,36). Reactions were performed using the catalytically
inactive R27A variant of I-BmoI, as bottom-strand nicked products would otherwise
occlude distortions surrounding the bottom-strand nicking site (34). We found no
difference in the binding affinity of I-BmoI for the three mutant substrates relative to the
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Figure 4.9: Mutations at G+7 affect I-BmoI activity
(A) Plot of reaction progress with I-BmoI and G+7 (WT) or G+7T plasmid substrates in
0.5 mM MgCl2. Curves are plotted as a fit to the mean of three replicates with standard
deviation shown. (B) In vivo survival of I-BmoI on thyA, G+7A, G+7C, and G+T toxic
reporter plasmid substrates, with four replicates plotted (C) Denaturing gel image of ingel OP-Cu footprinting reactions with R27A I-BmoI on bottom-strand labeled G+7
(WT), G+7A, G+7C, and G+7T substrates (Unb, unbound substrate; UC, full-length IBmoI bound to substrate). Sites that are hypersensitive to the footprinting reagent are
highlighted with an asterisk, and filled triangles indicate the bottom strand nick site. To
the right of the gel image is a graph of the normalized pixel density ratio for bands in the
UC lane vs. the Unb lane. (D) Coomassie stained SDS-gel of trypsin limited proteolysis
time-course experiments of I-BmoI in the presence of G+7 (WT), G+7A, G+7C, and
G+7T substrates. (E) Plot of the fraction of full length I-BmoI remaining over time for
reactions shown in panel (D), calculated as the fraction remaining after normalization to
the untreated lane (error bars represent the standard deviation of two replicates).
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Table 4.1: Rate constants for first- and second-strand nicking reactions on G+7
mutant substrates
substrate

k1 (s-1)

k2 (s-1)

G+7 (WT)
G+7A
G+7C
G+7T

0.0441 ± 0.0021
0.0478 ± 0.0010
0.0313 ± 0.0014
0.0172 ± 0.0009

0.0198 ± 0.0015
0.0303 ± 0.0007
0.0320 ± 0.0009
0.0082 ± 0.0005
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wild-type G+7 substrate. Footprinting reactions revealed drastic reductions in
hypersensitivity to OP-Cu versus the wild-type substrate at positions surrounding the
bottom-strand nicking site on the G+7C and G+7T substrates (G-5/G-4/G-3), while
modest reductions were observed on the G+7A substrate (Figure 4.9C). All three mutant
substrates did not exhibit sensitivity to OP-Cu on the bottom strand at position T+4 that
was previously observed for the R27A footprint on wild-type thyA substrate (34).
Additionally, a dramatic increase in sensitivity to OP-Cu was observed at A+11 on the
bottom strand on all 3 mutant substrates. A similar increase in OP-Cu sensitivity at A+11
was previously observed within the lower-complex footprint of I-BmoI (34). The lowercomplex consists of I-BmoI:thyA complexes that are unable to form DNA-contacts via
the catalytic domain, or proteolyzed I-BmoI fragments that retain DNA-binding activity
but presumably lack the catalytic domain entirely (23). The footprinting data in Figure
4.9C suggests that mutations at G+7 reduce I-BmoI catalytic domain and linker contacts
that are essential for inducing distortions adjacent to the bottom-strand nicking site, with
hypersensitivity at +11 resulting from the catalytic domain and linker of I-BmoI being
disengaged from substrate.
To provide further evidence that I-BmoI catalytic domain contacts are disturbed by G+7
substitutions, we performed protease-mapping experiments on I-BmoI:G+7A, G+7C, and
G+7T substrate complexes. Loss of catalytic domain or linker contacts to substrate would
be observed as an increase in protease sensitivity within the I-BmoI linker, and time
course reactions with trypsin revealed a reduction in the protection of full-length I-BmoI
from protease digestion (Figure 4.9D, 4.9E). An increase in abundance of the catalytic
and DNA-binding domain peptides was observed, indicating greater protease sensitivity
within the I-BmoI linker in the presence of G+7 mutant substrates versus I-BmoI:thyA
complexes. An increase in protease sensitivity was also observed for the 130C I-BmoI
DNA-binding domain construct in complex with the G+7T substrate. Trypsin digests
revealed a significantly greater rate of proteolytic degradation versus 130C I-BmoI:thyA
complexes, indicating that I-BmoI contacts to the G+7 base pair are C-terminal to I-BmoI
residue 130 (Supplementary Figure S4.9).
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The results from the physical assays probing G+7 interactions are consistent with a model
whereby G+7 mutations lead to 1) a reduction in I-BmoI catalytic domain or linker
contacts to DNA surrounding the cleavage site that are necessary to induce bottom strand
distortions near the bottom strand nicking site, 2) loss in sensitivity at +4 that is
indicative of changes in protein-DNA interactions downstream of the cleavage site, and
3) a disengagement of the catalytic domain from substrate that leads to new DNA
distortions at +11 as well as increased protease sensitivity within the linker and across the
DNA binding domain (Figure 4.10).

4.4 Discussion
Early efforts with I-TevI to address the mechanistic question of how the single active site
of GIY-HEs is utilized to make a DSB revealed that the two-domain protein bound DNA
as a monomer, that the linker connecting the functional domains was flexible, and that the
N-terminal GIY-YIG nuclease domain possessed a single active site (10,15,30,35). These
data all pointed towards GIY-HEs functioning as monomers, with significant domain
rearrangements postulated to reposition the nuclease domain between strand-specific
nicking reactions to generate a DSB. However, the extreme cytotoxicity of I-TevI
precluded necessary kinetic studies to determine whether the enzyme functioned as a
monomer in all stages of the reaction pathway, and prohibited the exclusion of alternative
cleavage mechanisms. A number of mechanisms have been described for monomeric
nucleases that make DSBs, and we discuss the relevance of these mechanisms in light of
our current data supporting a monomeric mode of action by I-BmoI whereby the Cterminal domain acts as a molecular anchor to tether the N-terminal nuclease domain to
sequentially nick both DNA strands.
As structurally bipartite enzymes, GIY-HEs closely resemble the type IIS restriction
enzymes FokI and MboII that bind DNA through N-terminal domains and cleave at a
distance via C-terminal single-active site catalytic domains (50,51). FokI can form a DSB
by a cooperative transient dimerization mechanism where a substrate bound FokI can
dimerize with additional solution monomers, or synapse with the catalytic domain of
another FokI molecule bound to a secondary target site (37,38). We did not find evidence
for I-BmoI functioning via a transient dimerization mechanism, as the rate of cleavage is
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Figure 4.10: The domains of I-BmoI form distinct DNA-contacts to distort DNA
prior to cleavage
(A) Schematic of I-BmoI domains and substrate modularity. The protease resistant
domains of I-BmoI and substrate bases required for efficient cleavage are highlighted.
Bottom- and top-strand nicking sites are indicated by filled and open triangles,
respectively. (B) Model of I-BmoI bending DNA to induce substrate distortions near the
bottom-strand nick site (indicated by yellow and orange filled stars that represent OP-Cu
hypersensitivity for R27A and WT I-BmoI footprinting reactions, respectively). Rotation
of the enzyme:substrate complex after bottom-strand nicking to reposition the nuclease
domain for top-strand nicking is indicated by a dashed arrow around a vertical axis.
Interactions at G-2 and G+7 may form a hinge necessary to distort DNA. (C) Schematic
of nucleotide substitutions and insertions that affect I-BmoI catalytic activity.
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linear with respect to protein concentration, addition of excess catalytic domain cleavage
does not stimulate product formation, and two-site plasmids are cleaved at the same rate
as a single site plasmid. Furthermore, the structure of the I-TevI catalytic domain and
homology model of the I-BmoI catalytic domain did not reveal an obvious dimer
interface (10,28,36). Interestingly, the type IIS enzyme Eco31I is also a two-domain
protein with a single HNH active site that cleaves close to its binding site (52,53). Unlike
FokI, Eco31I does not transiently dimerize to generate a DSB, meaning that the single
HNH active site sequentially nicks each strand. The reaction pathway of Eco31I proceeds
with roughly equal rate constants for both nicking reactions and therefore parallels that of
I-BmoI, where the single GIY-YIG active site sequentially nicks the bottom- and topstrands with only a ~2-fold difference in rates.
The two-domain structure of I-BmoI is also similar to I-HmuI, an HNH family homing
endonuclease that binds an extended target site (54). I-HmuI consists of an N-terminal
HNH catalytic domain, and a C-terminal DNA-binding domain composed of minorgroove binding α-helix (NUMOD3) and helix-turn-helix modules that are very similar to
those found within the I-TevI DNA-binding domain (43,54,55). I-HmuI, however, nicks
only one strand of its substrate, presumably because DNA-binding elements found on
either side of the HNH nuclease motif prevent release of the catalytic domain after
nicking. Our data suggest that the I-BmoI catalytic domain is released from substrate
between nicking reactions, as the minimal I-BmoI N-terminal domain (N92) possesses
weak DNA affinity (KD > 23 µM), and limited-protease digestions of full-length I-BmoI
on intron-containing and G+7 mutant substrates revealed that the catalytic domain was
disengaged from substrate. Moreover, the homology model of the I-BmoI catalytic
domain does not possess additional units of protein structure that bind DNA, consistent
with the evolutionary acquisition of distinct DNA-binding modules by GIY-YIG family
enzymes due to the inherently weak DNA affinity of the nuclease domain.
DNA cleavage mechanisms that require conformational changes and rearrangements of
single active sites have been proposed for the phospholipase D superfamily restriction
enzyme BfiI and the type IIP restriction enzymes BcnI and MvaI (56-58). BfiI exists as a
dimer yet forms only a single active site at the dimer interface that rotates and switches
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orientation between sequential nicking reactions (56). I-BmoI is unlike BfiI as there
remains no evidence for the formation of an I-BmoI dimer, and the proposed catalytic
mechanism for BfiI involves a covalent DNA intermediate. Based on active site
similarity to other GIY-YIG nucleases (10-14,36), it is unlikely that GIY-HEs form
covalent protein:DNA intermediates, and we have shown that I-BmoI does not function
via an intra-strand transesterification mechanism. Conversely, a mechanism has been
demonstrated for BcnI where the enzyme acts as a monomer to nick one strand prior to
‘hopping’ to the opposite strand where it interacts in the reverse orientation to generate
the second nick (57). The affinity of the I-BmoI DNA-binding domain for substrate and
the fact that I-BmoI remains bound to the cleavage product would preclude the fulllength enzyme from hopping to the opposite strand and nicking in an alternate
orientation. It is possible, however, that the I-BmoI catalytic domain dissociates and
rearranges between nicking reactions due to its inherently weak DNA affinity and the
flexible nature of the linker.
We envision a monomeric cleavage mechanism by I-BmoI where the DNA-binding
domain acts as a molecular tether to allow the GIY-YIG catalytic domain to diffuse and
reposition to effect the sequential nicking reactions. Conformational changes in the IBmoI:substrate complex that precede bottom-strand nicking are dependent on contacts to
the G-2 and G+7 base pairs, as mutation of either position abolishes DNA distortions by
I-BmoI that precede nicking (36). The function of the G+7 anchor point to position the IBmoI catalytic domain and linker is supported by +4/+5 and +8/+9 insertions in thyA
substrate that drastically reduce k1 or abolish activity, respectively. Insertions at +4/+5
extend the spacing that intervenes the cleavage site and G+7 anchor to a distance where
bottom-strand nicking is constrained, while insertions at +8/+9 destroy I-BmoI
interactions with G+7 leading to undetectable levels of cleavage. I-BmoI contains three
predicted NUMOD3 minor-groove DNA-binding repeats similar to those that are found
in I-TevI and I-HmuI, with the most N-terminal NUMOD3 of the I-BmoI DNA-binding
domain encompasses residues G144-S156 (28). We found a ~100-fold difference in the
KD values of N130 and N154 I-BmoI for thyA substrate, and protease mapping of 130C IBmoI performed on the G+7T mutant substrate led to a higher level of proteolytic
digestion than was observed on the wild-type thyA substrate. It is therefore possible that
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the N-terminal I-BmoI NUMOD3 repeat interacts with thyA substrate at G+7 to anchor
the linker to substrate to facilitate positioning of the nuclease domain.
Given that I-BmoI generates a DSB by sequentially nicking the bottom- and top-strands,
the GIY-YIG domain must reposition to the opposite DNA strand after first-strand
nicking to hydrolyze the phosphodiester bond that lies in the reverse orientation. The
observation that the two nicking reactions differ by only an ~2-fold rate difference
suggests that conformational changes during cleavage are not limiting for second-strand
nicking. Following first-strand hydrolysis, the nicked DNA intermediate could rotate
around the top-strand backbone, reducing the spatial reorientation required to move the
top-strand scissile phosphate bond into the active site of the catalytic domain. This model
is consistent with the fact that I-BmoI can cleave substrates where the bottom- or topstrands have been resected to leave a single-stranded target on the non-resected strand
(34).
Homing endonucleases often target functionally critical regions of conserved genes as a
strategy to ensure that their target site will be present in naïve genomes (59). For
instance, the critical G-C base pair at position -2 of the I-BmoI target corresponds to the
second nucleotide position of a conserved arginine codon that is present in all TS genes
(31,32). Likewise, the G-C base pair at position +7 that acts as an I-BmoI anchor point
corresponds to the first nucleotide position of an aspartate codon that is also highly
conserved. The same G-C base pair and aspartate codon is also present in the I-TevI td
target site, falling within a hypomutable region of the td DNA substrate (22).
Additionally, ethylation and methylation interference assays of I-TevI:td complexes
suggested that I-TevI contacts the G of the G-C base pair and phosphate backbone at this
position (22). It is therefore possible that mutations at this position would also impact ITevI cleavage efficiency; however this nucleotide position has not previously been the
target of mutagenesis studies.
In summary, we show that I-BmoI generates a DSB via a mechanism that is distinct from
other GIY-YIG domain containing enzymes that oligomerize. The I-BmoI GIY-YIG
domain is fused to a C-terminal DNA-binding domain to overcome the inherently weak
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affinity of the nuclease domain for DNA. The linker that connects the I-BmoI N- and Cterminal domains functions as both an anchor to position the catalytic domain and a
flexible tether to permit conformational rotation between the sequential nicking reactions.
It is interesting to note that the I-BmoI and I-TevI linkers share significant amino acid
similarity, suggesting that the enzymes function via similar cleavage mechanisms.
Moreover, the fact that both the I-BmoI and I-TevI substrates share the G+7 nucleotide in
their native substrates becomes an important consideration when targeting chimeric GIYYIG nucleases for genome-editing applications.. In particular, investigating whether ITevI cleavage efficiency is also influenced by the analogous G+7 position will help
determine if the proximity of the anchor point to the cleavage site can influence catalytic
activity of chimeric GIY-YIG nucleases.
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Chapter 5

5

Monomeric site-specific nucleases for genome editing

The work presented in this chapter is reproduced (with permission, Appendix S1) from:
Kleinstiver, B.P., Wolfs, J.M., Kolaczyk, T., Roberts, A.K., Hu, S.X., Edgell, D.R.
(2012) Monomeric site-specific nucleases for genome editing. Proceedings of the
National Academy of Sciences USA 109(21):8061-6
The reproduced text has been modified from the published version by the addition of
sections 5.3.5 and 5.3.6 to include data that was not available at the time of publication.
Other sections have also been modified accordingly.

5.1 Introduction
Precise genome editing often requires the introduction of a double-strand break (DSB) at
defined positions (1-3), and two distinct site-specific DNA endonuclease architectures
have been developed towards this goal. One of these architectures relies on
reprogramming the DNA-binding specificity of naturally occurring LAGLIDADG
homing endonucleases (LHEs) to target desired sequences (4,5). The other architecture
utilizes the reprogrammable DNA-binding specificity of zinc-finger proteins or TALeffector domains that are fused to the non-specific nuclease domain of the type IIS
restriction enzyme FokI to create chimeric zinc-finger nucleases (ZFNs) or TAL effector
nucleases (TALENs) (6-8). Regardless of the architecture, the underlying biology of the
component proteins imposes design challenges and the relative merits of the LHE and the
ZFN/TALEN architectures are the subject of much debate in the literature (6,9). One
notable constraint imposed by the FokI nuclease domain is the requirement to function as
a dimer to efficiently cleave DNA (10,11). For any given DNA target, this necessitates
the design of two distinct ZFNs (or two TALENs), such that each pair of zinc finger or
TAL effector domains is oriented for FokI dimerization and DNA cleavage (12).
Expanding the repertoire of DNA nuclease domains with distinctive properties is
necessary to facilitate the development of new genome editing reagents. Indeed, a
number of recent studies have explored the potential of the PvuII restriction enzyme as an
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alternative site-specific nuclease domain for genome editing applications (13,14). The
PvuII chimeras, however, share similar design constraints as ZFNs and TALENs,
requiring two nuclease fusions for precise targeting. In considering alternative nuclease
domains for genome editing, we were intrigued by the properties of the GIY-YIG
nuclease domain that is associated with a variety of proteins of diverse cellular functions
(15). The small (~100 aa) globular GIY-YIG domain is characterized by a structurally
conserved central three-stranded antiparallel β sheet, with catalytic residues positioned to
utilize a single metal ion to promote DNA hydrolysis (16-18). Intriguingly, the GIY-YIG
homing endonucleases, typified by the isoschizomers I-TevI and I-BmoI (19), bind DNA
as monomers (20), and generate a DSB with 2-nt, 3’ overhangs. It is unknown, however,
if GIY-YIG homing endonucleases function as monomers in all steps of the reaction, as
the oligomeric status during cleavage has yet to be studied. Notably, GIY-YIG homing
endonucleases prefer a specific DNA sequence to generate a DSB (21,22). For I-TevI, the
bottom (↑) and top (↓) strand nicking sites lie within a 5‘-CN↑NN↓G-3’ motif (CNNNG),
with the critical G optimally positioned ~28 bp from where the helix-turn-helix (H-T-H)
module of the I-TevI DNA-binding domain interacts with substrate (21,22). From an
engineering perspective, the modularity and sequence specificity of the GIY-YIG
nuclease domain is appealing to create new chimeric endonucleases. Indeed, swapping of
the I-BmoI and I-TevI catalytic and DNA-binding domains suggested that the GIY-YIG
nuclease domain could be fused to unrelated DNA-targeting platforms (23).
To highlight the genome engineering potential of the GIY-YIG nuclease domain, we
fused the domain to 3-member zinc fingers to construct GIY-YIG zinc finger
endonucleases (GIY-ZFEs). The GIY-ZFEs are active in bacterial and yeast cells, and in
vitro data show that they function catalytically as monomers and retain the cleavage
specificity associated with the parental GIY-YIG nuclease domain. The GIY-YIG
nuclease domain is also portable to the LHE platform, as we constructed monomeric
GIY-LHEs that are active in vivo and possess ~18-bp binding specificity. We selected
LHEs as a DNA targeting domain because of the greater sequence specificity compared
to 3-member zinc fingers, the ability to reprogram LHE DNA-binding specificity (24-26),
and recent success in generating PuvII-LHE fusions (13). Finally, we demonstrate the
flexibility and applicability of the I-TevI nuclease domain by fusing it the TAL platform
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(2), revealing that GIY-TALs are functional in yeast and can cleave substrates that
contain nucleotide mutations near the cleavage site. Collectively, our data highlight the
unique biochemical properties of the GIY-YIG nuclease domain as an alternative to the
FokI nuclease domain for genome editing applications.

5.2 Materials and methods
See detailed S5 Supplementary materials and methods. Briefly, Tev-ZFE, Tev-LHE, and
Tev-TAL fusions and hybrid target sites were modeled in PyMOL using the I-TevI 130C
(PDB 1I3J), Zif268 (PDB 1AAY), I-OnuI (PDB 3QQY), and PthXo1 (PDB 3UGM) cocrystal structures (25,27,28,38). The in vivo activity of fusions was determined using a
two-plasmid bacterial selection (31) or yeast-based reporter assay (that was used to
calibrate activity of Tev-ZFEs and Tev-TALs) against a characterized ZFN (35).
TevN201-ryA was purified using nickel affinity chromatography to determine the in vitro
biochemical properties of Tev-ZFEs. Cleavage assays were performed as described (43).
A custom Perl script was created to determine CNNNG occurrences relative to 8,829
predicted ZFN sites on zebrafish chromosome 1 (40).

5.3 Results
5.3.1 Construction and validation of GIY-zinc finger endonucleases
To create novel chimeric enzymes, we modeled GIY-zinc finger endonucleases (GIYZFEs) using existing crystal structures of the I-TevI 130C DNA binding domain and the
Zif268 zinc finger (27,28). One notable feature of our constructs is the polarity, as the ITevI nuclease domain is fused to the N-terminal end of the 3-finger ryA zinc-finger
protein to mimic it’s native orientation, unlike FokI constructs that are fused to the Cterminal end of zinc-finger proteins. We modeled the Zif268 zinc finger in place of the
H-T-H module at the C-terminus of I-TevI, providing the rationale to subsequently fuse
various lengths of the I-TevI N-terminal region to the ryA zinc finger that targets a
sequence in the Drosophila rosy gene to create Tev-ryA zinc finger endonucleases (TevZFEs, Figure 5.1A) (29). The Tev-zinc finger DNA substrates (TZ) consisted of 30 to 38
bps of the I-TevI td homing site joined to the 9-bp ryA target site. The TZ substrates
differ in the distance of the CNNNG cleavage motif relative to the ryA-binding site
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Figure 5.1: Design and functionality of Tev-ZFEs
(A) Modeling of a Tev-zinc finger fusion with DNA substrate (light green) using
structures of the I-TevI catalytic domain in green (PDB 1MK0), the I-TevI DNA-binding
domain co-crystal in blue (PDB 1I3J), and the Zif268 co-crystal in red (PDB 1AAY) (B)
The TZ-ryA substrate is colored according to the structural model. Shown is the top
strand of the I-TevI td homing site substrate fused to the 5’ end of the ryA-binding site
for all wild-type substrates tested. The substrate is numbered from the first base of the td
homing site sequence (the numbering scheme is reverse of that used for the native td
homing site). The substrates tested differ by insertion or deletion of td sequence at the
junction of the td/ryA sites. (C) Percent survival of three representative Tev-ryA ZFEs in
the bacterial two-plasmid selection. All Tev-ryA ZFEs were tested against plasmids
containing various length substrates (TZ1.30-1.38), plasmids lacking a target site
(p11lacY), and TZ1.33 plasmids with single or double mutations in the CNNNG motif
(G5A and C1A/G5A) (Supplementary Table S5.1). (D) Percent survival of TevN201-ryA
and TevN201-ryB ZFEs on their cognate and reciprocal target sites. Data are plotted with
standard deviation for n ≥ 3.
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(Figure 5.1B). Each TZ substrate possesses a single zinc finger targeting sequence, rather
than two head-to-head zinc finger sites necessary for efficient ZFN cleavage. A similar
set of I-BmoI-ryA fusions (Bmo-ZFEs) and substrates (BZ) were constructed
(Supplementary Figure S5.1). We tested the activity of the GIY-ZFEs using a welldescribed two-plasmid bacterial selection system, where survival is dependent on the
endonuclease cleaving a target plasmid (30,31). Eight Tev-ZFEs were tested on seven TZ
substrates cloned into the reporter plasmid (Figure 5.1B and C, Supplementary Table
S5.1). In general, the survival of all Tev-ZFEs was highest against TZ substrates where
the preferred CNNNG motif was positioned between 33 and 35-bp from the ryA binding
site. Low survival (~4-6%) was observed for all Tev-ZFEs against the TZ1.32 substrate,
while none survived on the TZ1.30 substrate. Likewise, there was no survival against the
longer substrates, with the exception that the longest fusion (TevS206-ryA) exhibited
~22% survival against the TZ1.36 substrate. No survival was observed when the TevZFEs were tested against the target plasmid without a target site (p11lacYwtx1).
Mutation of the catalytic arginine 27 of the I-TevI nuclease domain to alanine to create
TevR27A-ryAs showed that survival is dependent on GIY-YIG nuclease activity as none
of the Tev-R27A constructs survived (Supplementary Table S5.1).
We also constructed and tested a fusion of the TevN201 domain to a different 3-member
zinc finger, the ryB zinc finger, creating TevN201-ryB. The TevN201-ryB showed
survival in the bacterial selection assay against a corresponding TZ-ryB target, indicating
that the I-TevI nuclease domain can function in the context of two different 3-member
zinc fingers, but did not survive when tested against the TZ-ryA substrate (Figure 5.1D).
Likewise, the TevN201-ryA fusion did not survive against the TZ-ryB substrate,
indicating that the zinc finger alone directs DNA-binding. We also tested the Bmo-ZFEs
in the genetic selection, but did not observe significant survival for any of the fusions,
consistent with the ~750-fold reduced activity of wild-type I-BmoI relative to I-TevI
(32). However, as described below, enzymatic activity was detected in vitro using
purified Bmo-ZFEs. Collectively, these data show that two different GIY-YIG nuclease
domains could be fused to zinc finger DNA binding domains to create active site-specific
chimeric nucleases.
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5.3.2 Tev-ZFEs function as monomers to cleave at a specific
sequence
To study the GIY-ZFE biochemical characteristics in more detail, we purified TevN201ryA for cleavage assays and in vitro mapping. We first performed cleavage assays to
determine the relationship between TevN201-ryA enzyme concentration and initial
reaction velocity using a plasmid substrate with a single TZ-ryA target site. The reaction
progress curves indicated an initial burst of cleavage followed by a slower rate of product
accumulation (Figure 5.2A), consistent with product release being the rate-limiting step.
The initial burst phase was used to estimate initial velocity, and plotting against protein
concentration yielded a linear relationship (Figure 5.2A), suggesting that DNA hydrolysis
catalyzed by TevN201-ryA is first order with respect to protein concentration.
The model TZ-ryA substrates were designed as a single ryA zinc finger site fused to the
I-TevI target sequence. To determine if cleavage by TevN201-ryA was influenced by
additional Tev-ryA target sites, we constructed two-site plasmids that differed in whether
the target sites were in the same or opposite orientations relative to each other. The
single- or two-site plasmids were used in time-course cleavage assays under singleturnover conditions (~10-fold molar excess of protein to substrate) to determine reaction
rates. As shown in Figure 5.2B, cleavage of the one-site plasmid yielded kobs(1-site) = 0.099
± 0.001 s-1, and cleavage of the two-site plasmids with target sites in the opposite or same
(Supplementary Figure S5.2B) orientations generated very similar rate constants, kobs(2-site)
= 0.088 ± 0.001 s-1 and 0.089 ± 0.001 s-1, respectively, to the one-site plasmid. In
contrast, similar experiments with FokI showed a significant rate enhancement for twosite plasmids relative to one-site plasmids, consistent with FokI functioning as a dimer
(33). We conclude that cleavage by TevN201-ryA is non-cooperative and that efficient
DNA hydrolysis does not require two sites, consistent with TevN201-ryA functioning
catalytically as a monomer.
The I-TevI nuclease domain preferentially cleaves DNA within a 5’-CN↑NN↓G-3’ motif,
with ↑ and ↓ representing the bottom- and top-strand nicking sites, respectively (22). ITevI defaults to cleave at the wild-type distance on substrates in vitro when this motif is
moved closer to, or distant from, the primary binding site, whereas mutants in the I-TevI
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Figure 5.2: TevN201-ZFE is a monomer with a preferred cleavage site
(A) Left panel: plot of initial reaction progress for seven TevN201-ZFE concentrations
expressed as percent linear product. Protein concentrations from highest to lowest are 47
nM, 32.5 nM, 23 nM, 11nM, 6nM, 3 nM, and 0.7 nM. Right panel: graph of initial
reaction velocity (nM s-1) versus TevN201-ZFE concentration (nM). (B) Graphical
representation of cleavage assays with 90 nM TevN201-ZFE and 10 nM one- or two-site
TZ1.33 plasmids (left and right panels, respectively). The two-site plasmid had the TZryA sites in the opposite (shown) or same (Fig. S2B) orientation. SC, supercoiled; OC,
open-circle (nicked); FLL, full-length linear; L1+L2, linear products. (C) Mapping of
TevN201-ZFE cleavage sites on the TZ1.33 substrate, with top and bottom cleavage sites
indicated below on the TZ-ryA substrate by open and closed triangles, respectively. (D)
Activity of TevN201-ZFE on the wild-type TZ1.33, or the TZ1.33 G5A and TZ1.33
C1A/G5A mutant substrates. A graph of EC0.5max determinations for each substrate is
shown to the right, with EC0.5max values in nM. Data are plotted as averages of three
independent replicates with standard deviations
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specific zinc finger cleave at the correct sequence rather than the wild-type distance on
mutant substrates (34). To determine the cleavage preference of the TevN201-ryA
construct, we mapped the bottom- and top-strand nicking sites using strand-specific endlabeled substrates to the CNNNG motif (Figure 5.2C). Combined with data from the
genetic assays showing no survival on substrates that displace the CNNNG motif from an
optimal position, our data suggests that in the context of an ryA fusion, the
TevN201domain acts as a molecular ruler with a distance preference.
To further demonstrate TevN201-ryA cleavage preference, we introduced mutations in
the CNNNG motif that were previously shown to drastically reduce I-TevI cleavage
efficiency (Figure 5.2D) (21,22). Significantly, we observed no survival under selective
conditions in the two-plasmid assay on plasmids carrying either the single G5A
(CNNNA) or double C1A/G5A (ANNNA) substitutions (Figure 5.1C), equivalent to
positions C-27 and G-23 of the I-TevI td substrate, respectively. We also performed in
vitro cleavage assays on wild type and mutant substrates with increasing concentrations
of TevN201-ZFE to determine the amount of protein required for half-maximal cleavage
(EC0.5max). As shown in Figure 5.2D, ~60 fold and ~4.7 fold more protein were required
to achieve half-maximal cleavage of the double- and single-mutant substrates relative to
the wild-type substrate. The greater substrate discrimination observed in the genetic assay
likely reflects lower in vivo protein concentrations than those used for in vitro cleavage
assays. These results show that the TevN201-ryA fusion retains the cleavage specificity
of the parental I-TevI enzyme and that double nucleotide substitutions significantly
reduce cleavage efficiency. To determine if Bmo-ZFEs also retained substrate specificity,
the bottom- and top-strand nicking sites of the BmoN221-ryA fusion were mapped to a
5’-NN↑NN↓G-3’ motif, consistent with the cleavage site preference of I-BmoI
(Supplementary Figure S5.1D) (19).

5.3.3 Tev-ZFEs function in a yeast-based recombination assay
To extend the in vivo relevance of the Tev-ZFE fusions, we utilized a well-described
yeast-based recombination assay to test Tev-ZFE function in a eukaryotic system (35).
This assay provides a quantitative β-galactosidase readout if the nuclease cleaves its
target site that is positioned between a partially duplicated lacZ gene. Furthermore, the
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Figure 5.3: Tev-ZFEs can induce recombination in an eukaryotic system
Shown are normalized β-galactosidase units from a yeast-based recombination assay for
the indicated nuclease/substrate combinations. Activity was normalized to a homodimeric
FokI-Zif268 ZFN positive control. Data are plotted with standard deviation for n = 4.
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assay allowed us to calibrate TevN201-ryA activity relative to a homodimeric FokIZif268 control with previously measured in vivo activity sufficient to induce
recombination events for genome engineering applications (35). As shown in Figure 5.3,
the level of β-galactosidase activity for the TevN201-ryA fusion on its cognate TZ-ryA
substrate was ~1.4-fold higher than the Zif268 ZFN control. The TevN201-ryA or Zif268
ZFN constructs displayed no activity on each other’s substrates, and activity was
dependent on a functional I-TevI nuclease domain, as the TevN201R27A catalytic mutant
was unable to induce recombination. Furthermore, TevN201-ryA activity was not
observed on mutant substrates where one or both of the critical residues of the CNNNG
motif were mutated in the TZ1.33 substrate. Collectively, these assays show that the ITevI nuclease domain functions in a eukaryotic system with activity on par to a
characterized ZFN.

5.3.4 The I-TevI nuclease domain is portable to the LAGLIDADG
architecture
To demonstrate that the I-TevI nuclease domain functions in the context of DNAtargeting platforms with greater specificity than 3-member zinc fingers, we constructed
fusions of the domain to a catalytically inactive monomeric single-chain LAGLIDADG
homing endonuclease (Tev-LHE). As with the Tev-ZFE constructs, we modeled a TevLHE chimera using the co-crystal of I-OnuI with its DNA substrate such that the I-TevI
nuclease and linker domains were fused to the N-terminus of I-OnuI, which is partially
disordered in the structure (Figure 5.4A) (25). Based on this model, we fused TevN201G4
and TevK203 fragments to a catalytically dead I-OnuI E1 E22Q mutant. A series of
model DNA substrates were constructed by fusing the td target site to the I-OnuI E1
binding site in the human MAO-B gene, differing in the position of the CNNNG cleavage
motif relative to the I-OnuI E1 site (TO1.12 to TO1.30) (Figure 5.4B).
In the bacterial two-plasmid selection, we found that the TevN201G4-Onu and TevK203Onu fusions were active against a range of DNA substrates. Notably, the fusions
displayed maximal survival on longer targets (TO1.26, TO1.28, and TO1.30), and lower
survival against shorter targets (TO1.18 and TO1.20 targets). The two groups of substrate
differ by approximately one helical turn of DNA, meaning that the preferred CNNNG
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Figure 5.4: Design and functionality of Tev-LHEs
(A) Modeling of a Tev-Onu E1 fusion with DNA substrate (light green) using structures
of the I-TevI catalytic domain in green (PDB 1MK0), the I-TevI DNA-binding domain
co-crystal in blue (PDB 1I3J), and the I-OnuI co-crystal in red (PDB 3QQY). Shown are
fusion points at which the I-TevI fragment has been shortened. (B) The Tev-Onu E1 (TO)
substrate is colored according to the structural model. Shown is the top strand of the ITevI td homing site substrate fused to the 5’ end of the Onu E1-binding site. The
substrates are numbered from the first base of the td homing site sequence and differ by
the deletion of td nucleotides at the junction of the td/Onu E1 sites. (C) Percent survival
of Tev-LHEs in the bacterial two-plasmid selection with various length target sites
(TO1.12-1.30). All Tev-LHEs tested were in the I-OnuI E1 E22Q background. (D)
Percent survival of TevR27A(N201G4)-OnuE1 and TevR27A(N201G4)-OnuE1(E22Q)
on TO1.30, TO1.30G5A, and TZ1.33. Data are plotted with standard deviation for n = 3.
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motif would be presented on the same face of the substrate even though the motif is
closer to the I-OnuI E1 binding site on the shorter targets. Similar periodic cleavage
patterns have been observed in vitro with I-TevI on substrates with a displaced CNNNG
motif (36). This result also implies that the N-terminus of I-OnuI possesses inherent
flexibility to allow the I-TevI nuclease domain to search out the CNNNG motif, in
contrast to the ruler-like behaviour of the Tev-ZFE constructs, likely because the zinc
finger N-terminus is inflexible. Importantly, the Tev-Onu fusions were not active against
the TZ-ryA zinc finger substrates (Supplementary Table S5.2), showing that the LHE,
and not the I-TevI linker, directs DNA targeting. Survival was also dependent on an
active I-TevI nuclease domain, as TevR27A fusions in the context of the I-OnuI E22Q
mutant did not survive (Figure 5.4D). Conversely, the targeting and activity of wild-type
I-OnuI E1 was not affected by fusion of the I-TevI domain, as the TevR27A-OnuWT
fusions survived against TO substrates (Figure 5.4D).
The apparent flexibility of the N-terminus and the greater specificity of I-OnuI prompted
us to test fusions containing shorter fragments of the I-TevI nuclease domain (Figure
5.4A). Based on structural and genetic data, we constructed TevS114-Onu, TevD127Onu, TevN140-Onu, TevN169-Onu, and TevD184G2-Onu fusions, progressively
removing amino acid residues of I-TevI that make specific base-pair contacts to the td
substrate (Figure 5.4A) (28). Notably, the TevS114, TevD127, TevN140 and TevN169
removed the α-helix that binds in the minor groove, as well as residues shown by
structural data to make base-specific contacts (28). The TevS114 fusion point lies at the
boundary of the deletion tolerant region of the I-TevI linker, and represents a functionally
minimal GIY-YIG nuclease domain (36,37). We found that the shorter fusions were not
active against the longer TO1.28 and TO1.30 substrates, yet displayed the same periodic
activity on the shorter substrates (Figure 5.4C and Supplementary Table S5.2). A single
exception was the TevD184G2 fusion that showed low survival against the TO1.22
substrates, against which no other fusion survived. No survival was observed on mutant
substrates that contained single (CNNNA) or double (ANNNA) mutations in the
CNNNG motif, recapitulating the necessity for an appropriately positioned CNNNG as
seen with the Tev-ZFE fusions.
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5.3.5 I-TevI fusions to the TAL effector PthXo1 are functional
To expand the binding capacity of chimeric I-TevI nucleases beyond that of engineered
ZFEs and LHEs, the logical next step was to model fusions of the I-TevI nuclease domain
with the recently solved crystal structure of the modular PthXo1 TAL effector DNAbinding platform (Figure 5.5A) (38). The repetitive structure of TAL effectors can be
exploited to assemble highly specific DNA-binding modules whose nucleotide specificity
is dictated at a 1:1 ratio via the RVDs (repeat variable diresidues) within the repeated unit
(2,7,35). To capitalize on the customizable specificity of TALs, multiple truncation
points within the I-TevI linker and the N- and C-terminal ends of the PthXo1 backbone
were explored to generate a set of I-TevI-PthXo1 fusions (Tev-TALs, Figure 5.5B).
Additionally, model hybrid substrates comprising td and PthXo1 target site sequences
with varied spacer lengths were cloned into the yeast based recombination assay vector to
assess activity.
Several constructs revealed appreciable in vivo activity, with the N169-T120 Tev-PthXo1
fusion demonstrating the most robust activity across targets with varied spacer lengths
(Figure 5.5C). The periodic activity of the N169 I-TevI truncation is reminiscent of the
cleavage pattern observed for the similar Tev-LHE construct, though the magnitude of
activity across a larger number of targets appears to be greater for the Tev-TAL platform.
This may reflect an increased flexibility of the N169 fusion in the context of the TAL
versus LHE platforms, or may result from greater sensitivity inherent to the in vivo
activity assays (yeast reporter compared to survival in bacteria). Similar to the Tev-ZFEs
tested in the yeast-based recombination system, the N169-T120 construct has activity on
par with a ZFN pair that induces recombinogenic events at a level sufficient for gene
targeting in plant and mammalian cells (35).

5.3.6 Tev-TALs tolerate nucleotide substitutions in the DNA spacer
To determine the tolerance of the Tev-TAL architecture to mutations that intervene the
cleavage motif and substrate spacer, hybrid target sites were generated containing
sequences from alternative bacteriophage thymidylate synthase alleles. The N169-T120
construct efficiently cleaved most substrates with activity comparable to the cognate td
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Figure 5.5: Design and functionality of Tev-TALs
(A) Modeling Tev-PthXo1 fusions using structures of the I-TevI nuclease and DNAbinding domains coloured in orange (PDB 1MK0 and 1I3J), aligned with the
multicoloured PthXo1 cocrystal (PDB 3UGM). Various truncation points of I-TevI and
PthXo1 were utilized to identify functional constructs (B) Tev-PthXo1 model substrates
with td sequence coloured orange and the PthXo1 binding site coloured blue. Substrates
are numbered from the first base of the td homing site and differ by the number of
nucleotides included prior to the junction of the td/PthXo1 binding site. (C) Activity of
the N169-T120 (I-TevI and N-terminal PthXo1 truncation points, respectively)
TevPthXo1 construct on various model substrates, reported as β-galactosidase activity
normalized to a Zif268 ZFN control. Substrates are numbered according to the length of
the spacer sequence that intervenes the G of the CnnnG cleavage motif and the PthXo1
binding site. (D) Normalized β-galactosidase activity of N169-T120 TevPthXo1 on
mutant target sites generated from alternative thymidylate synthase alleles.
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allele from bacteriophage T4 (Figure 5.5D). Observed exceptions included the Tu1a
allele that displayed activity almost 2-fold greater than the td target, and the RB32 allele
that was poorly cleaved. These results are consistent with previous in vitro results that
suggested I-TevI is tolerant to nucleotide substitutions within its homing site (39).
Interestingly, the nucleotide analogous to the critical G+7 anchor point observed for the
GIY-YIG homing endonuclease I-BmoI was not mutated in any of the tested alleles
(Figure 5.5D, see also Chapters 4.3.7 and 6.4).

5.3.7 A 5’-CNNNG-3’ cleavage motif is not limiting for targeting
An important consideration in the design of engineered GIY-YIG nucleases for genomeediting applications is the targeting requirements, notably the need for the CNNNG dinucleotide cleavage motif (Figure 5.6A). In a complex genome of ~ 3x 109 bp, the
statistically predicted occurrence of the CNNNG motif is once every 15 bp assuming a
50% GC content. To determine if the frequency of the CNNNG motif would be limiting
for targeting applications, we examined 35 bp flanking 8,829 computationally predicted
ZFN sites on zebrafish chromosome 1 for the occurrence of the CNNNG motif (40). As
shown in Figure 5.6B, the motif is highly represented at all positions within a 35-bp
window relative to the ZFN sites. Of the 8,829 sites examined, 88% (7,845) of ZFN sites
possessed at least one motif within 35 bp of the predicted binding site (Figure 5.6C).
These requirements contrast sharply with those of the recently described PvuII-LHEs and
PvuII-ZFNs that require the 6-bp 5’-CAGCTG-3’ PvuII site in addition to the LHE or ZF
binding site (13,14). Of the 8,829 ZFN sites, 97% lacked a PvuII site within the 35-bp
window (Supplementary Figure S5.3). Thus, the requirement for a di-nucleotide cleavage
motif in the context of GIY-YIG engineered nucleases will not severely limit potential
targeting sites.

5.4 Discussion
Here, we provide evidence that the GIY-YIG nuclease domain is a potential alternative to
the currently used FokI nuclease domain for genome editing applications. We show that
the I-TevI GIY-YIG nuclease domain is portable to the three reprogrammable DNAbinding scaffolds utilized in the field, the 3-member zinc fingers, catalytically inactive
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Figure 5.6: Cleavage requirements do not limit GIY-EN applicability
(A) A diverse set of monomeric and sequence specific reagents can be generated by
fusing distinct GIY-YIG domain linker lengths to engineered DNA-binding platforms,
including zinc-finger arrays, inactive LAGLIDADGs, and TAL effectors (GIY-ENs). (B)
Shown is the distribution of the CNNNG motif in a 35-bp window flanking 8,829
predicted ZFN sites on zebrafish chromosome 1. The number of occurences of the ‘C’ of
the motif at each distance is indicated. (C) Unique ZFN sites were grouped according to
the number of occurences of the CNNNG motif in the 35-bp window. The red line is the
expected number of ZFN sites for each group based on a binomial distribution.
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LAGLIDADG homing endonucleases, and modular TAL effectors. The Tev-ZFE, TevLHE, and Tev-TAL fusions are active in vitro and in vivo, with the activity of Tev-ZFEs
and Tev-TALs in a yeast-based recombination assay on par with that of a characterized
ZFN. We foresee the monomeric nature of the I-TevI fusions to each platform as a key
advantage over existing ZFNs and TALENs, as a single fusion protein need be designed
to target a given sequence, rather than two ZFNs or TALENs required to promote
dimerization of the FokI nuclease domain (12). Moreover, the fact that the I-TevI
nuclease domain possesses a preferred cleavage motif adds another layer of specificity to
targeting requirements, potentially limiting DSBs at off-target sites that do not posses the
cleavage motif.
One targeting consideration for chimeric GIY-YIG endonucleases is the DNA sequence
requirement of the I-TevI linker. The I-TevI linker is a complex structure, consisting of
defined structural elements with distinct roles in I-TevI function (28,34,36). The primary
role of the linker is to position the nuclease domain on substrate for cleavage at the
CNNNG motif, which is found at a defined distance from the binding site on naturally
occurring I-TevI substrates. However, the linker can direct the nuclease domain in vitro
to search out displaced CNNNG motifs on both native and non-native substrates with
insertions or deletions, albeit with reduced cleavage efficiency (39). Our Tev-LHE
fusions recapitulate this distance versus sequence behaviour in vivo, as the fusions can
cleave displaced CNNNG motifs with a periodicity that parallels the helical nature of
DNA. We partially attribute this ability of the Tev-Onu fusions to the flexible N-terminus
of I-OnuI. The substrate flexibility of different length Tev-Onu fusions is an important
consideration for targeting, as CNNNG motifs at various positions relative to the LHE
binding site would be accessible by the choice of the appropriate Tev-LHE fusion. In
contrast, the apparently inflexible N-terminus of the 3-member zinc fingers constrains
cleavage to a distance of 33-36 bp from the ryA-binding site, mimicking the spacing of
the CNNNG motif on native td substrate. Our longest Tev-ZFE and Tev-LHE fusions
encompass all the known elements of the I-TevI linker that make multiple base-specific
and non-specific contacts to DNA (28). However, biochemical studies revealed that ITevI retains significant cleavage activity on substrates with multiple substitutions in the
central region of its cognate DNA substrate that is contacted by the linker, equivalent to
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positions 6-33 of our longest chimeric substrates (39). The shortest Tev-LHE fusions do
not contain any linker elements that are known to make base-specific DNA contacts, and
cleave only at the preferred CNNNG motif, implying that the I-TevI linker may contact
substrate nucleotides adjacent to the CNNNG motif. The presumption the I-TevI linker
can tolerate changes within the substrate spacer is supported by the fact that Tev-TAL
fusions can cleave substrates composed of alternative thymidylate synthase alleles. The
substrates examined, however, did not provide a saturating mutagenic approach making it
difficult to draw conclusions about all nucleotide positions. Interestingly, no changes
were made at a position equivalent to the G+7 nucleotide in the GIY-YIG homing
endonuclease I-BmoI substrate that corresponds to a critical protein:DNA anchor
(Chapter 4.3.7). Should this functional interaction be conserved within the context of ITevI chimeric nucleases, potential contacts may play a role in the positioning of the
nuclease domain rather than being necessary for cleavage (36).
Future work on Tev-ZFEs, Tev-LHEs, and Tev-TALs will require a more thorough
dissection of binding affinity and specificity, and characterization of cellular toxicity that
results from cleavage at off-target sites. In their current form, the targeting specificity of
the Tev-ZFEs is a function of the 3-zinc finger domain, which could be further enhanced
by addition of zinc fingers to generate a 4-, 5-, or 6-zinc finger fusion to increase
specificity, as has been done with a variety of ZFNs (41). In contrast, the ~18-bp
specificity of LHEs is sufficient to direct targeting and cleavage at endogenous loci in
human cells. LHEs, however, are tolerant of nucleotide substitutions within their
recognition sequence, and I-OnuI E1 cleaves off-target sites that differ by one or two
nucleotide substitutions (25). In the context of Tev-LHEs, decoupling of DNA-cleavage
and DNA-binding activity by using a catalytically dead LHE scaffold, combined with the
requirement for a preferred I-TevI CNNNG cleavage motif, would significantly reduce
cleavage at off-target sites (Supplementary Figure S5.4). Another advantage of the
decoupled activities of Tev-LHEs is that they would not require re-optimization of
catalytic activity that is often necessary in LHEs that have been reprogrammed to bind
non-native target sites (25,42). The Tev-TAL platform, however, appears to be able
provide the specificity required to target a monomeric nuclease within the human
genome. Studies have shown that TALENs can be specifically targeted to sites in a
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variety of organisms (7,35), and that assembly of custom DNA-binding units is relatively
straightforward (2,35). Similar to the exploration of alternative DNA-binding platforms
(2), it is imperative to incorporate nuclease domains with distinct biochemical properties
into the genome engineering pipeline to create highly precise tools. With further
optimization, the I-TevI nuclease domain may become an alternative to the FokI-derived
ZFNs and TALENs.
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Chapter 6

6

Discussion

Selfish mobile genetic elements (MGEs) that encode DNA endonucleases can initiate the
lateral transfer of genetic material between organisms. Consequently, MGEs comprise a
significant proportion of any given genome (1-3), subsets of which encode genes of sitespecific homing endonucleases (HEs) (4-6). HEs encode six distinct class-defining
active-site motifs and differ from most other cellular endonucleases by targeting long
recognition sites (14-36 base pairs) (5,7). While each family of HE utilizes a number of
different strategies to cleave DNA, the mechanism by which GIY-YIG family homing
endonucleases (GIY-HEs) initiate their own genomic mobility has remained poorly
understood until now. Within this thesis I demonstrate that the model GIY-HE I-BmoI
functions as a monomer and investigate the dynamic protein:DNA interactions that
contribute to DNA-hydrolysis. Further, I explicitly test models for double-strand break
(DSB) formation by monomeric nucleases to elucidate the mechanism by which single
active site GIY-HEs cleave DNA. To apply these findings within the context of
engineered nucleases, I demonstrate that the cleavage properties of GIY-HEs are
recapitulated in the context of GIY-YIG engineered nucleases (GIY-ENs) when the
nuclease domain of I-TevI is fused to three different re-targetable DNA-binding
platforms. GIY-ENs are functional in vivo and operate via a different mechanism than
canonical FokI nuclease domain fusions that constitute the majority of engineered
nuclease architectures. Distinctly, GIY-ENs cleave at a preferred nucleotide motif and
function as monomers, whereas FokI-derived nucleases cleave nonspecifically and
function as dimers. These topics are elaborated further below, where I discuss the
advantageous properties of GIY-ENs for genome editing applications.

6.1 GIY-HE cleavage mechanism
Unlike DNA hydrolysis mechanisms that have been established for other HE families
(5,7), the inherently high nuclease activity of the GIY-HE I-TevI prohibited expression
and purification from bacteria that would enable detailed in vitro or in vivo analyses. To
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investigate the quarter-century old question of how GIY-HEs generate a DSB, I purified
the related GIY-HE I-BmoI to study the sequential protein:DNA interactions that mediate
DNA cleavage. DSB formation by I-BmoI proceeds through a number of substrate
distortions that are dependent on contacts to nucleotides that surround the cleavage site
(8,9). In Chapters 2 and 3, I investigated the contributions of amino acid and nucleotide
positions to hydrolysis by generating mutations in the catalytic domain or substrate
cleavage motif, respectively. In Chapter 4, I discovered additional protein:DNA
interactions outside of the cleavage motif that act as an anchor point to position the IBmoI linker on substrate and initiate DNA distortions. Importantly, I determined that IBmoI functions as a monomer at all steps of the reaction pathway and does not hydrolyze
DNA through protein- or DNA-mediated transesterification reactions. The cumulative
evidence from Chapters 2, 3, and 4 suggests a highly dynamic monomeric cleavage
mechanism and also validates predictions made previously for I-TevI (10). It is plausible
that I-TevI is mechanistically comparable to I-BmoI, as they share high similarity in their
nuclease domains and linkers (11-13), bind analogous thymidylate synthase alleles as
monomers (10,14), encode single predicted active sites (9,13,15), and induce significant
distortions in their respective substrates adjacent to their cleavage site (8,10). I therefore
propose a model for DSB formation by GIY-HEs where the DNA-binding domain
anchors the low-affinity GIY-YIG nuclease domain on substrate to sequentially nick both
DNA strands at a preferred sequence (Figure 6.1).
To further characterize the sequential conformational changes that mediate DSB
formation, it may be possible to perform fluorescence resonance energy transfer (FRET)
experiments as has been done to track changes in the PI-SceI:substrate complex through
the cleavage reaction (16). I-BmoI contains a single cysteine within the nuclease domain
(exposed on the surface opposite to the catalytic cleft), and one cysteine within the
remainder of the protein located in the linker (which has previously been mutated to
serine without affecting activity, Figure 4.5). Using FRET, the effects of amino acid
mutations within the nuclease domain, roles of divalent metal and nucleotide
substitutions at the cleavage site, and effects of substrate insertions within the spacer
detailed in Chapters 2, 3, and 4, respectively, could be further examined and exploited to
confirm the mechanistic predictions for GIY-HEs.
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Figure 6.1: Conformational change DSB mechanism for I-BmoI
I-BmoI utilizes multiple DNA-distortions and a critical anchor point within the linker to
overcome the inherently weak DNA-binding affinity of the nuclease domain to hydrolyze
DNA.

182

The proposed monomeric DSB mechanism for GIY-HEs contrasts with the models
established for other endonucleases of the GIY-YIG family (17,18). As described in
Chapter 1.2.2, other enzymes that contain the GIY-YIG motif have acquired context
dependent adaptations that promote oligomeric assembly to nick both DNA strands (1822), or constitute components of larger architectures that allow the GIY-YIG domain to
function as a nickase (23,24). The GIY-YIG nuclease domain is therefore highly
adaptable and can function via context-dependent single- or double-strand hydrolysis
mechanisms. Interestingly, studies that swapped the nuclease and DNA-binding domains
of I-TevI and I-BmoI revealed that each domain retained their intrinsic functional
properties when removed from their natural context (11). Additionally, the sequencetolerant DNA-binding domains utilized by I-BmoI and I-TevI display evidence of shared
functionality with other enzymes, as similar NUMOD and helix-turn-helix modules are
found in the ββα-Me HE family (5,25-28). These properties, along with the evolutionary
flexibility and mechanistic plasticity of the nuclease motif, suggested the GIY-YIG
domain as an ideal candidate to consider within the context of novel engineered
nucleases.

6.2 Considerations for engineered nucleases
The ability to manipulate genomes for reverse genetics studies in model organisms or
alter genes in human cell lines for the treatment of monogenic diseases has led to
significant academic, clinical, and biotechnological interest in the development and
implementation of engineered nucleases. Their application has been so widespread that in
2011, Nature Methods chose genome editing with engineered nucleases as their Method
of the Year (29). The efficacy of a zinc-finger nuclease (ZFN) mediated therapy to treat
HIV-1 infection is currently the subject of a clinical trial (30). Unfortunately, the inherent
biology of the FokI nuclease component of ZFNs was not rigorously understood prior to
the study, with many suggesting inadequate fidelity of engineered ZFNs for human cell
therapy (31,32). The requirement of the FokI nuclease domain to form a dimer and it’s
ability to cleave DNA non-specifically has led to undesirable off-target DSBs in model
systems. Off-target DSBs can occur when one ZFN module binds an unintended
degenerate target site and recruits another ZFN to initiate cleavage (Figure 6.2A). In this
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Figure 6.2: FokI requirements can lead to off-target DSBs
(A) The dimerization mechanism of FokI and imperfect binding specificity of zincfingers leads to promiscuous cleavage at off-target sites where either or both ZFN units
interact with an unintended target. (B) ZFNs that contain an engineered obligate
heterodimeric version of the FokI nuclease domain reduce mechanisms of off-target
cleavage, but still remain prone to a subset of off-target DSBs.
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scenario, the secondary ZFN molecule is not necessarily substrate-bound and can also
result from homodimerization between the FokI domains of identical ZFN subunits. To
circumvent undesirable homodimerization, studies have been conducted to engineer an
obligate heterodimeric FokI dimer interface where a ‘left’ and ‘right’ ZFN interaction
constitutes the only condition that is productive for cleavage (Figure 6.2B) (33).
Unfortunately, dimerization can still occur between a DNA-bound left ZFN unit and a
right ZFN that is weakly bound or in solution, leading to apprehension regarding the
specificity of FokI-derived ZFNs and TALENs (TAL effector nucleases) (31,34). The
frequencies of off-target DSBs at unintended sites are an important consideration for both
platforms, as they can have toxic consequences in the form of severe adverse events
(discussed in Chapter 1.5).
Another aspect of genome editing procedures to consider is the ability to bias intrinsic
cellular DNA-repair pathways to mutagenic nonhomologous end-joining (NHEJ) events
in the absence of an exogenous template, or corrective homologous recombination (HR)
pathways when an exogenous donor template is provided. NHEJ mediated events can
either proceed through a classical mechanism that generally results in precise repair or
through an alternative NHEJ pathway where DNA end-processing enzymes generate
deletions and frameshifts (35,36). In scenarios where deleterious events are desired,
studies have shown that engineered nucleases can be coupled with exonucleases to
increase the frequency of mutagenic repair via alternative NHEJ pathways (37).
Unfortunately, NHEJ-mediated repair events are often associated with significant
genomic instability in the forms of sequence loss or chromosomal translocations.
Consequently, there has been interest in the development of engineered site-specific
nickases to circumvent these unfavourable outcomes, as they initiate HR at similar
frequencies to cleavases, yet do not activate NHEJ (38). Nickase variants of engineered
LAGLIDADG HEs (LHEs) and FokI-derived platforms have therefore been explored to
more precisely modulate gene repair outcomes (39,40). As described in Chapter 6.3, it
may also be possible to expand the potential of GIY-ENs by generating engineered GIYYIG nickases.
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Another important consideration beyond the mutagenic event induced by each nuclease
technology is the specificity associated with the three DNA-targeting platforms described
within this thesis. The construction of highly precise zinc-finger arrays has not proven to
be as trivial as once hoped as many nucleotide triplets remain inaccessible by engineered
zinc-fingers (41), and the modular assembly of multiple fingers does not appear to
circumvent their inherent promiscuous binding (32). These issues are further
compounded by the fact that the specificity provided by an array of 4-5 zinc-fingers (that
bind a 12-15 base pair target) within the context of a monomeric nuclease may be
insufficient for targeting in human cells. Conversely, many LHEs offer the capacity to
bind genomic sites with greater than 18 base pair specificity. Combined with their small
size and potential to maintain a second active catalytic motif, engineered LHEs represent
an interesting platform to continue to pursue within the context of GIY-YIG fusions.
TAL effectors have shown great promise for the design and assembly of modules that can
target virtually any sequence with binding sites that exceed 20 base pairs. While their
large size and repetitive coding sequence may present challenges for viral based delivery
approaches, monomeric GIY-YIG fusions to the TAL platform reduce the size and design
complexity of TALENs by a factor of 2. At present it appears that TAL effectors may
offer the most customizable and high fidelity option for specific binding (42), though the
specificity and promiscuity of all platforms must be rigorously tested to determine the
utility and relevance of each architecture.
While the benefits and limitations of existing genome editing technologies are analyzed, I
have been motivated to consider the GIY-YIG nuclease domain as an alternative nuclease
module. In Chapter 5, I demonstrate that the I-TevI nuclease domain can be fused to three
targetable DNA-binding platforms to generate functional I-TevI-zinc-finger (Tev-ZFE),
I-TevI-LAGLIDADG (Tev-LHE), or I-TevI-TAL effector (Tev-TAL) engineered
nucleases (collectively abbreviated Tev-ENs) (Figure 6.3A). Significantly, the intrinsic
properties of I-TevI are recapitulated within the context of Tev-ENs as they function
catalytically as monomers and require an appropriately spaced CnnnG cleavage motif to
generate a DSB. Fusions of the I-BmoI nuclease domain to the zinc-finger architecture
(to create Bmo-ZFEs, Supplementary Figure S5.1) hydrolyzed substrates in vitro at the
preferred cleavage site, however significant activity in vivo was not detected. The failure
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Figure 6.3: Design of engineered GIY-YIG endonucleases
(A) Models of the Tev-ZFE, Tev-LHE, and Tev-TAL platforms. (B) Schematic
illustrating the fundamental differences between engineered GIY-YIG and FokI nuclease
platforms.
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of Bmo-ZFEs in vivo can likely be attributed to the lack of structural information required
to rationally design functional fusions to the zinc-finger domain, as well as the difference
in specific activity versus I-TevI (~750-fold lower) (14). Nevertheless, Tev-ZFEs and
Tev-TALs induce gene conversion events in yeast on par with an established ZFN pair
(Figures 5.3 & 5.5), and Tev-LHEs have activity in bacteria comparable to the engineered
catalytically active LHE alone (Figure 5.4). Overall, the presented results are encouraging
as GIY-ENs are functionally robust and mechanistically distinct when compared to
analogous FokI-derived nucleases. However, there are properties of the I-TevI GIY-YIG
domain and linker that must be considered for GIY-ENs as an alternative genome editing
technology.

6.3 Implications of GIY-HEs for GIY-ENs
A cautionary lesson stemming from the implementation of FokI-containing ZFNs and
TALENs is that one must understand the inherent biology of a nuclease domain prior its
application in engineered architectures (31). Consequently, I envision the monomeric and
sequence-tolerant GIY-YIG domain as an alternative to the FokI nuclease domain due to
their structural and mechanistic differences (Figure 6.3B). One advantageous property of
GIY-ENs is the decrease in design complexity by a factor of 2 versus FokI chimeras. Not
only does this simplify the targeting of GIY-ENs to a single site, it also reduces the
amount of fusion-encoding DNA that must be transfected into cells. This is an important
consideration when utilizing the TALEN architecture, as the TAL domain is significantly
larger than other DNA-binding platforms and a pair of nucleases must be transfected.
Another advantageous property of GIY-ENs is the requirement to recognize a preferred
nucleotide motif for cleavage (43,44). In scenarios where the DNA-binding module of a
GIY-EN interacts with an unintended target site, the off-target site may be rendered
immune to cleavage unless an appropriate cleavage motif is found within an appropriate
linker/spacer distance (Supplementary Figure S5.4). Therefore, the monomeric
mechanism and sequence preference by GIY-ENs offer advantages over ZFNs and
TALENs by simplifying the assembly and delivery processes and potentially reducing
off-target DSB frequencies.
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One property observed for GIY-YIG family endonucleases by examining their natural
functional diversity is the contextual ability to function as a nickase, as many GIY-YIG
enzymes nick only a single strand of DNA (see also Chapter 1.2.2) (23,45,46). As
described in Chapter 6.2, nickases represent a potentially safer nuclease mediated
technology to induce desired gene conversion outcomes via HR. It may be possible to
convert the GIY-YIG nuclease domain to a functional nickase through directed selection
approaches or by altering the contextual modularity of the domain itself. For example,
high-throughput selections and rational design methods have been utilized to convert
both REs and LHEs into functional nickases (38-40,47-49). Conversely, additional DNAbinding elements could be fused upstream of the GIY-YIG domain to constrain
repositioning of the nuclease motif after nicking (similar to the modular structure of GIYYIG DNA-repair enzymes or the H-N-H HE I-HmuI) (28,50), or the nuclease domain
could be fused to the C-terminal end of the LHE or TAL DNA-binding platforms to
mimic the natural polarity of the LEM associated or Penelope nucleases (51,52).

6.4 Potential of GIY-YIG engineered nucleases
While progress has been made in assembling sequence-specific GIY-ENs that are distinct
from FokI-derived chimeras, a number of properties must be further investigated for the
technology to become widely applicable (Figure 6.4). Nucleotide requirements within the
I-TevI cleavage motif and substrate spacer must be robustly investigated in both the LHE
and TAL platforms to be able to predict which genomic sequences will be efficiently
cleaved by Tev-ENs and whether additional targeting constraints exist. Preliminary data
with Tev-TALs suggest that the substrate spacer preference at G+7 observed for I-BmoI
may be recapitulated within the context of Tev-ENs (Figures 4.8 & 5.5). This result must
be reexamined in a more robust manner, however, as this screen was limited due to the
codon conservation of the thymidylate synthase genes. An added nucleotide preference
for I-TevI in the substrate spacer would increase the nuclease domain’s specificity from a
CnnnG di-nucleotide to a tri-nucleotide motif. While this property may serve to further
de-toxify GIY-ENs by conferring a more stringent cleavage preference, it may also limit
the targeting capacity to fewer genomic sites. Accordingly, it may be important to
identify and modify the residues that form protein:DNA contacts at G+7 for I-BmoI or an
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Figure 6.4: Considerations for engineered GIY-YIG nucleases
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analogous position for Tev-ENs. If after further study the cleavage requirements of ITevI limit the targeting potential of Tev-ENs, it would be prudent to investigate the
nucleotide preferences of additional GIY-HE nuclease domains. Preliminary results
indicate that a nuclease domain from a GIY-HE similar to I-TevI (from the bacteriophage
Tu1a) has substantially different nucleotide preferences in the substrate spacer (J. Wolfs,
unpublished). Over 150 putative GIY-HEs with potentially different targeting constraints
have been identified from bacteriophage, bacterial, eukaryotic, and marine metagenomic
sequences, many of which could be used to expand the diversity and specificity of GIYENs (13,17,53-55).
Another important consideration is functionality in relevant cellular systems. Genome
editing interventions using engineered nucleases are most prominently implemented in
model organisms to understand biological processes, or within plant and human cells for
agriculture or experimental medicine. While it is encouraging that GIY-ENs fused to all
three DNA-binding platforms are functional in bacteria and yeast, it will be necessary to
ensure that this functionality is preserved within all relevant organisms. At this point it
remains unknown if endogenous expression pathways would express GIY-ENs or
whether their presence would elicit an innate immune response. If DSB efficiencies to
similar FokI-derived architectures can be achieved in the relevant systems, a head-tohead comparison between the GIY-YIG and FokI platforms would be obligatory to
compare on-target versus off-target cleavage rates. These studies would also elucidate
whether the added specificity provided by GIY-ENs would detoxify existing
technologies, or simply limit their targeting potential.
The data presented within this thesis towards the development of a novel monomeric
genome-editing platform is encouraging, as GIY-ENs may serve as an alternative genome
editing technology to begin to answer interesting biological questions and treat
monogenic diseases. Ultimately, however, further refinements of each GIY-EN platform
will dictate the utility, safety, and potential of GIY-ENs.
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Appendix S2: Supplementary information for Chapter 2
S2 Supplementary materials and methods
The WT, N12D, and I71N time-course data were fit via regularized nonlinear leastsquares to the first-order kinetic model
k

k

1
2
C !!
" N !!
" L
which describes the stepwise conversion of DNA from circular to nicked to linear form.
Regression curves (Figure S4) are shown overlaid with data and empirical monotonic
Hermite smoothing-spline interpolants. These figures show no inconsistency between the
first order kinetic model and the observed data for WT, N12D and I71N proteins.

In contrast, the first-order model above cannot account for the behavior of the I67N or
S20Q mutants. Instead, values of k1 were estimated in the absence of nicked or linear
forms. For S20Q, circular DNA concentrations were fit to the empirical formula
C = C0 + exp(!" 1t + " 2 ) + " 3
where the comparable initial reaction velocity is given as k1 = ! 1e! 2 . This empirical
model could not reproduce the dynamic behavior of the I67N mutant due to the rapid
initial conversion of C to N. Instead, the initial reaction velocity was estimated by the
slope of the smoothing spline at time zero. The empirical differences in reaction kinetics
between the I67N and S20Q mutants suggest that each has distinct mechanistic changes
compared to each other, not just WT.
Since the total concentration of circular, nicked, and linear DNA is presumed constant, a
ternary plot showing the relative proportion of each component is presented in Figure S4.
Ternary-plot trajectories are displayed without regard to time, and the overall shapes of
the reaction regression curves suggest mechanistic differences without regard to
differences in reaction rate. Specifically, the plot suggests that the (WT, N12D, I71N),
(I67N), and (S20Q) reaction curves are all mechanistically distinct since they group into
three observably different classes.

201

S2 Supplementary figures
Nat
CO

ATGAAATCAGGCGTTTATAAAATAACAAATAAAAATACAGGGAAGTTTTATATTGGCAGTTCAGAAGAC
ATGAAATCTGGTGTTTACAAAATCACCAACAAAAACACCGGTAAATTCTACATCGGTTCTTCTGAAGAC
M K S G V Y K I T N K N T G K F Y I G S S E D

Nat
CO

TGTGAAAGTAGACTAAAAGTTCATTTTAGAAATCTAAAAAACAATAGACATATTAATAGATATTTAAAC
TGCGAATCTCGTCTGAAAGTTCACTTCCGTAACCTGAAAAACAACCGTCACATCAACCGTTACCTGAAC
C E S R L K V H F R N L K N N R H I N R Y L N
AATTCGTTTAATAAACATGGAGAGCAGGTATTTATTGGAGAGGTAATTCATATTTTGCCCATAGAAGAG
AACTCTTTCAACAAACACGGTGAACAGGTTTTCATCGGTGAAGTTATCCACATCCTGCCGATCGAAGAA
N S F N K H G E Q V F I G E V I H I L P I E E

Nat
CO
Nat
CO

GCTATAGCCAAGGAGCAATGGTATATTGATAATTTCTATGAAGAAATGTACAACATAAGTAAATCAGCT
GCTATCGCTAAAGAACAGTGGTACATCGACAACTTCTACGAAGAAATGTACAACATCTCTAAATCTGCT
A I A K E Q W Y I D N F Y E E M Y N I S K S A

Nat
CO

TACCATGGCGGAGACTTAACAAGCTATCACCCAGACAAACGAAACATCATCCTCAAAAGAGCCGACAGT
TACCACGGTGGTGACCTGACCTCTTACCACCCGGACAAACGTAACATCATCCTGAAACGTGCTGACTCT
Y H G G D L T S Y H P D K R N I I L K R A D S

Nat
CO

TTGAAGAAAGTTTATTTGAAGATGACATCTGAAGAAAAGGCTAAGCGATGGCAATGTGTTCAAGGAGAA
CTGAAAAAAGTTTACCTGAAAATGACCTCTGAAGAAAAAGCTAAACGTTGGCAGTGCGTTCAGGGTGAA
L K K V Y L K M T S E E K A K R W Q C V Q G E

Nat
CO

AATAATCCGATGTTTGGAAGAAAACATACAGAAACGACAAAGCTAAAGATTTCAAATCATAATAAGCTT
AACAACCCGATGTTCGGTCGTAAACACACCGAAACCACCAAACTGAAAATCTCTAACCACAACAAACTG
N N P M F G R K H T E T T K L K I S N H N K L

Nat
CO

TATTACTCAACTCACAAAAATCCATTTAAAGGTAAAAAACATAGTGAGGAGAGTAAGACTAAGTTGTCA
TACTACTCTACCCACAAAAACCCGTTCAAAGGTAAAAAACACTCTGAAGAATCTAAAACCAAACTGTCT
Y Y S T H K N P F K G K K H S E E S K T K L S

Nat
CO

GAATATGCTTCTCAAAGAGTGGGTGAAAAAAATCCGTTCTATGGAAAAACACACAGTGATGAATTTAAG
GAATACGCTTCTCAGCGTGTTGGTGAAAAAAACCCGTTCTACGGTAAAACCCACTCTGACGAATTCAAA
E Y A S Q R V G E K N P F Y G K T H S D E F K

Nat
CO

ACTTATATGTCTAAAAAGTTTAAAGGCAGAAAGCCAAAAAATTCAAGACCAGTTATCATAGATGGAACA
ACCTACATGTCTAAAAAATTCAAAGGTCGTAAACCGAAAAACTCTCGTCCGGTTATCATCGACGGTACC
T Y M S K K F K G R K P K N S R P V I I D G T

Nat
CO

GAATATGAAAGTGCTACAGAAGCTTCAAGACAGTTAAATGTAGTTCCTGCTACTATCCTCCATAGAATC
GAATACGAATCTGCTACCGAAGCTTCTCGTCAGCTGAACGTTGTTCCGGCTACCATCCTGCACCGTATC
E Y E S A T E A S R Q L N V V P A T I L H R I

Nat
CO

AAAAGTAAAAATGAAAAATACAGTGGATACTTTTACAAA
AAATCTAAAAACGAAAAATACTCTGGTTACTTCTACAAA
K S K N E K Y S G Y F Y K

Supplementary Figure S2.1: Comparison of the sequence of codon-optimized (CO)
I-BmoI with the native sequence (Nat). Optimized codons for expression in E. coli
are shown in red.
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Supplementary Figure S2.2: Nucleotide mutation frequencies.
(A) Substitution frequencies from 87 selected and 62 unselected clones. (B) Predicted
distributions based on simulations of the mutagenic method.
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S2 Supplementary tables
Supplementary Table S2.2: Oligonucleotides used in Chapter 2
Name

Sequence (5'-3')

Notes

DE-331

CGCGCGCGCCATATGAAATCTGGTGTTTACAAA
ATC

NdeI site underlined

DE-384

CGCGCGCGCCTCGAGTTATTATTTGTAGAAGTA
ACCAGAGTATTTTTCG

XhoI site underlined

DE-395

CTAGAAAGAGCCCGTAGTAATGACATGGCCTTG
GGAAATCCCTTCAATGTATTCCAGGCATG

XbaI (5') and SphI (3')
overhangs underlined

DE-396

CCTGGAATACATTGAAGGGATTTCCCAAGGCCA
TGTCATTACTACGGGCTCTTT

XbaI (5') and SphI (3')
overhangs underlined

DE-419

GAAGACTGCGAATCTGCCCTGAAAGTTCACTTC

Alanine codon
underlined for R27A

DE-420

GAAGTGAACTTTCAGGGCAGATTCGCAGTCTTC

Reverse complement of
DE-419

DE-429

CTAGAAACATAAGTGAGTAATGACATGGCCTTG
GGAAATCCCTTCAATGTATTCCAGGCATG

XbaI (5') and SphI (3')
overhangs underlined

DE-430

CCTGGAATACATTGAAGGGATTTCCCAAGGCCA
TGTCATTACTCACTTATGTTT

XbaI (5') and SphI (3')
overhangs underlined

DE-490

GTATAAGAAGGAGATATACATATG

NdeI site underlined

DE-491

TTCTTTACCAGACTCGAGTTATTA

XhoI site underlined
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Supplementary Table S2.3: EoS values and mutations for nuclease & linker residues
Position

Codon

Residue

log2_EoS

Sel. clones
# sub.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48

ATG
AAA
TCT
GGT
GTT
TAC
AAA
ATC
ACC
AAC
AAA
AAC
ACC
GGT
AAA
TTC
TAC
ATC
GGT
TCT
TCT
GAA
GAC
TGC
GAA
TCT
CGT
CTG
AAA
GTT
CAC
TTC
CGT
AAC
CTG
AAA
AAC
AAC
CGT
CAC
ATC
AAC
CGT
TAC
CTG
AAC
AAC
TCT

M
K
S
G
V
Y
K
I
T
N
K
N
T
G
K
F
Y
I
G
S
S
E
D
C
E
S
R
L
K
V
H
F
R
N
L
K
N
N
R
H
I
N
R
Y
L
N
N
S

6.17
7.35
2.93
0.15
0.05
5.77
7.21
5.75
2.91
5.84
3.49
3.26
-0.56
-0.50
1.52
2.19
5.89
2.15
-0.60
3.00
0.26
1.22
3.22
0.51
-0.14
0.25
0.08
2.73
7.42
2.96
3.21
0.72
0.11
5.93
2.81
0.30
-0.75
2.12
0.22
0.33
2.28
5.89
0.31
0.61
2.81
2.35
-0.34
3.12

0
0
2
5
6
0
0
1
0
1
2
10
4
2
2
1
0
2
2
1
4
1
0
2
3
6
1
0
0
0
0
2
2
1
0
6
4
2
5
1
1
0
1
2
1
1
3
2

Sel. clones
#nonsynon.
sub.
0
0
0
0
1
0
0
0
0
0
1
10
2
1
2
1
0
1
1
0
1
1
0
1
2
1
0
0
0
0
0
2
0
0
0
3
4
1
0
1
1
0
0
2
0
1
3
0

Unsel. clones
# sub.

Unsel. clones
#nonsynon. sub.

0
3
3
5
8
1
6
6
3
2
3
8
4
4
4
4
2
6
1
4
7
1
3
2
4
8
4
3
6
2
6
3
4
1
0
5
4
3
5
3
4
6
3
1
6
6
5
3

0
2
0
1
5
1
4
6
2
2
3
7
4
1
3
4
2
5
0
3
3
1
3
2
2
4
2
2
6
1
6
3
2
1
0
5
4
3
2
3
3
6
0
1
6
6
5
1
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49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91	
  
92	
  
93	
  
94	
  
95	
  
96	
  
97	
  
98	
  
99	
  
100	
  
101	
  

TTC
AAC
AAA
CAC
GGT
GAA
CAG
GTT
TTC
ATC
GGT
GAA
GTT
ATC
CAC
ATC
CTG
CCG
ATC
GAA
GAA
GCT
ATC
GCT
AAA
GAA
CAG
TGG
TAC
ATC
GAC
AAC
TTC
TAC
GAA
GAA
ATG
TAC
AAC
ATC
TCT
AAA
TCT	
  
GCT	
  
TAC	
  
CAC	
  
GGT	
  
GGT	
  
GAC	
  
CTG	
  
ACC	
  
TCT	
  
TAC	
  

F
N
K
H
G
E
Q
V
F
I
G
E
V
I
H
I
L
P
I
E
E
A
I
A
K
E
Q
W
Y
I
D
N
F
Y
E
E
M
Y
N
I
S
K
S	
  
A	
  
Y	
  
H	
  
G	
  
G	
  
D	
  
L	
  
T	
  
S	
  
Y	
  

-0.29
5.98
7.39
0.33
0.29
4.65
-0.30
-0.40
6.00
-0.58
0.11
0.11
2.79
2.01
0.32
0.53
2.74
-0.47
5.67
-0.14
0.08
0.06
5.66
-0.57
1.45
4.69
3.23
0.53
2.27
2.13
3.18
5.87
0.67
5.75
4.57
1.33
2.41
5.98
5.93
2.13
2.82
3.52
2.95	
  
0.19	
  
5.65	
  
3.30	
  
0.19	
  
0.13	
  
3.01	
  
2.56	
  
0.26	
  
0.24	
  
2.18	
  

3
0
2
1
1
1
5
6
0
5
1
2
3
1
1
3
0
2
0
3
2
1
1
2
5
1
0
1
1
1
0
0
2
0
0
2
1
0
1
1
0
1
3	
  
0	
  
1	
  
0	
  
3	
  
2	
  
0	
  
0	
  
2	
  
2	
  
1	
  

3
0
0
1
0
0
4
2
0
4
0
2
0
1
1
2
0
1
0
2
2
0
0
1
2
0
0
1
1
1
0
0
2
0
0
1
1
0
0
1
0
1
0	
  
0	
  
0	
  
0	
  
0	
  
0	
  
0	
  
0	
  
1	
  
1	
  
1	
  

6
6
5
2
4
3
3
6
5
6
4
1
4
4
1
7
3
1
2
3
3
3
4
1
6
2
4
1
2
5
3
2
5
3
1
6
7
5
6
5
4
2
3	
  
5	
  
0	
  
5	
  
4	
  
3	
  
5	
  
4	
  
1	
  
0	
  
6	
  

6
5
4
2
2
3
2
2
5
6
1
1
4
4
1
6
3
1
2
1
2
1
4
0
5
1
4
1
2
5
2
2
5
2
0
4
7
5
6
5
4
2
2	
  
1	
  
0	
  
5	
  
0	
  
1	
  
5	
  
4	
  
1	
  
0	
  
6	
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102	
  
103	
  
104	
  
105	
  
106	
  
107	
  
108	
  
109	
  
110	
  
111	
  
112	
  
113	
  
114	
  
115	
  
116	
  
117	
  
118	
  
119	
  
120	
  
121	
  
122	
  
123	
  
124	
  
125	
  
126	
  
127	
  
128	
  
129	
  
130	
  
131	
  
132	
  
133	
  
134	
  
135	
  
136	
  
137	
  
138	
  
139	
  
140	
  
141	
  
142	
  
143	
  
144	
  
145	
  
146	
  
147	
  
148	
  
149	
  
150	
  
151	
  
152	
  
153	
  
154	
  

CAC	
  
CCG	
  
GAC	
  
AAA	
  
CGT	
  
AAC	
  
ATC	
  
ATC	
  
CTG	
  
AAA	
  
CGT	
  
GCT	
  
GAC	
  
TCT	
  
CTG	
  
AAA	
  
AAA	
  
GTT	
  
TAC	
  
CTG	
  
AAA	
  
ATG	
  
ACC	
  
TCT	
  
GAA	
  
GAA	
  
AAA	
  
GCT	
  
AAA	
  
CGT	
  
TGG	
  
CAG	
  
TGC	
  
GTT	
  
CAG	
  
GGT	
  
GAA	
  
AAC	
  
AAC	
  
CCG	
  
ATG	
  
TTC	
  
GGT	
  
CGT	
  
AAA	
  
CAC	
  
ACC	
  
GAA	
  
ACC	
  
ACC	
  
AAA	
  
CTG	
  
AAA	
  

H	
  
P	
  
D	
  
K	
  
R	
  
N	
  
I	
  
I	
  
L	
  
K	
  
R	
  
A	
  
D	
  
S	
  
L	
  
K	
  
K	
  
V	
  
Y	
  
L	
  
K	
  
M	
  
T	
  
S	
  
E	
  
E	
  
K	
  
A	
  
K	
  
R	
  
W	
  
Q	
  
C	
  
V	
  
Q	
  
G	
  
E	
  
N	
  
N	
  
P	
  
M	
  
F	
  
G	
  
R	
  
K	
  
H	
  
T	
  
E	
  
T	
  
T	
  
K	
  
L	
  
K	
  

3.26	
  
0.17	
  
3.23	
  
7.54	
  
0.17	
  
-‐0.61	
  
2.08	
  
2.05	
  
0.10	
  
7.54	
  
-‐0.48	
  
0.06	
  
3.30	
  
2.88	
  
2.74	
  
0.34	
  
3.47	
  
0.20	
  
6.00	
  
2.24	
  
-‐0.69	
  
2.54	
  
0.19	
  
0.09	
  
-‐0.08	
  
4.53	
  
3.58	
  
0.25	
  
7.36	
  
0.23	
  
3.33	
  
3.21	
  
0.34	
  
0.22	
  
-‐0.45	
  
-‐0.38	
  
-‐0.01	
  
5.84	
  
5.74	
  
0.00	
  
2.57	
  
0.59	
  
0.33	
  
-‐0.59	
  
1.54	
  
0.31	
  
-‐0.70	
  
-‐0.03	
  
2.91	
  
0.25	
  
0.12	
  
2.65	
  
3.59	
  

0	
  
1	
  
0	
  
1	
  
0	
  
5	
  
2	
  
3	
  
1	
  
1	
  
4	
  
2	
  
0	
  
0	
  
0	
  
4	
  
3	
  
2	
  
0	
  
6	
  
6	
  
1	
  
1	
  
2	
  
3	
  
1	
  
1	
  
0	
  
1	
  
1	
  
0	
  
0	
  
1	
  
5	
  
2	
  
3	
  
3	
  
0	
  
0	
  
0	
  
1	
  
2	
  
1	
  
1	
  
2	
  
1	
  
3	
  
3	
  
0	
  
1	
  
4	
  
0	
  
1	
  

0	
  
0	
  
0	
  
0	
  
0	
  
4	
  
1	
  
1	
  
1	
  
0	
  
1	
  
0	
  
0	
  
0	
  
0	
  
3	
  
1	
  
1	
  
0	
  
6	
  
5	
  
1	
  
1	
  
1	
  
2	
  
0	
  
1	
  
0	
  
0	
  
0	
  
0	
  
0	
  
1	
  
1	
  
2	
  
1	
  
2	
  
0	
  
0	
  
0	
  
1	
  
2	
  
0	
  
1	
  
2	
  
1	
  
2	
  
2	
  
0	
  
1	
  
3	
  
0	
  
1	
  

7	
  
0	
  
2	
  
7	
  
5	
  
6	
  
5	
  
5	
  
3	
  
12	
  
3	
  
3	
  
0	
  
3	
  
5	
  
14	
  
5	
  
8	
  
3	
  
1	
  
12	
  
5	
  
3	
  
0	
  
8	
  
1	
  
3	
  
2	
  
8	
  
2	
  
3	
  
2	
  
4	
  
8	
  
5	
  
2	
  
3	
  
6	
  
1	
  
2	
  
6	
  
7	
  
1	
  
5	
  
6	
  
3	
  
3	
  
6	
  
4	
  
3	
  
7	
  
2	
  
9	
  

6	
  
0	
  
2	
  
6	
  
1	
  
6	
  
3	
  
5	
  
3	
  
11	
  
1	
  
1	
  
0	
  
1	
  
5	
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S48

N42

H31

S20

Y17

!
-

Co-evol.
partner
(Table 2.1)
none

Mutations in
selected
clones.
H2

Mutations in
unselected
clones
5.89

EoS Score
(Fig. 2.5 &
Table S2.2)
Y17

I-TevI
Residue
Y29

UvrC Residue
F

Mutation made
in I-BmoI
0

Genetic selection
Survival vs. WT
(Table 2.2)

I71

none

P2, T

3

S20

K32

A

0

-

none

L2, P, R2, Q

3.21

H31

Y43

0.003
0

A
F

-

none

D, I, S2, T, Y

5.89

S42

-

A

0

0.29
N10
none
A
3.12
S48
E57
A
1.02
S48 lies in a 9 amino acid stretch (from L45 to G53) that shows a high degree of conservation (formerly partly characterized as motif C). Along with K51
and H52, this stretch of amino acids comprises most of α-helix 2. There is a hydrogen bond network between the side chains of N10, S48, and Y86 (with
N10 and Y86 being well conserved). S48 coevolves with N10, and while the interaction may be structural, it was our goal to investigate the function of
interaction. The S48A mutation was made not only because it is a potentially deleterious substitution, but also because there is a tendency for this position to
be alanine.

D
0
I-TevI has a serine at this position (S42), whereas no similar residues are present UvrCs at this position. This residue was of interest to mutate due to the fact
that it was highly mutable in the unselected population, yet intolerant of mutation in the selected population, and had a high EoS score. In the alignment,
slightly polar residues are prevalent at this position, and the I-BmoI homology model predicts that N42 is surface exposed. Interestingly, the amino group of
N42 appears to be within hydrogen bonding distance of the hydroxyl of Y17. The N42A mutation was made to determine whether N42 is required for
function, while the N42D mutation was made to specifically remove the positive nature of the asparagine side chain and to disrupt contacts to Y17.

0.45

Y
0
H31 is found in α-helix 1 and is conserved in most GIY-YIG-like endonucleases, and is either a Y or an H in all UvrC members. H31 of I-TevI is hydrogenbonded to both Y6 and H40, and Y43 of UvrC is hydrogen bonded to Y19. In both I-TevI and UvrC, the residue is surface exposed in the catalytic pocket,
and in the I-BmoI homology model, H31 is within hydrogen-bonding distance of Y17. The I-BmoI H31A mutation was made to determine whether H31
was essential, H31F was made as a structurally similar but chemically inert substitution to determine the role of the H31 side chain, and the H31Y mutation
was generated in an attempt to mimic the proton shuttle if in fact the H31 side chain does have a role in catalysis.

2

Q
0.12
S20, which is also found in β-strand 2, is a serine in some GIY-YIG members (including I-TevI) but is a stricly conserved lysine in UvrCs (K32). In the
UvrC and I-TevI structures, K32 and S20 are solvent accessible and positioned in close proximity to the coordinated metal ion. In addition, UvrC K32 is
near UvrC R39 (analogous to I-TevI R27), and thus may be involved in stabilization of the 5'P of the cleavage intermediate. The I-BmoI S20Q mutation
was made since it was the most common substitution found among co-evolving S20-I71 pairs, and the S20A mutation was made to determine the
requirement for polar residue at this position. In addition, this residue has not been mutated in any previous study.

0.48

H
0
Y17 is extremely well conserved in all GIY-YIG enzymes and lies in β-strand 2. The hydroxyl of I-TevI Y17 is surface exposed and points into the catalytic
pocket. When modelled onto I-PpoI, Y17 is in a similar position to H98, which activates H2O to act as a nucleophile. I-TevI Y17A is marginally soluble,
and has 1% of WT activity. Y29 of UvrC forms a hydrogen bond to a metal-bound H2O, and Y29A and Y29F mutants have ~1-2% activity. In UvrC, the
Y29 hydroxyl protrudes from the active site surface and is in close proximity to divalent metal, where it is thought to lower the pKa to serve as a general
base (a proton shuttle). We made a Y17F mutation in I-BmoI as structurally inert mimic, while Y17H was made with the rationale that histidine mutant may
retain activity if it can function as a base.

3.95

Information
Content
(Fig. 2.2A)
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Supplementary Table S2.4: Rationale for selecting co-evolving residues to
investigate

Y86

I71

I67

H52

K51

Co-evol.
partner
(Table 2.1)

Mutations in
selected
clones.

Mutations in
unselected
clones

EoS Score
(Fig. 2.5 &
Table S2.2)
I-TevI
Residue
UvrC Residue

Mutation made
in I-BmoI

Genetic selection
Survival vs. WT
(Table 2.2)

K51

R

L2

0.33

H52

-

R

0.43

S20

none

F4

5.66

I72

F73

A

0.22

3.0
none
C2, D, F2
5.98
Y89
Y87
F
0.99
Y86 is highly conserved in all GIY-YIG enzymes and is found next to the functionally critical N87 in a loop region between α-helix 3 and the linker region.
This residue was mutated because of its high degree of conservation, and because it forms a hydrogen bond network with N10 and S48. The Y86F mutation
was generated to determine the affect of removing the polar hydroxyl group.

N
0.20
I71 is found in α-helix 3 and co-evolves with S20, which is the highest-scoring co-evolving pair. I-TevI also contains an isoleucine at this position and
UvrC's have a highly conserved phenylalanine. The analogous Leu 116 of I-PpoI is in the metal binding α-helix and is inserted into the minor groove of
substrate, forming Van der Waals contacts with adenine. A L116A mutant in I-PpoI has reduced catalytic activity, and a DNA-binding defect. The I71N
mutation was generated because asparagine was the second most common amino acid at this position among 146 sequences, and the I71A mutation was
generated to determine the effect of the loss of the large hydrophobic sidechain.

0..07

0.04
none
N, V
5.67
Y66
N68
N
0.06
I67 is found in an unstructured region between β-strand 3 and α-helix 3, and was interesting to investigate from a structural standpoint. It is one of 4
isoleucines that are solvent exposed and flank the catalytic pocket (two on either side of the cleft). Similar to the proposed role for I71, I67 may be involved
in contacting substrate. The I67N mutation was generated to substitute the inert nature of an isoleucine residue with the charge of an asparagine residue,
while maintaining a similar size.

Y
0.96
This residue is also a part of α-helix 2, where is it is either a histidine or tyrosine. The rationale for mutation of this position was similar to that for K51.
Interestingly, we isolated a clone from the unigenic evolution screen that had a single mutation at this position (H52R). The H52Y mutation was made
because tyrosine was the second most common residue at that position in the alignment, and tyrosine would be structurally similar to histidine.

0.34

1.66
H52
none
N, V, X2
7.39
K51
L
0.86
K51 is a well-conserved residue that lies in α-helix 2, and may form important structural contacts. K51 lies in a stretch of conserved residues that comprise
motif C in previous alignments; S48-G53 is conserved between I-TevI and I-BmoI, while UvrC lacks K51-F56 (all of motif C). K51 has a very high EoS
score, and K51 co-evolves with H52 (K51-H52 is the third highest scoring co-evolving pair). The K51L mutation removes the charges functional groups
from the side chain, but also was the second most common amino acid at the position from the alignment.

Information
Content
(Fig. 2.2A)
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Appendix S3: Supplementary information for Chapter 3
S3 Supplementary tables
Supplementary Table S3.1: Strains and plasmids used in this study
Strains
DH5α

Description
-

Source

F , φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1,
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1
F- λ- fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 Δ(mcrCmrr)114::IS10 R(mcr-73::miniTn10-TetS)2 R(zgb-210::Tn10)(TetS)
endA1 [dcm]
Description

Invitrogen

Ref 1.

pDE213

pTYB1 derivative containing the 266 amino acid codon-optimized I-BmoI
gene
pBS derivative containing a 48-base pair XbaI/BamHI insert corresponding
to the intronless B. mojavensis thyA gene
Similar to pBmoHS, with the intron-containing sequence upstream of the
intron insertion site (substitutions relevant to this study are: T-1G, G-2T,
C-3G, C-4A, C-5A, and G-6T)
Similar to pBmoHS, with a T-1G substitution

pDE214

Similar to pBmoHS, with a G-2T substitution

Ref 2.

pDE215

Similar to pBmoHS, with a C-3G substitution

Ref 2.

pDE216

Similar to pBmoHS, with a C-4A substitution

Ref 2.

pDE217

Similar to pBmoHS, with a C-5A substitution

Ref 2.

pDE218

Similar to pBmoHS, with a G-6T substitution

Ref 2.

pDE219

Similar to pBmoHS, with T-1G and G-2T substitutions

Ref 2.

pDE220

Similar to pBmoHS, with G-2T and C-3G substitutions

Ref 2.

pDE221

Similar to pBmoHS, with G-2T and C-4A substitutions

Ref 2.

pDE222

Similar to pBmoHS, with G-2T and C-5A substitutions

Ref 2.

pDE223

Similar to pBmoHS, with C-3G and C-4A substitutions

Ref 2.

pDE224

Similar to pBmoHS, with C-3G and C-5A substitutions

Ref 2.

pDE225

Similar to pBmoHS, with C-4A and C-5A substitutions

Ref 2.

pDE227

Similar to pBmoHS, with T-1G, G-2T, and C-3G substitutions

Ref 2.

pDE228

Similar to pBmoHS, with T-1G, C-3G, and C-5A substitutions

Ref 2.

pDE229

Similar to pBmoHS, with G-2T, C-3G, and C-4A substitutions

Ref 2.

pDE230

Similar to pBmoHS, with G-2T, C-4A, and G-6T substitutions

Ref 2.

pDE231

Similar to pBmoHS, with C-3G, C-4A, and C-5A substitutions

Ref 2.

pDE232

Similar to pBmoHS, with C-4A, C-5A, and G-6T substitutions

Ref 2.

pDE233

Similar to pBmoHS, with G-2T, C-3G, C-4A, and C-5A substitutions

Ref 2.

ER2566
Plasmids
pTYBmoI
pBmoHS
pDE212

1.
2.

N.E.B.
Source

Ref 2.
Ref 2.

Ref 2.

Kleinstiver, B.P., Fernandes, A.D., Gloor, G.B. and Edgell, D.R. (2010) A unified genetic,
computational and experimental framework identifies functionally relevant residues of the homing
endonuclease I-BmoI. Nucleic Acids Res, 38, 2411-2427.
Edgell, D.R., Stanger, M.J. and Belfort, M. (2003) Importance of a single base pair for discrimination
between intron-containing and intronless alleles by endonuclease I-BmoI. Curr Biol, 13, 973-978.
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Supplementary Table S3.2: Oligonucleotides used in Chapter 3
Name

Sequence (5'-3')

Notes

DE-37

CCACCTTGAGGTAAGAGCCCGTAGTAATGACAT
GGCCTTGGGAAATCCCTTCAATGTATTCCAG
CTGGAATACATTGAAGGGATTTCCCAAGGCCAT
GTCATTACTACGGGCTCTTACCTCAAGGTGG
AAACTCCACCTTGAGGTAAGAGCCCGTAGTAA
TGACATGGCCTTGGGAAATCCCTTCAATGTATT
CCAGTACAA
TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTACGGGCTCTTACCTCAAGG
TGGAGTTT
AGTAGCGACTTCTACTGAACATAAGTGAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTCACTTATGTTCAGTAGAAG
TCGCTACT
AAACTCCACCTTGAGGTAAGAGCCCTTAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTAAGGGCTCTTACCTCAAGG
TGGAGTTT
AAACTCCACCTTGAGGTAAGAGCCCATAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTATGGGCTCTTACCTCAAGG
TGGAGTTT
AAACTCCACCTTGAGGTAAGAGCCCCTAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTAGGGGCTCTTACCTCAAGG
TGGAGTTT
AGTAGCGACTTCTACTGAACATAAGGGAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTCCCTTATGTTCAGTAGAAGT
CGCTACT

Top strand intronless thyA 64mer from +22 to 42 relative to the intron insertion site
Bottom strand intronless thyA 64mer from
+22 to -42 relative to the intron insertion site
Top strand intronless thyA 74mer from +27 to 47 relative to the intron insertion site

DE-38
DE-116
DE-117
DE-444
DE-445
DE-446
DE-447
DE-459
DE-460
DE-461
DE-462
DE-463
DE-464

Bottom strand intronless thyA 74mer from
+27 to -47 relative to the intron insertion site
Top strand intron-containing thyA 74mer from
+27 to -47 relative to the intron insertion site
Bottom strand intron-containing thyA 74mer
from +27 to -47 relative to the intron insertion
site
Top strand intronless thyA 74mer from +27 to 47 relative to the intron insertion site, with a G2T substitution
Bottom strand intronless thyA 74mer from
+27 to -47 relative to the intron insertion site,
with a C-2A substitution
Top strand intronless thyA 74mer from +27 to 47 relative to the intron insertion site, with a G2A substitution
Bottom strand intronless thyA 74mer from
+27 to -47 relative to the intron insertion site,
with a C-2T substitution
Top strand intronless thyA 74mer from +27 to 47 relative to the intron insertion site, with a G2C substitution
Bottom strand intronless thyA 74mer from
+27 to -47 relative to the intron insertion site,
with a C-2G substitution
Top strand intron-containing thyA 74mer from
+27 to -47 relative to the insertion site, with a
A-2G substitution
Bottom strand intron-containing thyA 74mer
from +27 to -47 relative to the insertion site,
with a T-2C substitution

A

A

A

A

A

A

A

A

A

G

G

G

G

T

T

T

T

G

G

n.d.

n.d.

0.00018

n.d.

n.d.

0.00008

n.d.

G

0.00035

G

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

0.0002

n.d.

n.d.

0.00016

n.d.

0.00037

n.d.

n.d.

n.d.

n.d.

0.00027

0.00025

G

T

G

0.0045

0.0105

0.0044

0.0082

0.0095

0.0102

0.0308

0.0572

0.0043

0.0103

0.0042

0.008

0.0095

0.01

0.0266

0.0504

0.0501

0.0461

median
0.0574

low
0.0531

G

T

T

T

G

-1
T

k1 (s )

-1 a

n.d.

n.d.

0.00021

n.d.

n.d.

0.00025

n.d.

0.0004

n.d.

n.d.

n.d.

n.d.

0.00028

0.0046

0.0106

0.005

0.0086

0.0095

0.0104

0.0315

0.061

0.0645

0.0628

high

n.d.

n.d.

0.00008

n.d.

n.d.

n.d.

n.d.

0.00026

n.d.

n.d.

n.d.

n.d.

n.d.

0.0146

0.0164

0.015

0.0088

0.015

0.0083

0.0095

0.0239

0.0207

0.0236

low

2mM MgCl2

n.d.

n.d.

0.00169

n.d.

n.d.

n.d.

n.d.

0.00053

n.d.

n.d.

n.d.

n.d.

n.d.

0.0154

0.017

0.0153

0.0091

0.0155

0.0084

0.0095

0.0241

0.0279

0.026

median

k2 (s )

-1 b

n.d.

n.d.

0.00271

n.d.

n.d.

n.d.

n.d.

0.0015

n.d.

n.d.

n.d.

n.d.

n.d.

0.0155

0.019

0.0156

0.0094

0.0156

0.0085

0.0101

0.0244

0.0561

0.0281

high

low

n.d.

n.d.

0.00039

n.d.

n.d.

0.00032

n.d.

0.00085

n.d.

n.d.

n.d.

n.d.

0.00059

0.0129

0.0269

0.0128

0.0243

0.0282

0.0243

0.0534

0.0763

0.0922

0.0762

n.d.

n.d.

0.00052

n.d.

n.d.

0.00035

n.d.

0.0013

n.d.

n.d.

n.d.

n.d.

0.00061

0.0135

0.0277

0.0136

0.0244

0.0309

0.0246

0.0651

0.0872

0.1044

0.111

median

k1 (s )

-1

n.d.

n.d.

0.0007

n.d.

n.d.

0.00036

n.d.

0.00145

n.d.

n.d.

n.d.

n.d.

0.00063

0.0143

0.0287

0.0143

0.0245

0.0312

0.0263

0.0755

0.0937

0.1178

0.131

high

n.d.

n.d.

0.0087

n.d.

n.d.

0.0022

n.d.

0

n.d.

n.d.

n.d.

n.d.

n.d.

0.0453

0.0467

0.0411

0.0218

0.0409

0.0247

0.0245

0.0556

0.0537

0.068

low

10mM MgCl2

n.d.

n.d.

0.0091

n.d.

n.d.

0.0026

n.d.

0.0138

n.d.

n.d.

n.d.

n.d.

n.d.

0.0468

0.0484

0.0434

0.0221

0.0421

0.0249

0.0245

0.0575

0.0571

0.0738

median

k2 (s-1)

b

k 1, the mean of the 95% confidence interval for the rate constant that describes the first nicking reaction, which generates nicked intermediate
k 2, the mean of the 95% confidence interval for the rate constant that describes the second nicking reaction, which generates linear product
n.d., not determined

a

intron-containing T

T

A

A

A

G

T

A

G

G

(no rescue)

A

A

A

A

T

A

T

A

A

T

T

-6
G

Class III

(rescue)

Class II

(like wild-type)

Class I

intronless

Substrate
-5 -4 -3 -2
C C C G

n.d.

n.d.

0.0106

n.d.

n.d.

0.0028

n.d.

0.0148

n.d.

n.d.

n.d.

n.d.

n.d.

0.0486

0.0502

0.0448

0.0225

0.0428

0.0257

0.0255

0.0586

0.0591

0.0759

high
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Supplementary Table S3.3: Confidence intervals for rate constants determined on
mutant substrates in low and high MgCl2 concentrations.
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Appendix S4: Supplementary information for Chapter 4
S4 Supplementary materials and methods
DNA-binding affinity of I-BmoI domains. Binding reactions shown in Supplementary
Figure S4.2 contained 200 mM NaCl, 50 mM tris pH 8.0, 5% glycerol, either 10 mM
EDTA or 10 mM MgCl2, 6 µM thyA 74-mer substrate, and 12 µM full-length I-BmoI or
domain truncation in 15 µl volumes. Reactions were incubated at room temperature for
15 minutes, stopped by the addition of 5 µl loading buffer (10% glycerol, 100mM
EDTA), and half of the reaction was loaded on a 10% native polyacrylamide (19:1) gel.
Gels were stained in ethidium bromide (Caledon) prior to analysis on an
AlphaImagerTM3400 (Alpha Innotech).
Cross-linking reactions. Prior to cross-linking reactions, purified I-BmoI was dialyzed
into 50 mM HEPES pH 8.0, 500 mM NaCl, and 5% glycerol. Typically, 20-µl reactions
contained 7.6 µM I-BmoI, 15 mM MgCl2, and 1.125 µM thyA 74mer substrate (DE116/DE-117) when included. Reactions were supplemented with dilutions of 1-ethyl-3(3-dimethylaminopropyl) carbodiimide) (EDC, Fluka Analytical) from 144 µM to 48 mM
in conjunction with N-Hydroxysuccinimide (NHS, Sigma-Aldrich Inc.) from 92 µM to 31
mM. I-BmoI was the final component to be added to the reactions that were subsequently
stopped by adding 12 µl of stop buffer (792 mM Tris-HCl pH 8.0, 4 % SDS, 20 %
glycerol) at either 2, 5, or 10 minutes. Stopped reactions were run against a medium
molecular weight ladder (PiNK plus, GeneDirex) and proteins were identified after
electrophoresis on 15% SDS-PAGE gels either by coommassie stain (86 pmol I-BmoI per
lane) or Western blot (3.6 pmol per lane, see below). Additional cross-linking reactions
were conducted with a range of I-BmoI concentrations and were conditionally
supplemented with 15 mM MgCl2, thyA 74-mer substrate (DE-116/DE-117), and various
concentrations of EDC/NHS, bissulfosuccinimidyl suberate (BS3, Thermo Scientific), or
glutaraldehyde (EM grade, Polysciences Inc.).
For Western blot analysis, a polyclonal anti-N111 I-BmoI antibody (Pacific
Immunology) was raised against the N111 truncation of I-BmoI. Electrophoresis of 3.5
pmol of I-BmoI cross-linking reactions on a 15% SDS-PAGE gel was conducted prior to
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transfer to a PVDF membrane (Pall Life Sciences) at 100V. Membranes were washed on
a rocker in casein blocking buffer (Sigma) for 60 minutes, washed with a 1:10,000
dilution of the anti-N111 antibody in TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.1% Tween 20) for 60 minutes, washed 4 x 5 minutes in TBST, exposed to a 1:10,000
dilution of anti-rabbit IgG peroxidase conjugate (Sigma) for 60 minutes in TBST, and
washed 4 x 5 minutes in TBST. Luminescent peptides were detected using ECL Plus (GE
Healthcare) detection reagent and were visualized at 450 nM on a StormTM860
(Molecular Dynamics).
Substrate topology assays. Cleavage assays were performed similar to those described
in the Methods section (Chapter 4.2), on supercoiled pLBmo, pLBmo linearized with
SwaI, and the relaxed plasmids pLBmoNa, pLBmoNb, and pLBmo2N that were prenicked by Nt.BbvCI (N.E.B.).
Cleavage assays with immobilized substrates. The immobilized substrate consisted of
duplex oligonucleotides, where the 5’ end of the top strand contained a biotin moiety
(DE-746), and the bottom strand (DE-747) was 5’ labeled with γ32-P prior to annealing.
Duplex oligonucleotides (0.32 pmol) were incubated with 10 µg streptavidin coated
magnetic beads (binding capacity of 1 nmol/mg Promega) to achieve ~3% occupancy.
The beads were subsequently washed in triplicate in 0.5x SSC (75 mM NaCl, 7.5 mM
Na3Citrate) prior to excess I-BmoI (175 nM) binding in 50 mM Tris-HCl pH 8.0, 50 mM
NaCl for 5 minutes at 37°C. Protein-substrate complexes were washed in triplicate in
wash buffer (20 mM Tris-HCl pH 8.0, 250 mM NaCl, 5% glycerol, 10 mM EDTA) prior
to the addition cleavage buffer (20 mM Tris-HCl pH 8.0, 250 mM NaCl, 5% glycerol, 10
mM MgCl2). Cleavage by I-BmoI was determined by monitoring the release of radiolabel
into the supernatant using a scintillation counter (Beckman Coulter CS5801).
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S4 Supplementary figures

Supplementary Figure S4.1: Time-course proteolysis of I-BmoI.
(A) Images of coomassie stained SDS-gels of elastase and chymotrypsin limited
proteolysis time-course experiments performed on I-BmoI and I-BmoI pre-incubated
with intronless thyA substrate. Aliquots were removed at the indicated time points. In-gel
trypsin digest followed by mass spectrometry was performed to identify the peptide
products indicated with an asterisk (*). M, protein marker (sizes in kDa indicated to the
left). (B) Western blot image of trypsin limited proteolysis time-course experiment. The
western blot was performed with an antibody against N111 I-BmoI on a gel with aliquots
of similar reactions to those shown in Figure 4.1A.
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Supplementary Figure S4.2:
purified domains.

DNA-binding activity of full-length I-BmoI and

Image of a native polyacrylamide gel with binding reactions containing full length and
truncated I-BmoI:thyA complexes, stained with ethidum-bromide. Binding reactions
contained either 10 mM EDTA (E) or MgCl2 (M).
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Supplementary Figure S4.3: Crosslinking of I-BmoI in solution and in complex with
substrate.
(top panels) Representative SDS-gel images of cross-linking reactions of I-BmoI or IBmoI:substrate complexes using (A) NHS and EDC, or (B) BS3. (bottom panels) Western
blots using an anti-N111 I-BmoI antibody performed to detect cross-linked complexes
below the detection limit of coomassie stain. (right panels) Positive control cross-linking
reactions performed at equivalent protein:cross-linker ratios with the Aeh1 NrdA subunits
that are known to associate (60). Molecular weight markers are shown beside the gels, in
kDa.
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Supplementary Figure S4.4: Substrate topology does not affect I-BmoI cleavage
kinetics:
(A) Representative gel images of in vitro time-course cleavage assays in 0.5 mM MgCl2
on supercoiled, relaxed, or linear substrate (top, middle, and bottom panels, respectively).
The left-most lane contains a DNA size marker, and the second lane from the left
contains unreacted substrate (-). Relaxed (R), linear (L), supercoiled (S), and two linear
product (L1, L2) DNA forms are indicated on the right, with product species for each
reaction boxed and colored according to reaction progress curves in (B). (B) Plots of
product formation for cleavage assays with 0.5 mM, 2 mM, and 10 mM MgCl2 (top,
middle, and bottom panels, respectively) on supercoiled, relaxed, or linear substrate (blue
box, red diamond, and green circle, respectively). The average and standard deviation of
three replicates is shown.
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Supplementary Figure S4.5: I-BmoI cleavage of a double target-site plasmid.
Plot of reaction progress for in vitro cleavage assays on the two-site substrate plasmid
with the target sites in the same orientation. Cleavage assays were performed in triplicate.
L1+L2, linear products from 2-site plasmid cleavage.
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Supplementary Figure S4.6: Immobilized substrates are cleaved by I-BmoI.
Schematic of the assembly of immobilized I-BmoI:thyA substrate complexes using
streptavidin coated magnetic beads. Cleavage was detected by measuring the release of
radiolabel into solution. (B) Graph of cleavage activity between various primary and
secondary treatments, reported as cleavage normalized relative to EcoRI (an EcoRI site is
found between the biotin tag and the I-BmoI cleavage site). Secondary treatments
containing I-BmoI were performed with excess I-BmoI. At least two replicates were
performed for the trials where standard error is shown, otherwise only one replicate.
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Supplementary Figure S4.7: Gel images of I-BmoI cleavage assays on supercoiled
substrates with nucleotide insertions.
Cleavage reactions contained (A) 0.5 mM, (B) 2 mM, or (C) 10 mM MgCl2, and
substrates described in Figure 7A. The left lane contains DNA size marker, and the
second lane from the left contains unreacted substrate (-). Relaxed (R), linear (L), and
supercoiled (S) DNA forms are shown to the right.
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Supplementary Figure S4.8: Frequency of nucleotides in the survivor pool.
(A) Sequencing results from cleavable targets represented as a position-specific scoring
matrix. (B) Plots to compare the change in nucleotide proportion in the randomized target
site for survivor versus input and survivor versus dead plasmid pools (top and bottom
panels, respectively).
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Supplementary Figure S4.9: Limited proteolysis of 130C I-BmoI.
(A) Coomassie stained SDS-gel of trypsin proteolysis time-course experiments
performed with 130C I-BmoI:substrate and 130C:G+7T substrate complexes. Aliquots
were removed at the indicated time points prior to electrophoresis. M, protein marker
(sizes in kDa indicated to the left). (B) Plot of the fraction of 130C I-BmoI remaining
over time for reactions shown in panel (A). Disappearance of 130C I-BmoI is calculated
as the fraction remaining after normalization to the untreated lane, with error bars and
standard deviation of two replicates.
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S4 Supplementary tables
SupplementaryTable S4.1: Strains and plasmids used in Chapter 4
Strains

Description

Source

DH5α

Invitrogen

Plasmids

F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1,
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1
F- λ- fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 Δ(mcrCmrr)114::IS10 R(mcr-73::miniTn10-TetS)2 R(zgb-210::Tn10)(TetS)
endA1 [dcm]
F- lacIq rrnBT14 DlacZWJ16 DphoBR580 hsdR514 DaraBADAH33
DrhaBADLD78 galU95 endABT333 uidA(DMluI)::pir+ recA1, λDE3
lysogen
Description

pTYB1

oriM13, amp

N.E.B.

pTYBmoI

pTYB1 derivative containing the 266 amino acid codon-optimized IBmoI gene
Similar to pTYBmoI, with an R27A mutation to knockout catalytic
activity
pTYB1 derivative containing residues 1-92 of codon-optimized IBmoI (cloned NdeI/XhoI)
pTYB1 derivative containing residues 1-111 of codon-optimized IBmoI (cloned NdeI/XhoI)
pTYB1 derivative containing residues 1-130 of codon-optimized IBmoI (cloned NdeI/XhoI)
pTYB1 derivative containing residues 1-154 of codon-optimized IBmoI (cloned NdeI/XhoI)
pTYB1 derivative containing residues 92-266 of codon-optimized IBmoI (cloned NdeI/XhoI)
pTYB1 derivative containing residues 106-266 of codon-optimized IBmoI (cloned NdeI/XhoI)
pTYB1 derivative containing residues 130-266 of codon-optimized IBmoI (cloned NdeI/XhoI)
pBS derivative containing a 54-base pair XbaI/BamHI insert
corresponding to the intronless B. mojavensis thyA gene
oriM13, amp

Ref 28.

LITMUS28i derivative, with the PvuII fragment of pBmoHS
(containg the 54 bp I-BmoI thyA target site) subcloned into PvuII
pLBmo derivative containing a second I-BmoI target site cloned into
SwaI using oligos DE-906/907 (sites in the opposite orientation)
Similar to pLBmo2a, except that the I-BmoI target sites are in the
same orientation
pLBmo derivative that contains an Nt.BbvCI nicking site 1082 base
pairs away from the I-BmoI top-strand cleavage site.
pLBmo derivative that contains an Nt.BbvCI nicking site 60 base
pairs away from the I-BmoI top-strand cleavage site.
pLBmo derivative that contains Nt.BbvCI nicking sites 1082 and 60
base pairs away from the I-BmoI top-strand cleavage site.
oripBR322, amp

This study

p11-lacY-wtx1 derivative with EcoRI site destroyed and new EcoRI
site between the XbaI and SphI sites using oligos DE-1173/ 1174

This study

ER2566
BW25141 (λDE3)

pTYBmoIR27A
pTYBmoN92
pTYBmoN111
pTYBmoN130
pTYBmoN154
pTYBmo92C
pTYBmo106C
pTYBmo130C
pBmoHS
LITMUS28i
pLBmo
pLBmo2a
pLBmo2b
pLBmoNa
pLBmoNb
pLBmo2N
p11-lacY-wtx1
pTox

N.E.B.
Ref 28.
Source

Ref 34.
This study
This study
This study
This study
This study
This study
This study
Ref 31.
N.E.B.

This study
This study
This study
This study
This study
Ref 40.
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pToxBmoHS
pToxBmoIn+
pKox
pKoxBmoHS
pKoxBmoIn+
pToxBmoG+7A
pToxBmoG+7C
pToxBmoG+7T
pLBmoG+7A
pLBmoG+7C
pLBmoG+7T
pLBmo+5T
pLBmo+5C
pLBmo+3Ta
pLBmo+3Ca
pLBmo+3Tb
pLBmo+3Cb

p11-lacY-wtx1 plus 52bp intronless thyA homing site insert in XbaI
and SphI sites
p11-lacY-wtx1 plus 52bp intron-containing homing site insert in
XbaI and SphI sites
pTox derivative that has the kanamycin promoter and gene blunt
cloned into the ScaI site
pKox derivative that contains a 52bp intronless thyA homing site
insert in XbaI and SphI sites
pKox derivative that contains a 52bp intron-containing homing site
insert in XbaI and SphI sites
pTox derivative that has the I-BmoI target site with a G+7A
mutation, cloned into the XbaI and EcoRI sites
pTox derivative that has the I-BmoI target site with a G+7C
mutation, cloned into the XbaI and EcoRI sites
pTox derivative that has the I-BmoI target site with a G+7T mutation,
cloned into the XbaI and EcoRI sites
LITMUS28i derivative that has the I-BmoI target site with a G+7A
mutation, cloned into the XbaI and EcoRI sites
LITMUS28i derivative that has the I-BmoI target site with a G+7C
mutation, cloned into the XbaI and EcoRI sites
LITMUS28i derivative that has the I-BmoI target site with a G+7T
mutation, cloned into the XbaI and EcoRI sites
LITMUS28i derivative that has the I-BmoI target site with a TATTT
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI
LITMUS28i derivative that has the I-BmoI target site with a CGCCC
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI
LITMUS28i derivative that has the I-BmoI target site with a TTT
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI
LITMUS28i derivative that has the I-BmoI target site with a CCC
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI
LITMUS28i derivative that has the I-BmoI target site with a TTT
insertion between base pairs +4 and +5, cloned into XbaI/EcoRI
LITMUS28i derivative that has the I-BmoI target site with a CCC
insertion between base pairs +4 and +5, cloned into XbaI/EcoRI

Ref 28.
Ref 28.
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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Supplementary Table S4.2: Oligonucleotides used in Chapter 4
Name

Sequence (5'-3')

Notes

DE-116

AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATGACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA

Top strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site

DE-117

TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT

Bottom strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site

DE-123

TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTACGG

DE-124

TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTACG

DE-125

GCTCTTACCTCAAGGTGGAGTTT

DE-130

GAGCCCGTAGTAATGACATGGCCTTG
GGAAATCCCTTCAATGTATT

DE-131

AATACATTGAAGGGATTTCCCAAGGC
CATGTCATTACTACGGGCTC

DE-144

AATTGTGAATTTAATTATCCGTGACG
AAGCCATCACGGCGTATATGTCGGAT
TGTTAGCTCAGGAGATT
AATCTCCTGAGCTAACAATCCGACAT
ATACGCCGTGATGGCTTCGTCACGGA
TAATTAAATTCACAATT
CGCGCGCGCCATATGAAATCTGGTGT
TTACAAAATC
AGTAGCGACTTCTACTGAACATAAGT
GAGTAATGACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA

Bottom strand intronless thyA 51-mer
from -4 to -47, relative to the intron
insertion site
Bottom strand intronless thyA 50-mer
from -3 to -47, relative to the intron
insertion site
Bottom strand intronless thyA 23-mer
from +27 to +5, relative to intron
insertion site
Top strand intronless I-BmoI thyA 46mer from +8 to -38 relative to the
intron insertion site
Bottom strand intronless I-BmoI thyA
46-mer from +8 to -38 relative to the
intron insertion site
Top strand non-specific 69-mer

DE-144 GC

DE-331
DE-444

Bottom strand non-specific 69-mer

NdeI site; for N-terminal cloning of IBmoI & truncations into pTYB1
Top strand intron-containing I-BmoI
target 74-mer from +27 to -47 relative
to the intron insertion site

DE-445

TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTCACTT
ATGTTCAGTAGAAGTCGCTACT

Bottom strand intron-containing IBmoI target 74-mer from +27 to -47
relative to the intron insertion site

DE-498

CGCGCGGGTACCCTTGGCAAAGCATT
TGTAGAAGTAACCAGAGTATTTTTCG

KpnI site; for C-terminal cloning of IBmoI & truncations into pTYB1

DE-680

CGCGGGTACCCTTGGCAAAGCAAGCA
GATTTAGAGATGTTGTACATTTCTTCG

DE-681

CGCGGGTACCCTTGGCAAAGCATTTC
AGGATGATGTTACGTTTGTCCGGG

KpnI site; for C-terminal cloning of
N92 I-BmoI into pTYB1 to create
pTYBmoN92
KpnI site; for C-terminal cloning of
N111 I-BmoI into pTYB1 to create
pTYBmoN111
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DE-682

CGCGGGTACCCTTGGCAAAGCATTTA
GCTTTTTCTTCAGAGGTCATTTTCAGG

DE-685

CGCGCCATATGCGTAACATCATCCTG
AAACGTGCTG

DE-686

CGCGCCATATGAAACGTTGGCAGTGC
GTTCAGGGTG

DE-746

(biotin)GCGAATTCGTAAGAGCCCGTA
GTAATGACATGGCCTTGGGAAATCCC
TTCAATGTATTCCA
TGGAATACATTGAAGGGATTTCCCAA
GGCCATGTCATTACTACGGGCTCTTA
CGAATTCGC
AGAGCCCGTAGTAATGACATGGCCTT
GGGAAATCCCTTCAATGTATTCC

KpnI site; for C-terminal cloning of
N130 I-BmoI into pTYB1 to create
pTYBmoN130
KpnI site; for C-terminal cloning of
N154 I-BmoI into pTYB1 to create
pTYBmoN154
NdeI site; for N-terminal cloning of
92C I-BmoI into pTYB1 to create
pTYBmo92C
NdeI site; for N-terminal cloning of
106C I-BmoI into pTYB1 to create
pTYBmo106C
NdeI site; for N-terminal cloning of
130C I-BmoI into pTYB1 to create
pTYBmo130C
Top strand (5’-biotin) modified
intronless thyA I-BmoI homing site
from -12 to +41 with EcoRI site
Bottom strand intronless thyA I-BmoI
homing site from -12 to +41 with
EcoRI site
Top strand intronless I-BmoI thyA
target 49-mer from +9 to -40

DE-683

CGCGGGTACCCTTGGCAAAGCATTTC
AGTTTGGTGGTTTCGGTGTGTTTACGA
CCG
CGCGCCATATGGCTTACCACGGTGGT
GACCTGACCTC

DE-907

GGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTACGGGCTCT

Bottom strand intronless I-BmoI thyA
target 49-mer from +9 to -40

DE-945

CCGAAGGTAACTGGCCTCAGCAGAG
CGCAGATACC

DE-946

GGTATCTGCGCTCTGCTGAGGCCAGT
TACCTTCGG

DE-956

GCTCGGAATTAACCCTCAGCAAAGG
GAACAAAAGCTTGC

DE-957

GCAAGCTTTTGTTCCCTTTGCTGAGG
GTTAATTCCGAGC

DE-1171

CACTATAGGGAGACCGGATTTCCTGG
CACGACAGG

DE-1172

CCTGTCGTGCCAGGAAATCCGGTCTC
CCTATAGTG

DE-1173

CTAGACATACGGAATTCCATACGCAT
G

DE-1174

TGTATGCCTTAAGGTATGC

DE-1228

GCGGAATTCGANNNNGNNNNNNNNN
CATGGCCTTGGGAAATCCCTTCAATG
TATTCCGGCATG

Top strand Quikchange primer to add
an Nt.BbvCI site to pLBmo to make
pLBmo2a
Bottom strand Quikchange primer to
add an Nt.BbvCI site to pLBmo to
make pLBmo2a
Top strand Quikchange primer to add
an Nt.BbvCI site to pLBmo to make
pLBmo2b
Bottom strand Quikchange primer to
add an Nt.BbvCI site to pLBmo to
make pLBmo2b
Top strand Quikchange primer to
remove the EcoRI site from p11-lacYwtx1
Bottom strand Quikchange primer to
remove the EcoRI site from p11-lacYwtx1
Top strand oligo containing an EcoRI
site to be cloned into p11-lacY-wtx1
XbaI/SphI
Bottom oligo containing an EcoRI site
to be cloned into p11-lacY-wtx1
XbaI/SphI
Top strand oligo with randomized base
pairs in the I-BmoI thyA target site (G2 fixed); EcoRI site and SphI overhang

DE-684

DE-747

DE-906
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DE-1229

CCGGAATACATTGAAGGG

DE-1230

AATTCGAGCCCGTAGTAATGATATTT
CATGGCCTTGGGAAATCCCTTCAATG
TATTCCGGCATG
CCGGAATACATTGAAGGGATTTCCCA
AGGCCATGAAATATCATTACTACGGG
CTCG
AATTCGAGCCCGTAGTAATGACGCCC
CATGGCCTTGGGAAATCCCTTCAATG
TATTCCGGCATG
CCGGAATACATTGAAGGGATTTCCCA
AGGCCATGGGGCGTCATTACTACGG
GCTCG
CTAGAGAGCCCGTAGTAATGATTTCA
TGGCCTTGGGAAATCCCTTCAATGTA
TTCCGG
AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGAAATCATTACTACG
GGCTCT
CTAGAGAGCCCGTAGTAATGACCCC
ATGGCCTTGGGAAATCCCTTCAATGT
ATTCCGG
AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGGGGTCATTACTACG
GGCTCT
CTAGAGAGCCCGTAGTATTTATGACA
TGGCCTTGGGAAATCCCTTCAATGTA
TTCCGG
AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTCATAAATACTACG
GGCTCT
CTAGAGAGCCCGTAGTACCCATGAC
ATGGCCTTGGGAAATCCCTTCAATGT
ATTCCGG
AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTCATGGGTACTACG
GGCTCT
CCATCTCATCCCTGCGTGTCTCCGACT
CAGTTGGTGGATAACAGGGTAATAT
CACGC

DE-1231

DE-1232

DE-1233

DE-1234

DE-1235

DE-1236

DE-1237

DE-1238

DE-1239

DE-1240

DE-1241

DE-1280

DE-1281

CCATCTCATCCCTGCGTGTCTCCGACT
CAGTCTTCGGATAACAGGGTAATATC
ACGC

DE-1282

CCATCTCATCCCTGCGTGTCTCCGACT
CAGTCAAGGGATAACAGGGTAATAT
CACGC

DE-1289

CCTCTCTATGGGCAGTCGGTGATGCA
TGCCGGAATACATTGAAGGG

Bottom strand primer with SphI site
used to fill in DE-1228
Top strand 49-mer thyA target with
TATTT insertion between +8/+9,
EcoRI/SphI
Bottom strand 49-mer thyA target with
AAATA insertion between +8/+9,
SphI/ EcoRI
Top strand 49-mer thyA target with
CGCCC insertion between +8/+9,
EcoRI/SphI
Bottom strand 49-mer thyA target with
GGGCG insertion between +8/+9,
SphI/ EcoRI
Top strand 49-mer thyA target with
TTT insertion between +8/+9,
XbaI/EcoRI
Bottom strand 49-mer thyA target with
AAA insertion between +8/+9,
EcoRI/XbaI
Top strand 49-mer thyA target with
CCC insertion between +8/+9,
XbaI/EcoRI
Bottom strand 49-mer thyA target with
GGG insertion between +8/+9,
EcoRI/XbaI
Top strand 49-mer thyA target with
TTT insertion between +4/+5,
XbaI/EcoRI
Bottom strand 49-mer thyA target with
AAA insertion between +4/+5,
EcoRI/XbaI
Top strand 49-mer thyA target with
CCC insertion between +4/+5,
XbaI/EcoRI
Bottom strand 49-mer thyA target with
GGG insertion between +4/+5,
EcoRI/XbaI
Primer with left adaptor for Ion Torrent
sequencing, barcode, and
complementarity to pKox (for the
substrate library)
Primer with left adaptor for Ion Torrent
sequencing, barcode, and
complementarity to pKox (for the nonsurvivor library)
Primer with left adaptor for Ion Torrent
sequencing, barcode, and
complementarity to pKox (for the
survivor library)
Primer with right adaptor for Ion
Torrent sequencing and
complementarity to pKox
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DE-1348

DE-1349

DE-1350

DE-1351

DE-1352

DE-1353

DE-1356

CTAGAGAGCCCGTAGTAATAACATGG
CCTTGGGAAATCCCTTCAATGTATTC
CGG
AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTTATTACTACGGGC
TCT
CTAGAGAGCCCGTAGTAATCACATGG
CCTTGGGAAATCCCTTCAATGTATTC
CGG
AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTGATTACTACGGGC
TCT
CTAGAGAGCCCGTAGTAATTACATGG
CCTTGGGAAATCCCTTCAATGTATTC
CGG
AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTAATTACTACGGGC
TCT
AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATAACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA

DE-1357

TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTTATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT

DE-1358

AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATCACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA

DE-1359

TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTGATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT

DE-1360

AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATTACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA

DE-1361

TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTAATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT

Top strand 49 mer thyA target with
G+7A mutation, XbaI/EcoRI ends
Bottom strand 49 mer thyA target with
G+7A mutation, EcoRI/XbaI ends
Top strand 49 mer thyA target with
G+7C mutation, XbaI/EcoRI ends
Bottom strand 49 mer thyA target with
G+7C mutation, EcoRI/XbaI ends
Top strand 49 mer thyA target with
G+7T mutation, XbaI/EcoRI ends
Bottom strand 49 mer thyA target with
G+7T mutation, EcoRI/XbaI ends
Top strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site, with G+7A
mutation
Bottom strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site, with C+7T
mutation
Top strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site, with G+7C
mutation
Bottom strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site, with C+7G
mutation
Top strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site, with G+7T
mutation
Bottom strand intronless I-BmoI thyA
target 74-mer from +27 to -47 relative
to the intron insertion site, with C+7A
mutation
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Supplementary Table S4.3: KD values (µM) for I-BmoI truncations on DNA
substrates
I-BmoI domain
substrate

N92

N111

N130

N154

intronless thyA

> 23

> 35

> 15

0.50 ± 0.05

intron-containing

> 23

> 35

> 15

0.44 ± 0.05

non-specific

> 23

> 35

> 42

> 15
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Appendix S5: Supplementary information for Chapter 5
S5 Supplementary materials and methods
Bacterial strains and plasmid construction. Escherichia coli strains DH5α and ER2566
(New England Biolabs) were used for plasmid manipulations and protein expression,
respectively. E.coli strain BW25141(λDE3) was used for genetic selection assays (1). A
complete description of all plasmids used in this study are listed in Supplementary Table
S5.3, and oligonucloetides are listed in Supplementary Table S5.4. The ryA and ryB zincfinger genes were synthesized by Integrated DNA Technologies with 5’-BamHI and 3’XhoI sites and a C-terminal 6-histidine tag, and cloned into pACYCDuet-1 to generate
pACYCryAZf+H and pACYCryBZF+H, respectively. A stop codon was introduced at
the 3’ end of the ryAZf gene using Quikchange (Stratagene) to generate pACYCryAZf.
To create GIY-ZFEs, the I-TevI and I-BmoI GIY-YIG domains were PCR amplified
from bacteriophage T4 gDNA and pACYCIBmoI, respectively, and cloned into the
NcoI/BamHI sites of pACYCryAZf+H, pACYCryAZf, and pACYCryBZf+H. TevN201ryA and TevN201R27A were subcloned into the XbaI and EcoRV sites of pTAL3 to
generate the expression plasmids for the yeast reporter assay (pYTZN201 and
pYTZN201R27A). To generate Tev-LHEs, the I-OnuI E1 gene was amplified with
BamHI and SalI ends to clone into the BamHI and XhoI sites of pACYCDuet-1(PciI) to
create pACYCOnuE1(+H). This vector was subsequently Quikchanged to introduce an
E22Q mutation in I-OnuI E1 to create pACYCOnuE1E22Q (+H). I-TevI catalytic
domains were amplified as above and cloned into PciI/BamHI of pACYCOnuE1E22Q
(+H). The R27A mutants of Tev-ZFEs and Tev-LHEs were generated using Quikchange
mutagenesis. Hybrid GIY-ZFE and Tev-LHE target sites (Fig. 5.1B and 5.4B,
Supplementary Tables S5.1 and S5.2) were cloned into the toxic plasmid p11-lacY-wtx1
to generate reporter plasmids for the bacterial selection. Tev-ryA and Bmo-ryA target
sites were cloned into pSP72 for in vitro cleavage assays. The Tev-ryA site hybrid
homing site was also cloned into LITMUS28i using BamHI and XhoI to generate
pTZHS1.35. The two-site Tev-ZF plasmids were created by sub-cloning the PvuII/HpaI
fragment from pTZHS1.35 into the SwaI site of pTZHS1.35 to generate pTZHS2.35 and
pTZHS3.35 (with the second TZHS in either orientation). The G5A or C1A/G5A
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mutations were introduced into pToxTZ and pTZHS plasmids by Quikchange
mutagenesis. To generate the target plasmids for the yeast reporter assay, the TZ-ryA
target sites from toxic plasmids containing TZ1.33, TZ1.33G5A, and TZ1.33C1A/G5A
were amplified and cloned into the BglII and SpeI sites of pCS753. All constructs were
verified by sequencing.
Two-plasmid genetic selection. The two plasmid genetic selection was performed as
described (1), with toxic (reporter) plasmids containing hybrid TZ-ryA, TZ-ryB, BZ-ryA,
TO target sites (Supplementary Tables S5.1 and S5.2), mutant target sites (with G5A or
C1A/G5A substitutions), or plasmids lacking a target site (p11-lacY-wtx1). Survival
percentage was calculated by dividing the number of colonies observed on selective by
those observed on non-selective plates.
Yeast reporter assay. Transformants of S.cerevisiae YPH500(α) with Tev-ZFE or TevTAL constructs and YPH499(a) with target constructs were grown overnight (~230 rpm)
at 30°C in synthetic complete medium lacking histidine (Tev-ZFEs and Tev-TALs) or
lacking tryptophan and uracil (targets). Tev-ZFEs and targets were mated by adding
equal densities (~400 µl) of overnight culture to 1 ml YPD and left stationary for 5-6
hours at 30°C. Cells harvested by centrifugation were washed in 1 ml and resuspended in
4 ml of synthetic medium lacking histidine and tryptophan prior to shaking overnight at
30°C. Cells were harvested by centrifugation, washed in 1 ml Z buffer (60 mM Na2PO4,
40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0), and suspended in 250 µl Z
buffer. The suspension was diluted 20-fold into 1 ml Z buffer containing 0.27% βmercaptoethanol, and 75 µl CHCl3 and 45 µl 0.1% SDS were added prior to vortexing.
Lysates were pre-incubated at 30°C prior to the addition of 100 µl 4 mg/ml ONPG.
Reactions proceeded until a yellow colour developed whereby progress was stopped by
the addition of 300 µl 1M Na2CO3. Stopped reactions were pelleted and the absorbance of
the supernatant was analyzed at 420 nm and 550 nm.
Protein purification. Cultures overexpressing either TevN201-ZFE or BmoN221-ZFE
were grown at 37°C to an OD600 ~0.5 and expression induced by 0.5 mM IPTG (Bio
Basic Inc.) overnight at 15°C. Cells were harvested by centrifugation at 8983 x g for 12
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minutes, re-suspended in binding buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 10 mM
imidazole, 5% glycerol, and 1 mM DDT), and lysed by homogenization at 15,000 psi.
The cell lysate was clarified by centrifugation at 20400 x g, followed by sonication for 30
seconds, and centrifugation at 20400 x g for 15 minutes. The clarified lysate was loaded
onto a 1 mL HisTrap-HP column (GE Healthcare), washed with 15 mL binding buffer
and then 10 mL wash buffer (20 mM Tris-HCl (pH 8.0), 500 mM NaCl, 50 mM
imidazole, 5% glycerol, and 1 mM DTT). Bound proteins were eluted in 1.5 mL fractions
in four 5 mL step elutions with increasing concentrations of imidazole. Fractions
containing GIY-ZFEs were dialyzed twice against 1L dialysis buffer (20 mM Tris-HCl
(pH 8.0), 500 mM NaCl, 5% glycerol, and 1 mM DDT) prior to storage at -80°C.
Cleavage assays. Single time-point cleavage assays to determine the EC0.5max of
TevN201-ryA were performed in buffer containing 20 mM Tris-HCl pH 8.0, 100 mM
NaCl, 10 mM MgCl2, 5% glycerol, 1 mM DTT and 10 nM pTZHS1.33. Reactions were
incubated for 3 minutes at 37°C, stopped with 5 µl stop solution (100 mM EDTA, 40%
glycerol, and bromophenol blue), and electrophoresed on a 1% agarose gel prior to
staining with ethiduium bromide and analysis on an AlphaImager™3400 (Alpha
Innotech). The EC0.5max was determined by fitting the data to the equation
f ([endo]) =

f max∗[endo] H
EC0.5max +[endo] H

where f([endo]) is the fraction of substrate cleaved at concentration of TevN201-ryA [endo],
€

fmax is the maximal fraction cleavage, with 1 being the highest value, and H is the Hill
constant that was set to 1. The initial reaction velocity was determined using supercoiled
plasmid substrate with varying concentrations of TevN201-ryA (0.7 nM to 47 nM) and
buffer as above. Aliquots were removed at various times, stopped and analyzed as above.
−k1t ) + k 2 t
The data for product appearance was fitted to the equation P = A(1 − e

where P is product (in nM), A is the magnitude of the initial burst, k1 is the rate constant
(s-1) of the initial burst phase and k2 is the steady state rate constant (s-1). The two-site
€
plasmid cleavage assays were conducted as above, using 10 nM pTZHS2.33 or
pTZHS3.33 as substrates, and ~90 nM purified TevN201-ryA. The kobs rate constants
were calculated from the decay of supercoiled substrate by fitting to the equation
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[C] = [C 0]exp(−k 1 t)

where [C] is the concentration (nM) of supercoiled plasmid at time t, [C0] is the initial
€

concentration of supercoiled substrate (nM), and k1 is the first order rate constant (in s-1).
At least 3 independent trials were conducted for each data set.
Cleavage mapping. Mapping of cleavage sites was performed as described (2). Briefly,
primers were individually end-labeled with γ -32P ATP, and used in PCR reactions with
pTox or pSP72 plasmids carrying TZ-ryA or BZ-ryA target sites to generate strandspecific substrates. The substrates were incubated with purified protein as above, and
electrophoresed in 8% denaturing gels alongside sequencing ladders generated by cycle
sequencing with the same end-labeled primers (US Biologicals).
Bioinformatics. The distribution of the CNNNG cleavage motif was examined using a
custom Perl script in a 35-bp window of ZFN sites predicted for Dania rerio
chromosome 1 (Ensembl release 51) (6). Briefly, 40 bp flanking the downstream region
of each predicted ZFN was extracted from the corresponding zebrafish chromosome 1
cDNA, and searched for position i = C and position i+4 = G, with the occurrences of each
CNNNG reported at position i (the C of the motif). The number of CNNNG motifs for
unique ZFN sites was fit to a binomial distrubtion, and plotted in R.
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S5 Supplementary figures

Supplementary Figure S5.1: Design and functionality of Bmo-ZFEs.
(A) Schematic of Bmo-ZFE constructs, with I-BmoI protein and substrate shown in grey,
and the ryA protein and binding site shown in red and yellow, respectively. Top panel,
the fusion points for each of the Bmo-ZFEs are indicated as the last I-BmoI amino acid,
with or without a 2xGlycine or 4xGlycine linker. Constructs were made with a 6xHis tag
on the C-terminal end. Bottom panel, the substrate shown consists of 33-nts of the top
strand I-BmoI thyA target site (BZ1.33), fused to the 5’ end of the ryA binding site.
Substrates tested differ by the insertion of one or two T nucleotides at the junction of the
thyA/ryA sites. (B) Purification of His-tagged BmoN221-ryA. Shown is a representative
SDS-PAGE gel; M, marker with molecular weights in kDa indicated on the left; UN,
uninduced culture; IND, induced culture; C, crude lysate; FT, flow-through from metalaffinity column; W, wash; E, elution. (C) BmoN221-ryA cleavage specificity. Shown are
representative agarose gels of cleavage assays with 10 nM pBZ1.33 or pSP72 (no target
site) substrates and the indicated concentrations of BmoN221-ryA under standard assay
conditions for 10 minutes. BmoN221-ryA cleaves the BZ-ryA target site plasmid
(BZ1.33) but not the control plasmid (pSP72) lacking the target site. N, nicked; L, linear;
SC, supercoiled. (D) Mapping of BmoN221-ryA cleavage sites on the BZ1.33 substrate,
with top and bottom cleavage sites indicated by open and closed triangles, respectively.
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Supplementary Figure S5.2: TevN201-ryA purification for in vitro experiments.
(A) Purification of TevN201-ryA. Shown is a representative SDS-PAGE gel; M, marker
with molecular weights in kDa indicated on the left; UN, uninduced culture; IND,
induced culture; C, crude lysate; FT, flow-through from metal-affinity column; W, wash;
E, elution. (B) Graphical representation of cleavage assays with 90 nM TevN201-ZFE
and 10 nM two-site pTZ1.33 plasmid with target sites in the same orientation. Data are
plotted as averages of three independent replicates with standard deviations; SC,
supercoiled; OC, open-circle (nicked); FLL, full-length linear; L1+L2, linear products.
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Supplementary Figure S5.3: PvuII site analysis.
(A) Shown is the distribution of the 5’-CAGCTG-3’ motif in a 35-bp window flanking
8,829 predicted ZFN sites on zebrafish chromosome 1 (6). The number of occurences of
the ‘C’ of the motif at each distance is indicated. (B) Unique ZFN sites were grouped
according to the number of occurences of the 5’-CAGCTG-3‘ motif in the 35-bp window.
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Supplementary Figure S5.4: Occurrence of the 5’-CNNNG-3’ motif upstream of IOnuI E1 off-target sites.
Shown is 37-nt of upstream sequence adjacent to the 22-nt I-OnuI E1 MAO-B target site,
along with 19 predicted off-target sites (3). CNNNG motifs are highlighted in red, with
only 3 of 19 predicted I-OnuI E1 off target sites containing a CNNNG motif at a
targetable distance by Tev-LHE fusions. Nucleotide differences of the off-target sites to
the I-OnuI E1 site are indicated in magenta lower case font.

WT
49.8 ± 9.8 (6)
38.6 ± 10.3 (4)
36.3 ± 7.1 (4)
0
51.0 ± 6.6 (5)
46.5 ± 10.9 (5)
48.0 ± 6.1 (4)
0
62.3 ± 12.4 (4)
44.2 ± 16.4 (4)
0

pToxTZ1.30
WT
0
ND
ND
ND
0
ND
ND
ND
0
ND
ND
ND
pToxTZ1.35
G5A
0
0
0
0
0
0
0
0
0
0
0

pToxTZ1.32
WT
4 ± 1.2 (3)
ND
ND
ND
5.4 ± 1.4 (3)
ND
ND
ND
0
ND
ND
ND
Toxic plasmid
pToxTZ1.36
C1A/G5A
WT
0
0
0
ND
0
ND
0
ND
0
1.6 ± 0.3 (3)
0
ND
0
ND
0
ND
0
26.1 ± 1.8 (3)
0
ND
0
ND

*ND,%not%determined;%±,%standard%deviation%of%replicates%indicated%in%brackets

TevS206G2
TevS206R27A

TevK203G2
TevK203G4
TevK203R27A
TevS206

TevN201G2
TevN201G4
TevN201R27A
TevK203

GIY-ZFE
TevN201

TevS206G2
TevS206R27A
TevN201-ryB

TevK203G2
TevK203G4
TevK203R27A
TevS206

TevN201G2
TevN201G4
TevN201R27A
TevK203

GIY-ZFE
TevN201

pToxTZ1.38
WT
0
ND
ND
ND
0
ND
ND
ND
0
ND
ND

p11lacywtx1
0
0
0
0
0
0
0
0
0
0
0

pTox ryB
WT
0
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND

Toxic plasmid
pToxTZ1.33
pToxTZ1.34
WT
G5A
C1A/G5A
WT
G5A
86.8 ± 5.9 (6)
0
0
59.9 ± 9.5 (6)
0
72.7 ± 10.7 (6)
0
0
56.9 ± 11.2 (6)
0
83.7 ± 15.2 (4)
0
0
42.8 ± 12.6 (6)
0
0
0
0
0
0
86.8 ± 7.1 (6)
0
0
50.7 ± 9.5 (6)
0
88 ± 13.9 (6)
0
0
53.7 ± 10.4 (6)
0
80.7 ± 7.9 (4)
0.2 ± 0.2 (3) 0.4 ± 0.3 (3) 43.6 ± 13.0 (6)
0
0
0
0
0
0
86.6 ± 6.9 (6)
0
0
47.1 ± 8.6 (6)
0
70.7 ± 8.7 (4)
0
0
27.8 ± 7.4 (6)
0
0
0
0
0
0
0
ND
ND
ND
ND
C1A/G5A
0.2 ± 0.1 (3)
0
0
0
0
0
0
0
0
0
0
ND
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S5 Supplementary tables

Supplementary Table S5.1: Tev-ZFE selection data

TevN201G4
TevN203

0
0

0.16(2)
0.16(2)

pToxTO1.16
WT
0
0.16(2)
0
0
0

76.06±612.36(3)
97.566±65.36(3)
ND
ND

0
0
ND
ND

ND

ND

0
0

ND

ND

87.16±69.56(3)
99.76±6126(3)

pToxTO1.28
WT
0
0
0
0.46±60.36(3)
0.0

0
0

101.66±64.16(3)

0

96.96±62.56(3)
87.26±60.86(3)

WT
0
0
0
0
0

Toxic,plasmid

29.56±61.26(3)
24.26±62.06(3)

pToxTO1.18
WT
C-1A/G-5A
16.56±66.26(3)
0
31.86±611.36(3)
0
40.26±63.86(3)
0
45.56±611.56(3)
0
256±66.96(3)
0

*ND,6not6determined;6±,6standard6deviation6of6replicates6indicated6in6brackets

OnuE1

OnuE16(E22Q)
TevR27A(N201G4)-

TevN201G4
TevN203
TevR27A(N201G4)-

Tev$LHE
TevS114
TevD127
TevN140
TevN169
TevD184G2

0
0.86(2)

Tev$LHE
TevS114
TevD127
TevN140
TevN169
TevD184G2

pToxTO1.14
WT
0
0
0
0
0.16(2)

pToxTO1.24
pToxTO1.26
WT
WT
C-1A/G-5A
0
65.26±696(3)
0
0
83.266±67.96(3)
0
0
74.96±64.26(3)
0
0
102.266±610.46(3)
0
0
87.066±64.76(3)
0

pToxTO1.12
WT
0.26(2)
0
0
0
0

Toxic,plasmid

93.36±64.66(3)

0

0
ND

pToxTO1.30
G-5A
ND
ND
ND
ND
ND

8.36±60.46(3)
7.76±63.16(3)

0
0

pToxTO1.22
WT
0
0
0
0
11.96±61.86(3)

ND

ND

0
ND

ND

ND

0
ND

pToxTZ1.33-ryA
C-1A/G-5A
WT
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND

0
0

pToxTO1.20
WT
C-1A/G-5A
11.66±63.76(3)
0
12.66±63.26(3)
0
24.66±60.46(3)
94.56±62.16(3)
0
98.36±67.16(3)
0
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Supplementary Table S5.2: Tev-LHE selection data
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Supplementary Table S5.3: Strains and plasmids used in Chapter 5
Strains

Description
-

Source
Invitrogen

S.cerevisiae YPH499
S.cerevisiae YPH500
Plasmids

F , φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1,
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1
F- λ- fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 Δ(mcrCmrr)114::IS10 R(mcr-73::miniTn10-TetS)2 R(zgb210::Tn10)(TetS) endA1 [dcm]
F- lacIq rrnBT14 DlacZWJ16 DphoBR580 hsdR514 DaraBADAH33
DrhaBADLD78 galU95 endABT333 uidA(DMluI)::pir+ recA1, λDE3
lysogen
MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3Δ200 leu2-Δ1
MATα ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3Δ200 leu2-Δ1
Description

pACYCDuet-1

orip15A, cm

Novagen

pACYCDuet-1(PciI)

Novagen

p11-lacY-wtx1

orip15A, cm, pACYCDuet-1 with a PciI site substituted for the
NcoI site
oripBR322, amp

pSP72

oripBR322, amp

Promega

LITMUS28i

oripMB1, amp

N.E.B.

pACYCIBmoI

Ref (1)

pryAzf

pACYCDuet-1, containing the 798bp codon optimized I-BmoI
gene in the NdeI and XhoI sites
oripUC, kan

pTAL3

oripBR322, amp

Dr. Bogdanove

pCP5.1

pCP5 derivative, amp, with ColE1 origin from pBluescript IIKS(), reporter plasmid for the yeast based recombination assay, see
[5]
oripBR322, amp

Dr. Bogdanove

pACYCDuet-1, containing the ryA zinc-finger gene with a cterminal 6-histidine tag cloned into the BamHI and XhoI sites
pACYCDuet-1, containing the ryA zinc-finger gene cloned into
the BamHI and XhoI sites
pACYCDuet-1, containing the ryB zinc-finger gene with a cterminal 6-histidine tag cloned into the BamHI and XhoI sites
pACYCryAZf (or +H), with residues 1-N201 of I-TevI
(DE832/840) cloned into the NcoI and BamHI sites (+/- 6xHis)
pACYCryBZf (or +H), with residues 1-N201 of I-TevI
(DE832/840) cloned into the NcoI and BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-N201 of I-TevI
(DE833/840) + 2 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-N201 of I-TevI
(DE834/840) + 4 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-K203 of I-TevI
(DE835/840) cloned into the NcoI and BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-K203 of I-TevI
(DE836/840) + 2 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)

This study

E.coli - DH5α
E.coli - ER2566
E.coli BW25141(λDE3)

pOnuE1
pACYCryAZf+H
pACYCryAZf
pACYCryBZf+H
pTevN201-ZFE (or
+H)
pTevN201-ryB (or
+H)
pTevN201G2-ZFE (or
+H)
pTevN201G4-ZFE (or
+H)
pTevK203-ZFE (or
+H)
pTevK203G2-ZFE (or
+H)

N.E.B.
Ref (1),(4)
Dr. Bogdanove
Ref (5)
Dr. Bogdanove
Ref (5)
Source

Ref (4)

I.D.T.

Ref (3)

This study
This study
This study
This study
This study
This study
This study
This study
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pTevK203G4-ZFE (or
+H)

This study

pTevN201R27A

pACYCryAZf (or +H), with residues 1-K203 of I-TevI
(DE837/840) + 4 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-S206 of I-TevI
(DE838/840) cloned into the NcoI and BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-S206 of I-TevI
(DE839/840) + 2 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-N221 of I-BmoI
(DE841/849) cloned into the NcoI and BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-N221 of I-BmoI
(DE842/849) + 2 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-N221 of I-BmoI
(DE843/849) + 4 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-R223 of I-BmoI
(DE844/849) cloned into the NcoI and BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-R223 of I-BmoI
(DE845/849) + 2 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-R223 of I-BmoI
(DE846/849) + 4 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-I226 of I-BmoI
(DE847/849) cloned into the NcoI and BamHI sites (+/- 6xHis)
pACYCryAZf (or +H), with residues 1-I226 of I-BmoI
(DE848/849) + 2 glycine residues cloned into the NcoI and
BamHI sites (+/- 6xHis)
Similar to pTevN201-ZFE, with an R27A mutation

pTevN201G2R27A

Similar to pTevN201G2-ZFE, with an R27A mutation

This study

pTevN201G4R27A

Similar to pTevN201G4-ZFE, with an R27A mutation

This study

pTevK203R27A

Similar to pTevK203-ZFE, with an R27A mutation

This study

pTevK203G2R27A

Similar to pTevK203G2-ZFE, with an R27A mutation

This study

pTevK203G4R27A

Similar to pTevK203G4-ZFE, with an R27A mutation

This study

pTevS206R27A

Similar to pTevS206-ZFE, with an R27A mutation

This study

pTevS206G2R27A

Similar to pTevS206G2-ZFE, with an R27A mutation

This study

pToxTZ1.35

p11-lacY-wtx1, that contains a 44-bp hybrid I-TevI/ryA zincfinger homing site (td bases -27 to +8 fused to the 9-bp ryAZf
site) cloned XbaI/SphI (DE824/825)
p11-lacY-wtx1, that contains a 44-bp hybrid I-BmoI/ryA zincfinger site (thyA bases -6 to +27 fused to the 9-bp ryAZf site)
cloned XbaI/SphI (DE826/827)
pSP72, that contains a 44-bp hybrid I-TevI/ryA zinc-finger
homing site (td bases -27 to +8 fused to the 9-bp ryAZf site)
cloned XbaI/SphI (DE824/825)
LITMUS28i, with the 44-bp hybrid I-TevI/ryA zinc-finger site (td
bases -27 to +8 fused to the 9-bp ryAZf site) sub-cloned from
pSP-TZHS1.35 into BamHI/XhoI
pSP72, that contains a 44-bp hybrid I-BmoI/ryA zinc-finger
homing site (thyA bases +6 to -27 fused to the 9-bp ryAZf site)
cloned XbaI/SphI (DE826/827)

This study

pTevS206-ZFE (or
+H)
pTevS206G2-ZFE (or
+H)
pBmoN221-ZFE (or
+H)
pBmoN221G2-ZFE
(or +H)
pBmoN221G4-ZFE
(or +H)
pBmoR223-ZFE (or
+H)
pBmoR223G2-ZFE
(or +H)
pBmoR223G4-ZFE
(or +H)
pBmoI226-ZFE (or
+H)
pBmoI226G2-ZFE (or
+H)

pToxBZ1.35
pSP-TZHS1.35
pTZHS1.35
pBZHS1.35

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

This study
This study
This study
This study
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pTZHS2.35

This study

pToxTZ1.35G5A

Similar to pTZHS1.35, with a second Tev-ZFE1.35 target site
sub-cloned from pSP-TZHS1.35 (using PvuII/HpaI) into the SwaI
site
Similar to pTZHS2.35, with the second Tev-ZFE1.35 target site
in the alternate orientation
Similar to pToxTZ1.35, with a G5A substitution (DE917/918)

pToxTZ1.35C1A/G5
A
pTZHS1.35G5A

Similar to pToxTZ1.35, with C1A and G5A substitutions
(DE919/920)
Similar to pTZHS1.35, with a G5A substitution

This study

pTZHS1.35C1A/G5A

Similar to pTZHS1.35, with C1A and G5A substitutions

This study

pToxTZ1.34

p11-lacY-wtx1, that contains a 43-bp hybrid I-TevI/ryA zincfinger homing site (td bases -27 to +7 fused to the 9-bp ryAZf
site) cloned XbaI/SphI
Similar to pToxTZ1.34, with G5A substitution

This study

Similar to pToxTZ1.34, with C1A and G5A substitutions

This study

p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/ryA zincfinger homing site (td bases -27 to +6 fused to the 9-bp ryAZf
site) cloned into the XbaI and SphI sites
Similar to pToxTZ1.33, with G5A substitution

This study

Similar to pToxTZ1.33, with C1A and G5A substitutions

This study

p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/ryB zincfinger homing site (td bases -27 to +6 fused to the 9-bp ryBZf
site) cloned into XbaI/SphI sites
p11-lacY-wtx1, that contains a 43-bp hybrid I-BmoI/ryA zincfinger site (thyA bases -6 to +26 fused to the 9-bp ryAZf site)
cloned XbaI/SphI (DE826/827)
p11-lacY-wtx1, that contains a 42-bp hybrid I-BmoI/ryA zincfinger site (thyA bases -6 to +25 fused to the 9-bp ryAZf site)
cloned into XbaI/SphI (DE826/827)
Similar to pTZHS1.35, with a 43-bp hybrid I-TevI/ryA zincfinger homing site (td bases -27 to +7 fused to the 9-bp ryAZf
site)
Similar to pTZHS1.35, with a 42-bp hybrid I-TevI/ryA zincfinger homing site (td bases -27 to +6 fused to the 9-bp ryAZf
site)
Similar to pBZHS1.35, with a 43-bp hybrid I-BmoI/ryA zincfinger homing site (thyA bases +6 to -26 fused to the 9-bp ryAZf
site)
Similar to pBZHS1.35, with a 42-bp hybrid I-BmoI/ryA zincfinger homing site (thyA bases +6 to -25 fused to the 9-bp ryAZf
site)
Similar to pTZHS2.35, with both Tev-ZFE target sites as 43-bp
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +7
fused to the 9-bp ryAZf site)
Similar to pTZHS3.35, with both Tev-ZFE target sites as 43-bp
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +7
fused to the 9-bp ryAZf site)
Similar to pTZHS2.35, with both Tev-ZFE target sites as 42-bp
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +6
fused to the 9-bp ryAZf site)

This study

pTZHS3.35

pToxTZ1.34G5A
pToxTZ1.34C1A/G5
A
pToxTZ1.33

pToxTZ1.33G5A
pToxTZ1.33C1A/G5
A
pToxTZ1.33-ryB
pToxBZ1.34
pToxBZ1.33
pTZHS1.34
pTZHS1.33
pBZHS1.34
pBZHS1.33
pTZHS2.34
pTZHS3.34
pTZHS2.33

This study
This study

This study

This study

This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
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pTZHS3.33

This study

pTZHS1.34G5A

Similar to pTZHS3.35, with both Tev-ZFE target sites as 42-bp
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +6
fused to the 9-bp ryAZf site)
Similar to pTZHS1.34, with a G5A substitution

pTZHS1.33G5A

Similar to pTZHS1.33, with a G5A substitution

This study

pTZHS1.34C1A/G5A

Similar to pTZHS1.34, with C1A and G5A substitutions

This study

pTZHS1.33C1A/G5A

Similar to pTZHS1.33, with C1A and G5A substitutions

This study

pToxTZ1.30

p11-lacY-wtx1, that contains a 39-bp hybrid I-TevI/ryA zincfinger site (td bases -27 to +3 fused to the 9-bp ryAZf site) cloned
XbaI/SphI (DE1085/1086)
p11-lacY-wtx1, that contains a 41-bp hybrid I-TevI/ryA zincfinger site (td bases -27 to +5 fused to the 9-bp ryAZf site) cloned
XbaI/SphI (DE1087/1088)
p11-lacY-wtx1, that contains a 45-bp hybrid I-TevI/ryA zincfinger site (td bases -27 to +9 fused to the 9-bp ryAZf site) cloned
XbaI/SphI (DE1134/1135)
p11-lacY-wtx1, that contains a 47-bp hybrid I-TevI/ryA zincfinger site (td bases -27 to +11 fused to the 9-bp ryAZf site)
cloned XbaI/SphI (DE1136/1137)
p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/ryB zincfinger homing site (td bases -27 to +6 fused to the 9-bp ryBZf
site) cloned XbaI/SphI
p11-lacY-wtx1, that contains a 34-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to -16 fused to the I-OnuI E1 site) cloned
XbaI/SphI (DE1072/1073)
p11-lacY-wtx1, that contains a 36-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to -14 fused to the I-OnuI E1 site) cloned
XbaI/SphI (DE1070/1071)
p11-lacY-wtx1, that contains a 38-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to -12 fused to the I-OnuI E1 site) cloned
XbaI/SphI (DE1068/1069)
p11-lacY-wtx1, that contains a 40-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to -10 fused to the I-OnuI E1 site) cloned
XbaI/SphI (DE1066/1067)
p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to -8 fused to the I-OnuI E1 site) cloned into the
XbaI and SphI (DE1064/1065)
p11-lacY-wtx1, that contains a 44-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to -6 fused to the I-OnuI E1 site) cloned
XbaI/SphI (DE1062/1063)
p11-lacY-wtx1, that contains a 46-bp hybrid I-TevI/I-OnuI E1
homing site (td bases -27 to -4 fused to the I-OnuI E1 site) cloned
XbaI/SphI (DE1060/1061)
p11-lacY-wtx1, that contains a 48-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to -2 fused to the I-OnuI E1 site) cloned into the
XbaI and SphI (DE1058/1059)
p11-lacY-wtx1, that contains a 50-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to +1 fused to the I-OnuI E1 site) cloned into
the XbaI and SphI (DE1056/1057)
p11-lacY-wtx1, that contains a 52-bp hybrid I-TevI/I-OnuI E1
site (td bases -27 to +3 fused to the I-OnuI E1 site) cloned into
the XbaI and SphI (DE976/977)

This study

pToxTZ1.32
pToxTZ1.36
pToxTZ1.38
pToxTZ1.33ryB
pToxTO1.12
pToxTO1.14
pToxTO1.16
pToxTO1.18
pToxTO1.20
pToxTO1.22
pToxTO1.24
pToxTO1.26
pToxTO1.28
pToxTO1.30

This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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pToxTO1.18C1A/G5
A
pToxTO1.20
C1A/G5A
pToxTO1.26
C1A/G5A
pToxTO1.30 G5A

Similar to pToxTO18, with C1A and G5A
substitution(DE1154/1155)
Similar to pToxTO20, with C1A and G5A
substitution(DE1156/1157)
Similar to pToxTO26, with C1A and G5A
substitution(DE1158/1159)
Similar to pToxTO30, with a G5A substitution

This study

pToxTO1.30
C1A/G5A
pACYCOnuE1(+H)

Similar to pToxTO30, with C1A and G5A substitution

This study

pACYCDuet-1(PciI), containing the I-OnuI E1 gene cloned into
the BamHI and XhoI sites
pACYCDuet-1(PciI), containing the I-OnuI E1 gene with a E22Q
mutation cloned into the BamHI and XhoI sites
pACYCOnuE1(E22Q)(+H), with residues 1-K203 of I-TevI (DE)
cloned into the PciI and BamHI sites
pACYCOnuE1(E22Q)(+H), with residues 1-N201 of I-TevI + 4
glycine residues (DE) cloned into the PciI and BamHI sites
(+6xHis)
pACYCOnuE1(E22Q)(+H), with residues 1-D184G2 of I-TevI +
2 glycine residues (DE) cloned into the PciI and BamHI sites
(+6xHis)
pACYCOnuE1(E22Q)(+H), with residues 1-N169 of I-TevI (DE)
cloned into the PciI and BamHI sites (+6xHis)
pACYCOnuE1(E22Q)(+H), with residues 1-N140 of I-TevI (DE)
cloned into the PciI and BamHI sites (+6xHis)
pACYCOnuE1(E22Q)(+H), with residues 1- D127 of I-TevI (DE)
cloned into the PciI and BamHI sites (+6xHis)
pACYCOnuE1(E22Q)(+H), with residues 1- S114 of I-TevI (DE)
cloned into the PciI and BamHI sites (+6xHis)
pACYCOnuE1(+H), with residues 1-N201 of I-TevI + 4 glycine
residues (DE) with a R27A mutation in I-TevI (+6xHis)
pACYCOnuE1(E22Q)(+H), similar to pTevN201G4OnuE1(E22Q) (+H) with an R27A mutation in I-TevI
pTAL3 expression vector containing homodimeric FokI-Zif268
ZFN
pCS753 reporter plasmid with a homodimeric FokI-Zif268 target
site interrupting a partially duplicated lacZ gene
pTAL3, with TevN201-ryA cloned in XbaI/EcoRV using
DE1121/1128
Similar to pYTZN201, with an R27A I-TevI mutation

This study

pCS753, with the 42-bp hybrid I-TevI/ryA zinc-finger homing
site cloned into the BglII/SpeI sites using DE1117/1118
Similar to PTZYHS1.33, with G5A substitution

This study

Similar to PTZYHS1.33, with C1A and G5A substitutions

This study

pACYCOnuE1(E22Q
) (+H)
pTevK203OnuE1(E22Q)
pTevN201G4OnuE1(E22Q) (+H)
pTevD184G2OnuE1(E22Q) (+H)
pTevN169OnuE1(E22Q) (+H)
pTevN140OnuE1(E22Q) (+H)
pTevD127OnuE1(E22Q) (+H)
pTevS114OnuE1(E22Q) (+H)
pTevN201G4R27AOnuE1(+H)
pTevN201G4R27AOnuE1(E22Q) (+H)
pZif268
pZif268target
pYTZN201
pYTZN201R27A
pTZYHS1.33
pTZYHS1.33G5A
pTZYHS1.33C1A/G5
A

This study
This study
This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Dr. Bogdanove
Ref (5)
Dr. Bogdanove
Ref (5)
This study
This study

This study

246

Supplementary Table S5.4: Oligonucleotides used in Chapter 5
Name

Sequence (5'-3')

Notes

DE410

GGAAGAAGTGGCTGATCTCAGC

DE411

CAGACCGCTTCTGCGTTCTG

DE613

GCTAAAGATTTTGAAAAGGCATGG
AAGAAGCATTTTAAAG
CTTTAAAATGCTTCTTCCATGCCTT
TTCAAAATCTTTAGC
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG
CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGCGTTGT
CTAGAGCCCGTAGTAATGACATGG
CCTTGGGAAATCCCTTTCCCACGCC
GCATG
CGGCGTGGGAAAGGGATTTCCCAA
GGCCATGTCATTACTACGGGCT
CCGCGGATCCATTACTAGGCTTTT
TACC
CCGCGGATCCACCACCATTACTAG
GCTTTTTACC
CCGCGGATCCACCACCACCACCAT
TACTAGGCTTTTTACC
CCGCGGATCCTTTAATATTACTAG
GCTTTTTAC
CCGCGGATCCACCACCTTTAATAT
TACTAGGCTTTTTAC
CCGCGGATCCACCACCACCACCTT
TAATATTACTAGGCTTTTTAC
CCGCGGATCCTGAAATCTTTTTAA
TATTACTAGGC
CCGCGGATCCACCACCTGAAATCT
TTTTAATATTACTAGGC
GCCGCCATGGGTAAAAGCGGAATT
TATCAGATT
CCGCGGATCCGTTTTTCGGTTTAC
GACC
CCGCGGATCCACCACCGTTTTTCG
GTTTACGACC
CCGCGGATCCACCACCACCACCGT
TTTTCGGTTTACGACC
CCGCGGATCCACGAGAGTTTTTCG
GTTTACG
CCGCGGATCCACCACCACGAGAGT
TTTTCGGTTTACG
CCGCGGATCCACCACCACCACCAC
GAGAGTTTTTCGGTTTACG
CCGCGGATCCGATAACCGGACGA
GAGTTTTTCGG

Forward primer to generate all cycle-seq products for
target sites cloned into pTox
Reverse primer to generate all cycle-seq products for
target sites cloned into pTox
Forward quikchange primer to create R27A Tev-ZFEs

DE614
DE824
DE825
DE826
DE827
DE832
DE833
DE834
DE835
DE836
DE837
DE838
DE839
DE840
DE841
DE842
DE843
DE844
DE845
DE846
DE847

Reverse quikchange primer to create R27A Tev-ZFEs
Top-strand oligo to clone the hybrid 35-bp I-TevI/9-bp
ryAZf using XbaI and SphI
Bottom-strand oligo to clone the hybrid 35-bp I-TevI/9bp ryAZf using XbaI and SphI
Top-strand oligo to clone the hybrid 35-bp I-BmoI/9-bp
ryAZf using XbaI and SphI
Bottom-strand oligo to clone the hybrid 35-bp I-BmoI/9bp ryAZf using XbaI and SphI
Reverse primer for TevN201-ZFE cloning, BamHI site
underlined
Reverse primer for TevN201G2-ZFE cloning, BamHI
site underlined
Reverse primer for TevN201G4-ZFE cloning, BamHI
site underlined
Reverse primer for TevK203-ZFE cloning, BamHI site
underlined
Reverse primer for TevK203G2-ZFE cloning, BamHI
site underlined
Reverse primer for TevK203G4-ZFE cloning, BamHI
site underlined
Reverse primer for TevS206-ZFE cloning, BamHI site
underlined
Reverse primer for TevS206G2-ZFE cloning, BamHI site
underlined
Forward primer for Tev-ZFE cloning, NcoI site
underlined
Reverse primer for BmoN221-ZFE cloning, BamHI site
underlined
Reverse primer for BmoN221G2-ZFE cloning, BamHI
site underlined
Reverse primer for BmoN221G4-ZFE cloning, BamHI
site underlined
Reverse primer for BmoR223-ZFE cloning, BamHI site
underlined
Reverse primer for BmoR223G2-ZFE cloning, BamHI
site underlined
Reverse primer for BmoR223G4-ZFE cloning, BamHI
site underlined
Reverse primer for BmoI226-ZFE cloning, BamHI site
underlined
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DE848
DE849
DE850
DE851
DE852
DE853
DE854
DE855
DE856
DE857
DE858
DE859
DE917
DE918
DE919
DE920
DE973
DE974
DE976
DE977
DE978
DE979
DE980

CCGCGGATCCACCACCGATAACCG
GACGAGAGTTTTTCGG
GCCGCCATGGGTAAATCTGGTGTT
TACAAAATC
CTTGGGTCTACCGTTCCCACGCCGC
ATG
CATGCGGCGTGGGAACGGTAGACC
CAAG
CTTGGGTCTACCGTCCCACGCCGC
ATG
CATGCGGCGTGGGACGGTAGACCC
AAG
GCCTTGGGAAATCCCTTCCCACGC
CGCATG
CATGCGGCGTGGGAAGGGATTTCC
CAAGGC
GCCTTGGGAAATCCCTCCCACGCC
GCATG
CATGCGGCGTGGGAGGGATTTCCC
AAGGC
CAGAAACAGCTGGTTTAATAACAT
CATCACCACtaactcg
cgagttaGTGGTGATGATGTTATTAAA
CCAGCTGTTTCTG
CTAGACAACACTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG
CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGTGTTGT
CTAGAAAACACTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG
CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGTGTTTT
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTAGCTACTAC
GCATG
CGTAGTAGCTAACGGTAGACCCAA
GAAAACATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTAGGTCCACATATTTAA
CCTTTTGCATG
CAAAAGGTTAAATATGTGGACCTAG
ACCCAAGAAAACATCTACTGAGCG
TTGT
CTAGACAACACTCAGTAGATGTTT
TCTTGGGTCTAGGTCCACATATTTAA
CCTTTTGCATG
CAAAAGGTTAAATATGTGGACCTA
GACCCAAGAAAACATCTACTGAGT
GTTGT
CTAGAAAACACTCAGTAGATGTTT
TCTTGGGTCTAGGTCCACATATTTAA
CCTTTTGCATG

Reverse primer for BmoI226G2-ZFE cloning, BamHI
site underlined
Forward primer for Bmo-ZFE cloning, NcoI site
underlined
Forward quikchange primer to make the 1.34 I-TevI/ryA
zinc-finger target site
Reverse quikchange primer to make the 1.34 I-TevI/ryA
zinc-finger target site
Forward quikchange primer to make the 1.33 I-TevI/ryA
zinc-finger target site
Reverse quikchange primer to make the 1.33 I-TevI/ryA
zinc-finger target site
Forward quikchange primer to make the 1.34 I-BmoI/ryA
zinc-finger target site
Reverse quikchange primer to make the 1.34 I-BmoI/ryA
zinc-finger target site
Forward quikchange primer to make the 1.33 I-BmoI/ryA
zinc-finger target site
Reverse quikchange primer to make the 1.33 I-BmoI/ryA
zinc-finger target site
Forward quikchange primer to add stops to the 3’-end of
the ryA zinc-finger
Reverse quikchange primer to add stops to the 3’-end of
the ryA zinc-finger
Top strand oligo similar to DE824 with G-23A
substitution
Bottom strand oligo similar to DE825 with C-23T
substitution
Top strand oligo similar to DE824 with G-23A and C27A substitutions
Bottom strand oligo similar to DE825 with C-23T and
G-27T substitutions
Top-strand oligo to clone the hybrid 33-bp I-TevI/9-bp
ryBZf using XbaI and SphI
Bottom-strand oligo to clone the hybrid 33-bp I-TevI/9bp ryBZf using XbaI and SphI
Top strand oligo to clone the hybrid 30-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom strand oligo to clone the hybrid 30-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top strand oligo similar to DE976 with G5A substitution
Bottom strand oligo similar to DE977 with G5A
substitution
Top strand oligo similar to DE976 with C1A and G5A
substitution
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DE981
DE982
DE983
DE991
DE1017
DE1040
DE1042
DE1044
DE1045
DE1056
DE1057
DE1058
DE1059
DE1060
DE1061
DE1062
DE1063
DE1064
DE1065
DE1066
DE1067
DE1068
DE1069

CAAAAGGTTAAATATGTGGACCTAG
ACCCAAGAAAACATCTACTGAGTG
TTTT
CGGTTTCGCCGACGCGCAAGGCTC
CTTTTTGCTGCG
CGCAGCAAAAAGGAGCCTTGCGC
GTCGGCGAAACCG
CGCGTCGACTTAGAATACTCTGCC
CTTGTTC
CGCGGATCCACCACCGTCTGAATG
CTTATGATTAAAG
CGCGGATCCAGAACGTTTCTTAAT
AATTTC
CGCGGATCCATCAGGTCCAAGTTT
AAGC
CGCGGATCCGTTTTTACTTCCGGG
TTTAC
CGCGGATCCATTTCTGCATTTACT
ACAAG
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCGGTCCACATATTTAACC
TTTTGCATG
CAAAAGGTTAAATATGTGGACCGAC
CCAAGAAAACATCTACTGAGCGTT
GT
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGGGTCCACATATTTAACCTT
TTGCATG
CAAAAGGTTAAATATGTGGACCCCCA
AGAAAACATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCCACATATTTAACCTTTT
GCATG
CAAAAGGTTAAATATGTGGACCCAA
GAAAACATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGTTT
TCTGGTCCACATATTTAACCTTTTGC
ATG
CAAAAGGTTAAATATGTGGACCAGA
AAACATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGTTT
TGGTCCACATATTTAACCTTTTGCAT
G
CAAAAGGTTAAATATGTGGACCAAA
ACATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGTTG
GTCCACATATTTAACCTTTTGCATG
CAAAAGGTTAAATATGTGGACCAAC
ATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGGGT
CCACATATTTAACCTTTTGCATG
CAAAAGGTTAAATATGTGGACCCATC
TACTGAGCGTTGT

Bottom strand oligo similar to DE977 with C1A and
G5A substitution
Forward quikchange primer to create E22Q I-OnuI E1
mutant
Reverse quikchange primer to create E22Q I-OnuI E1
mutant
Reverse primer to amplify the I-OnuI E1 gene with a 3’
SalI site
Reverse primer for TevD184G2 cloning, BamHI site
underlined
Reverse primer for TevS114 cloning, BamHI site
underlined
Reverse primer for TevD127 cloning, BamHI site
underlined
Reverse primer for TevN140 cloning, BamHI site
underlined
Reverse primer for TevN169 cloning, BamHI site
underlined
Top-strand oligo to clone the hybrid 28-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 28-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 26-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 26-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 24-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 24-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 22-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 22-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 20-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 20-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 18-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 18-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 16-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 16-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
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DE1070
DE1071
DE1072
DE1073
DE1074
DE1082
DE1085
DE1086
DE1087
DE1088
DE1117
DE1118
DE1121
DE1128
DE1134
DE1135
DE1136
DE1137
DE1154
DE1155
DE1156
DE1157
DE1158
DE1159

CTAGACAACGCTCAGTAGAGGTCC
ACATATTTAACCTTTTGCATG
CAAAAGGTTAAATATGTGGACCTCTA
CTGAGCGTTGT
CTAGACAACGCTCAGTAGGTCCAC
ATATTTAACCTTTTGCATG
CAAAAGGTTAAATATGTGGACCTACT
GAGCGTTGT
CGCGTCGACTTAGTGGTGATGATGG
TGATGGAATACTCTGCCCTTGTTC
GCGAGATCTGGTTCCGCCTATATG
TCCCG
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCTCCCACGCCGCA
TG
CGGCGTGGGAGGTAGACCCAAGA
AAACATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTATCCCACGCCGCATG
CGGCGTGGGATAGACCCAAGAAA
ACATCTACTGAGCGTTGT
GCAGATCTCTAGCATTACGCTAGG
G
GCACTAGTCTTCTCTCATCCGCC
CGTCTAGAATGAAAAGCGGAATTT
ATCAGATT
CGGATATCTTATTAAACCAGCTGT
TTCTGACGCAGG
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTTTCCCACGC
CGCATG
CGGCGTGGGAAAACGGTAGACCCA
AGAAAACATCTACTGAGCGTTGT
CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG
CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGCGTTGT
CTAGAAAACACTCAGTAGATGTTT
TCTTGGGGGTCCACATATTTAACCTT
TTGCATG
CAAAAGGTTAAATATGTGGACCCCCA
AGAAAACATCTACTGAGTGTTTT
CTAGAAAACACTCAGTAGATGTTT
TGGTCCACATATTTAACCTTTTGCAT
G
CAAAAGGTTAAATATGTGGACCAAA
ACATCTACTGAGTGTTTT
CTAGAAAACACTCAGTAGATGTTG
GTCCACATATTTAACCTTTTGCATG
CAAAAGGTTAAATATGTGGACCAAC
ATCTACTGAGTGTTTT

Top-strand oligo to clone the hybrid14-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 14-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 12-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 12-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Reverse primer to amplify the I-OnuI E1 gene with a 3’
his-tag and SalI site
Forward primer to amplify the I-OnuI E1 gene with a 5’
BamHI site
Top-strand oligo to clone the hybrid 32-bp I-TevI/9-bp
ryAZf using XbaI and SphI
Bottom-strand oligo to clone the hybrid 32-bp I-TevI/9bp ryAZf using XbaI and SphI
Top-strand oligo to clone the hybrid 30-bp I-TevI/9-bp
ryAZf using XbaI and SphI
Bottom-strand oligo to clone the hybrid 30-bp I-TevI/9bp ryAZf using XbaI and SphI
Forward primer to amplify target site in pTox with 5’
BglII site to clone into pCS753
Reverse primer to amplify target site in pTox with 3’
SpeI site to clone into pCS753
Forward primer to amplify I-TevI with 5’ XbaI site to
clone into pTAL3
Reverse primer to amplify ryAZF with 3’ EcoRV site to
clone into pTAL3
Top-strand oligo to clone the hybrid 36-bp I-TevI/9-bp
ryAZf using XbaI and SphI
Bottom-strand oligo to clone the hybrid 36-bp I-TevI/9bp ryAZf using XbaI and SphI
Top-strand oligo to clone the hybrid 38-bp I-TevI/9-bp
ryAZf using XbaI and SphI
Bottom-strand oligo to clone the hybrid 38-bp I-TevI/9bp ryAZf using XbaI and SphI
Top-strand oligo to clone the hybrid 26-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 26-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 20-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 20-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
Top-strand oligo to clone the hybrid 18-bp I-TevI/22-bp
I-OnuI E1 using XbaI and SphI
Bottom-strand oligo to clone the hybrid 18-bp I-TevI/22bp I-OnuI E1 using XbaI and SphI
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